You can search products by Ctrl+F by CAT.#, CAS# or product name.
Cat. # |
Description |
Amino Acid Sequence |
CAS # |
CA-1270 |
A-779 |
Asp-Arg-Val-Tyr-Ile-His-D-Ala | |
CA-1271 |
A-A-A-Y-G-G-F-L |
Ala-Ala-Ala-Tyr-Gly-Gly-Phe-Leu | |
CA-1272 |
4A/4B, 5A/5B Peptide |
Ac-Asp-Glu-Met-Glu-Glu-Cys-Ser-Met-Ser-Tyr-NH2 | |
CA-1273 |
2A/2B Dengue Protease Substrate |
Ac-Arg-Thr-Ser-Lys-Lys-Arg-pNA | |
CA-1274 |
4A/4B, Peptide (1) |
Asp-Glu-Met-Glu-Glu-Cys-Ser-Gln-His-Leu-Pro-Tyr-Ile | |
| CA-1279 | 5A/5B Peptide (1) | Glu-Asp-Val-Val-Abu-Cys-Ser-Met-Ser-Tyr | |
| CA-1280 | 5A/5B Peptide (3) | Ac-Glu-Glu-Val-Val-Ala-Cys-pNA | |
CA-1275 |
3/4A, Dengue Protease Substrate |
Ac-Phe-Ala-Ala-Gly-Arg-Lys-pNA | |
CA-1277 |
AbII probe |
Ser-Ala-Pro-Arg-Ala-Thr-Ile-Ser-His-Tyr-Leu-Met-Gly-Gly |
|
CA-1278 |
AbIII probe |
Ser-Ser-Trp-Asp-Met-His-Gln-Phe-Phe-Trp-Glu-Gly-Val-Ser-Arg |
|
| CA-0566 | ABEI | 66612-29-1 | |
CA-1276 |
Abl Cytosolic Substrate |
Glu-Ala-Ile-Tyr-Ala-Ala-Pro-Phe-Ala-Lys-Lys-Lys |
|
| CA-2086 | Abltide | Lys-Lys-Gly-Glu-Ala-Ile-Tyr-Ala-Ala-Pro-Phe-Ala-NH2 | |
| CA-1281 | Ac-5A/5B Peptide | Ac-Glu-Asp-Val-Val-Cys-Cys-Ser-Met-Ser-Tyr-NH2 | |
| CA-1282 | Ac-ACTH(1-17) | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg | |
| CA-1283 | Ac-ACTH(1-14), 10-1-12A | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly | |
CA-1489 |
Ac-Amyloid β-Protein(15-20) amide |
Ac-Gln-Lys-Leu-Val-Phe-Phe-NH2 | |
CA-1291 |
Ac-a-CGRP(19-37)(human) |
Ac-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | |
| CA-2087 | Ac-Adhesin(1025-1044)amide | Ac-Gln-Leu-Lys-Thr-Ala-Asp-Leu-Pro-Ala-Gly-Arg-Asp-Glu-Thr-Thr-Ser-Phe-Val-Leu-Val-NH2 | |
| CA-1286 | Ac-Amylin(8-37), human | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | |
| CA-1287 | Ac-Amylin(8-37), rat | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | |
| CA-2088 | Ac-Amyloid β-Protein(15-20) amide | Ac-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | |
| CA-1284 | Ac-Angiotensinogen(1-14), human | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | |
| CA-1285 | Ac-Angiotensinogen(1-14), porcine | Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | |
| CA-1288 | Ac-[Asn30,Tyr32]-Calcitonin(8-32)(salmon I) | Ac-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Asn-Thr-Tyr-NH2 | 151804-77-2 |
| CA-1289 | Ac-Calpastatin(184-210)(human) | Ac-Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala-NH2 | |
| CA-1290 | Ac-Choline Receptor α1(129-145) | Glu-Ile-Ile-Val-Thr-His-Phe-Pro-Phe-Asp-Glu-Gln-Asn-Cys-Ser-Met-Lys | |
CA-1292 |
Ac-[Cys(Acm)33,42]-EGF(33-42)amide(mouse) |
Ac-Cys(Acm)-Val-Ile-Gly-Tyr-Ser-Gly-Asp-Arg-Cys(Acm)-NH2 | |
CA-1293 |
[Ac-Cys4,D-Phe7,Cys10] a-MSH(4-13), amide |
Ac-Cys-Glu-His-D-Phe-Arg-Trp-Cys-Lys-Pro-Val-NH2 | |
| CA-1296 | Ac-a-Endorphin | Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr | |
CA-1294 |
Ac-D-E |
Ac-Asp-Glu | |
CA-1296 |
Ac-a-Endorphin |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr | |
CA-1297 |
Ac-g-Endorphin |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | |
CA-1298 |
Ac-β-Endorphin, bovine, camel, ovine |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | |
CA-1299 |
Ac-d-Endorphin(bovine, camel, mouse, ovine) |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His | |
CA-1300 |
Ac-β-Endorphin(human) |
Ac-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
CA-1301 |
Ac-Endothelin-1(16-21),human |
Ac-His-Leu-Asp-Ile-Ile-Trp | |
CA-1302 |
Acetalin 1, Opioid Receptor Antagonist 1 |
Ac-Arg-Phe-Met-Trp-Met-Arg-NH2 | |
CA-1303 |
Acetalin 3, Opioid Receptor Antagonist 3 |
Ac-Arg-Phe-Met-Trp-Met-Thr-NH2 | |
| CA-462 |
N-alpha-Acetyl-L-carnosine
|
56353-23-0 |
|
CA-1305 |
Ac-[Leu28,31]-Neuropeptide Y(24-36) |
Ac-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CA-1306 |
Ac-GPK(Ac)-pNA |
Ac-Gly-Pro-Lys(Ac)-pNA | |
CA-1307 |
Ac-GPK-pNA |
Ac-Gly-Pro-Lys-pNA | |
CA-1308 |
Ac-GRP(20-26)(human,porcine, canine) |
Ac-His-Trp-Ala-Val-Gly-His-Leu-NH2 | |
CA-1309 |
Ac-Glutamine |
Ac-Gln | 35305-74-9 |
CA-1310 |
Achatin-1 |
Gly-D-Phe-Ala-Asp | |
CA-1311 |
Ac-Hirudin(55-65)(desulfated) |
Ac-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln | |
CA-1312 |
Ac-IEAR-pNA |
Ac-Ile-Glu-Ala-Arg-pNA | |
CA-1313 |
Ac-IETD-pNA |
Ac-Ile-Glu-Thr-Asp-pNA | |
CA-1314 |
Ac-LEHD-pNA |
Ac-Leu-Glu-His-Asp-pNA | |
CA-1304 |
Ac-[Lys0,Nle3]-g2-MSH amide |
Ac-Lys-Tyr-Val-Nle-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | |
| CA-2089 | Ac-[D-Lys2,Sar3]-Melanotropin-Potentiating Factor | Ac-Lys-D-Lys-Sar-Glu | |
CA-1315 |
Ac-MBP (4-14) Peptide |
Ac-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | |
CA-1316 |
Ac-Neurotrophin Receptor(368-381)amide(human) |
Ac-Ala-Thr-Leu-Asp-Ala-Leu-Leu-Ala-Ala-Leu-Arg-Arg-Leu-Gln-nh2 | |
| CA-2090 | Ac-[Nle4,D-Phe7] a-MSH (4-10), amide | Ac-Nle-Glu-His-D-Phe-Arg-Trp-Gly-NH2 | |
CA-1317 |
Ac-PACAP-38(human, mouse,ovine, porcine, rat) |
Ac-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CA-1318 |
Ac-Pepstatin |
Ac-Val-Val-Sta-Ala-Sta | |
CA-1319 |
Ac-P-G-A |
Ac-Pro-Gly-Ala | |
CA-1320 |
Ac-Phe-Gly-pNA |
Ac-Phe-Gly-Pna | |
| CA-2091 | Ac-[Pro18, Asp21] β- Amyloid(17-21), amide, iAb5p Pro18 Asp21 | Ac-Leu-Pro-Phe-Phe-Asp-NH2 | |
CA-1321 |
Ac-RYYRIK-NH2 |
Ac-Arg-Tyr-Tyr-Arg-Ile-Lys-NH2 | 200959-48-4 |
CA-1322 |
Ac-S-D-K-P |
Ac-Ser-Asp-Lys-Pro | |
CA-1323 |
ACTH(1-4) |
Ser-Tyr-Ser-Met | |
CA-1324 |
ACTH(1-14) |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly | |
CA-1325 |
ACTH(4-9) |
Met-Glu-His-Phe-Arg-Trp | |
CA-1326 |
ACTH(4-11) |
Met-Glu-His-Phe-Arg-Trp-Gly-Lys | |
CA-1327 |
ACT(5-10) |
Glu-His-Phe-Arg-Trp-Gly | |
CA-1328 |
ACTH(22-39) |
Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1329 |
ACTH(11-24) |
Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CA-1330 |
ACTH(34-39) |
Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1331 |
ACTH(1-39)(guinea pig) |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Ala-Asn-Gly-Ala-Glu-Glu-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1332 |
ACTH(1-10), human |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly | |
CA-1333 |
ACTH(1-13), human |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val | |
CA-1334 |
ACTH(1-16), human |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys | |
CA-1335 |
ACTH(1-17), human |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg | |
CA-1336 |
ACTH(1-24), human |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CA-1337 |
ACTH(1-39),human |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1338 |
ACTH(4-10), human |
Met-Glu-His-Phe-Arg-Trp-Gly | |
CA-1339 |
ACTH(7- 38), human |
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu | |
CA-1340 |
ACTH(3-24), human |
Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CA-1341 |
ACTH(6-24), human |
His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CA-1342 |
ACTH(18-39), human |
Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1343 |
ACTH(18-39) (human) (Adrenocorticotropic Hormone) (Biotin) |
BiotinArg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1344 |
ACTH(1-39), rat |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1345 |
ACTH(12-39), rat |
Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Val-Ala-Glu-Asn-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CA-1346 |
ACTH(4-9), Tyr |
Tyr-Met-Glu-His-Phe-Arg-Trp-Gly | |
CA-1347 |
Activity-Dependent Neurotrophic Factor-14 |
Val-Leu-Gly-Gly-Gly-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala | |
CA-1348 |
Activity–Dependent Neurotrophic Factor, ADNF |
Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala | |
CA-1349 |
Activated Protein C(390-404)(human) |
Tyr-Gly-Val-Tyr-Thr-Lys-Val-Ser-Arg-Tyr-Leu-Asp-Trp-Ile-His | |
CA-1295 |
Ac-[D-Trp16] Endothelin-1(16-21), human |
Ac-D-Trp-Leu-Asp-Ile-Ile-Trp | |
CA-1350 |
Ac-[Tyr1,D-Arg2]-GRF(1-29) amide(human) |
Ac-Tyr-D-Arg-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | |
CA-1351 |
Ac-[Tyr1,D-Phe2]-GRF(1-29) amide(human) |
Ac-Tyr-D-Phe-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | |
CA-1352 |
Ac-VEID-pNA |
Ac-Val-Glu-Ile-Asp-pNA | |
CA-1353 |
Acyl Carrier Protein (65-74) (acid) |
Val-Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly | |
CA-1354 |
Acyl Carrier Protein (65-74) (amide) |
Val-Gln-Ala-Ala-Ile-Asp-Tyr-Ile-Asn-Gly-NH2 | |
CA-1355 |
Ac-YVAD-pNA |
Ac-Tyr-Val-Ala-Asp-pNA | 149231-66-3 |
CA-1358 |
Adipokinetic Hormone |
Pyr-Leu-Thr-Phe-Thr-Ser-Trp-Gly-NH2 | |
CA-1359 |
Adipokinetic Hormone, G (AKH-G) |
pyr-Val-Asn-Phe-Ser-Thr-Gly-Trp-NH2 | |
CA-1360 |
Adipokinetic Hormone, AKH,locust |
Pyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2 | |
CA-1361 |
Adipokinetic Hormone II from Schistocera gregaria |
Pyr-Leu-Asn-Phe-Ser-Thr-Gly-Trp-NH2 | |
CA-1362 |
Adipokinetic Hormone II Locusta Migratoria |
Pyr-Leu-Asn-Phe-Ser-Ala-Gly-Trp-NH2 | |
CA-1363 |
Adipokinetic Hormone (Apis mellifera ligustica, Bombyx mori, Heliothis zea, Manduca sexta) |
Glp-Leu-Thr-Phe-Thr-Ser-Ser-Trp-Gly-NH2 | |
CA-1364 |
Adipophilin |
Ser-Val-Ala-Ser-Thr-Ile-Thr-Gly-Val | |
CA-1365 |
ADP-Ribosylation Factor 1, ARF1 (2 - 17) |
Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu | |
CA-1366 |
ADP-Ribosylation Factor 6, ARF6 (2-13) |
Gly-Lys-Val-Leu-Ser-Lys-Ile-Phe-Gly-Asn-Lys-Glu | |
CA-1367 |
ADR1-derived peptide |
Leu-Lys-Lys-Leu-Thr-Arg-Arg-Ala-Ser-Phe-Ser-Gly-Gln | |
CA-1368 |
Adrenomedullin (1-12), human |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg | |
CA-1369 |
Adrenomedullin (1-52), human |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2（Disulfide bridge Cys16-Cys21） | |
CA-1370 |
Adrenomedullin (13-52), human |
Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp- Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 (Disulfide bridge:Cys16-Cys21） | |
CA-1371 |
Adrenomedullin (22-52), human |
Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | |
CA-1372 |
Adrenomedullin (26-52), human) |
Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Asn-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 | |
CA-1373 |
Adrenomedullin (16-31) (human, pig) |
Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-NH2 (Disulfide bridge:Cys1-Cys6) | |
CA-1374 |
Adrenomedullin (1- 52), porcine |
Tyr-Arg-Gln-Ser-Met-Asn-Asn-Phe-Gln-Gly-Leu-Arg-Ser-Phe-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Val-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Val-Ala-Pro-Arg-Ser-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2 (Disulfide bridge Cys16-Cys21) | |
CA-1375 |
Adrenomedullin (1-50), rat |
Tyr-Arg-Gln-Ser-Met-Asn-Gln-Gly-Ser-Arg-Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2(Disulfide bridge Cys14-Cys19 ) | |
| CA-2092 | Adrenomedullin (11-50) (rat) | Ser-Thr-Gly-Cys-Arg-Phe-Gly-Thr-Cys-Thr-Met-Gln-Lys-Leu-Ala-His-Gln-Ile-Tyr-Gln-Phe-Thr-Asp-Lys-Asp-Lys-Asp-Gly-Met-Ala-Pro-Arg-Asn-Lys-Ile-Ser-Pro-Gln-Gly-Tyr-NH2(Disulfide bridge Cys4-Cys9 ) | |
CA-1356 |
Adrenorphin |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-NH2 | |
CA-1357 |
Adrenorphin, Free Acid |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val | |
| CA-2093 | AF-1 | Lys-Asn-Glu-Phe-Ile-Arg-Phe-NH2 | |
| CA-2094 | A-F-A | Ala-Phe-Ala | |
CA-1376 |
A-18-F-NH2 |
Ala-Gly-Glu-Gly-Leu-Ser-Ser-Pro-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 | 99588-52-0 |
CA-1377 |
AF-2, nematode |
Lys-His-Glu-Tyr-Leu-Arg-Phe-NH2 | |
CA-1378 |
A-G-D-V |
H-Ala-Gly-Asp-Val | |
CA-1379 |
AGRP (25-51) |
Leu-Ala-Pro-Met-Glu-Gly-Ile-Arg-Arg-Pro-Asp-Gln-Ala-Leu-Leu-Pro-Glu-Leu-Pro-Gly-Leu-Gly-Leu-Arg-Ala-Pro-Leu | |
CA-1380 |
AGRP (54-82) |
Thr-Thr-Ala-Glu-Gln-Ala-Glu-Glu-Asp-Leu-Leu-Gln-Glu-Ala-Gln-Ala-Leu-Ala-Glu-Val-Leu-Asp-Leu-Gln-Asp-Arg-Glu-Pro-Arg | |
CA-1381 |
AGRP (87-132), human |
Ac-Cys-Val-Arg-Leu-His-Glu-Ser-Cys-Leu-Gly-Gln-Gln-Val-Pro-Cys-Cys-Asp-Pro-Cys-Ala-Thr-Cys-Tyr-Cys-Arg-Phe-Phe-Asn-Ala-Phe-Cys-Tyr-Cys-Arg-Lys-Leu-Gly-Thr-Ala-Met-Asn-Pro-Cys-Ser-Arg-Thr | |
| CA-2095 | A-H-A | Ala-His-Ala | |
CA-1382 |
A-K-R-R-R-L-S-S-L-R-A |
Ala-Lys-Arg-Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala | |
CA-1383 |
AKT/PKB/Rac - Protein Kinase Substrate |
Ala-Arg-Lys-Arg-Glu-Arg-Thr-Tyr-Ser-Phe-Gly-His-His-Ala | |
CA-1384 |
Akt Specific Substrate Peptide, Akt/PKB |
Arg-Pro-Arg-Ala-Ala-Thr-Phe | |
| CA-2096 | A-L-A | Ala-Leu-Ala | |
CA-1385 |
[Ala31, Aib32]-Neuropeptide Y (porcine) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | |
| CA-2097 | D-Ala-D-Ala | D-Ala-D-Ala | |
CA-1386 |
[Ala5, β-Ala8]-α-Neurokinin Fragment 4-10 |
Asp-Ala-Phe-Val-ß-Ala-Leu-Met-NH2 | 127633-71-0 |
| CA-2098 | [Ala13]-Apelin-13 | Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Ala | |
| CA-2099 | [D-Ala2, D-Arg6] Dynorphin A, (1-13), porcine | Tyr-D-Ala-Gly-Phe-Leu-D-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | |
| CA-2100 | [Ala9] Autocamtide 2; Autocamtide-2-Related Inhibitory Peptide | Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Ala-Val-Asp-Ala-Leu | |
CA-1387 |
[β-Ala70]-C3a (70-77) |
β-Ala-Ser-His-Leu-Gly-Leu-Ala-Arg | |
CA-1388 |
[Ala286]-Calmodulin-Dependent Protein Kinase II (281-302) ((Ala286)-CaMK-II (281-302)) |
Met-His-Arg-Gln-Glu-Ala-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala | |
CA-1391 |
[D-Ala2]-β-Casomorphin(1-3) amide |
Tyr-D-Ala-Phe-NH2 | |
CA-1389 |
[D-Ala2]-β-Casomorphin(1-4) amide (bovine) |
Tyr-D-Ala-Phe-Pro-NH2 | |
| CA-2101 | [D-Ala2]-β-Casomorphin(1-5) amide (bovine) | Tyr-D-Ala-Phe-Pro-Gly-NH2 | |
| CA-2102 | [D-Ala2]-β-Casomorphin(1-5), bovine | Tyr-D-Ala-Phe-Pro-Gly | |
| CA-2103 | [D-Ala2]-β-Casomorphin(1-6), bovine | Tyr-D-Ala-Phe-Pro-Gly-Pro | |
CA-1392 |
[D-Ala2] Deltorphin I |
Tyr-D-Ala-Phe-Asp-Val-Val-Gly-NH2 | 122752-15-2 |
CA-1394 |
[D-Ala2] Deltorphin II |
Tyr-D-Ala-Phe-Glu-Val-Val-Gly-NH2 | 122752-16-3 |
CA-1398 |
[D-Ala2] Dynorphin A(1-9), porcine |
Tyr-D-Ala-Gly-Phe-Leu-Arg-Arg-Ile-Arg | |
CA-1399 |
[Ala18] Endothelin-1, human |
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Ala-Ile-Ile-Trp | |
CA-1400 |
[D-Ala2]-GRF(1-29)amide(human) |
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | 89453-59-8 |
CA-1401 |
[Ala8]-Humanin, [Ala8]-HN, Shna |
Met-Ala-Pro-Arg-Gly-Phe-Ser-Ala-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | |
CA-1402 |
[D-Ala2,Hyp4,Tyr5]-β-Casomorphin(1-5) amide |
Tyr-D-Ala-Phe-Hyp-Tyr-NH2 | |
| CA-2104 | A-L-A-L | Ala-Leu-Ala-Leu | |
| CA-2105 | D-Ala-Leu | D-Ala-Leu | |
CA-1403 |
[D-Ala2,Leu5,Arg6] Enkephalin |
Tyr-D-Ala-Gly-Phe-Leu-Arg | |
CA-1404 |
[D-Ala2]Leu-Enkephalin |
Tyr-D-Ala-Gly-Phe-Leu | 64963-01-5 |
| CA-1405 | [D-Ala2]Leu-Enkephalin, amide | Tyr-D-Ala-Gly-Phe-Met-NH2 | |
CA-1395 |
[D-Ala2,D-Leu5]Enkephalin amide |
Tyr-D-Ala-Gly-Phe-D-Leu-NH2 | |
CA-1406 |
[Ala11,D-Leu15]-Orexin B(human) |
Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Ala-Gln-Arg-Leu-D-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | |
CA-1407 |
[Ala9,10, Lys11,12]Glycogen Synthase(1-12) |
Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys | 291524-04-4 |
CA-1408 |
[Ala4]-MBP(1-11) |
Ac-Ala-Ser-Gln-Ala-Arg-Pro-Ser-Gln-Arg-His-Gly | |
CA-1409 |
[Ala81]-MBP(74-85) |
Gln-Lys-Ser-Gln-Arg-Ser-Gln-Ala-Glu-Asn-Pro-Val | |
CA-1410 |
[D-Ala2,Met5]-ß-Casomorphin(1-5), bovine |
Tyr-D-Ala-Phe-Pro-Met | |
CA-1411 |
[D-Ala2,Met5]-β-Casomorphin(1-5) , bovine ,amide |
Tyr-D-Ala-Phe-Pro-Met-NH2 | |
| CA-2106 | [D-Ala2] Met-Enkephalin | Tyr-D-Ala-Gly-Phe-Met | |
CA-1396 |
[D-Ala2,D-Met5]Enkephalin |
Tyr-D-Ala-Gly-Phe-D-Met | |
| CA-2107 | [Ala2] Met-Enkephalin, amide | Tyr-Ala-Gly-Phe-Met-NH2 | |
CA-1412 |
[β-Ala8]-Neurokinin A (4-10) |
Asp-Ser-Phe-Val-β-Ala-Leu-Met-NH2 | |
CA-1413 |
[Ala3,11,18, Nle7] Endothelin-1, human |
Cys-Ser-Ala-Ser-Ser-Leu-Nle-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Cys-His-Leu-Ala-Ile-Ile-Trp | |
CA-1414 |
[Ala1]-PAR-4(1-6)amide(mouse) |
Ala-Tyr-Pro-Gly-Lys-Phe-NH2 | |
CA-1415 |
[Ala1]-PAR-4(1-6)(mouse) |
Ala-Tyr-Pro-Gly-Lys-Phe | 380900-00-5 |
CA-1416 |
[D-Ala1] Peptide T, amide |
D-Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-NH2 | 106362-34-9 |
CA-1417 |
[Ala144]-PLP (139-151) A144-PLP(139-151) |
His-Ser-Leu-Gly-Lys-Ala-Leu-Gly-His-Pro-Asp-Lys-Phe | |
| CA-351 | Ala-Pro Hydrate | 13485-59-1 | |
CA-1397 |
[D-Ala2,D-Pro4,Tyr5]-β-Casomorphin (1-5), amide |
Tyr-D-Ala-Phe-D-Pro-Tyr-NH2 | |
CA-0464 |
Alarelin acetate |
79561-22-1 |
|
CA-1418 |
[D-Ala4]-Substance P(4-1) |
D-Ala-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | 181381-50-2 |
| CA-2108 | [D-Ala2,4,Tyr5] -β-Casomorphin(1-5), amide, bovine | Tyr-D-Ala-Phe-D-Ala-Tyr-NH2 | |
| CA-2109 | [Ala11,22,28]-VIP(human, bovine, porcine, rat) | His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Ala-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Ala-Leu-Asn-Ser-Ile-Leu-Ala-NH2 | |
CA-1419 |
Aldosterone Secretion Inhibiting Factor(1-35) (bovine) |
Ala-Leu-Arg-Gly-Pro-Lys-Met-Met-Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr (Disulfide bridge:Cys13-Cys29) | |
CA-1420 |
Allatostatin I |
Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu-NH2 | 123338-10-3 |
CA-1421 |
Allatostatin II |
Gly-Asp-Gly-Arg-Leu-Tyr-Ala-Phe-Gly-Leu-NH2 | 123338-11-4 |
CA-1423 |
Allatostatin III |
Gly-Gly-Ser-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 | 123338-12-5 |
CA-1424 |
Allatostatin IV |
Asp-Arg-Leu-Tyr-Ser-Phe-Gly-Leu-NH2 | 123338-13-6 |
CA-1425 |
Allatostatin VI |
Tyr-Pro-Gln-Glu-His-Arg-Phe-Ser-Phe-Gly-Leu-NH2 | |
CA-1426 |
Allatostatin VII |
Asp-Gly-Arg-Met-Tyr-Ser-Phe-Gly-Leu-NH2 | |
CA-1427 |
Allatostatin I(free acid) |
Ala-Pro-Ser-Gly-Ala-Gln-Arg-Leu-Tyr-Gly-Phe-Gly-Leu | |
CA-1428 |
Allatotropin, Mas -AT |
Gly-Phe-Lys-Asn-Val-Glu-Met-Met-Thr-Ala-Arg-Gly-Phe-NH2 (Disulfide bridge:Cys2-Cys7) | |
CA-1429 |
Alloferon 1 |
His-Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly | 347884-61-1 |
CA-1430 |
Alloferon 2 |
Gly-Val-Ser-Gly-His-Gly-Gln-His-Gly-Val-His-Gly | |
CA-0314 |
Aln-Gln |
39537-23-0 |
|
CA-1431 |
Alternate Syntide |
Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ser-Ser-Leu-Pro-Gly-Leu-NH2 | |
CA-1432 |
Alytesin |
Pyr-Gly-Arg-Leu-Gly-Thr-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
| CA-0559 | 7-Amino-4-(trifluoromethyl)coumarin | 53518-15-3 | |
CA-1433 |
β-Amyloid(1-11) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu | |
CA-1434 |
β-Amyloid(1-15) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln | |
CA-1435 |
β-Amyloid(1-16) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys | |
CA-1436 |
β-Amyloid(1-28) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | |
CA-1437 |
β-Amyloid(1-33) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly | |
CA-1438 |
β-Amyloid(1-34) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu | |
CA-1439 |
β-Amyloid(1-37) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly | |
CA-1440 |
β-Amyloid(1-38) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | |
CA-1441 |
β-Amyloid(1-39) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val | |
CA-1442 |
β-Amyloid(1-49) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala-Thr-Val-Ile-Val-Ile-Thr-Leu | |
CA-1443 |
β-Amyloid(2-40) |
Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1444 |
β-Amyloid(4-10) |
Phe-Arg-His-Asp-Ser-Gly-Tyr | |
CA-1445 |
β-Amyloid(7-22) |
Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu | |
CA-1446 |
β-Amyloid(8-38) |
Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly | |
CA-1447 |
β-Amyloid(10-20) |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | |
CA-1448 |
β-Amyloid(10-35) |
Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | |
CA-1449 |
β-Amyloid(11-22) |
Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu | |
CA-1450 |
β-Amyloid(11-40) |
Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1451 |
β-Amyloid(12-20) |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | |
CA-1452 |
β-Amyloid(12-28) |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | |
CA-1453 |
β-Amyloid(13-27) |
His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | |
CA-1454 |
β-Amyloid(15-21) |
Gln-Lys-Leu-Val-Phe-Phe-Ala | |
CA-1455 |
β-Amyloid 16-20) |
Lys-Leu-Val-Phe-Phe | |
CA-1457 |
β-Amyloid(16-23) |
Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp | |
CA-1458 |
β-Amyloid(16-26) |
Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser | |
CA-1459 |
β-Amyloid(17-21) |
Leu-Val-Phe-Phe-Ala | |
CA-1460 |
β-Amyloid(17-40) |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1461 |
β-Amyloid(17-42) |
Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | |
CA-1462 |
β-Amyloid(18-28) |
Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | |
CA-1463 |
β-Amyloid(22-35) |
Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | |
CA-1464 |
β-Amyloid(25-35) |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met | |
CA-1465 |
β-Amyloid(30-16) |
Cys-Thr-Phe-Val-Arg-Thr-His-Ile-Phe-Cys-Lys-Glu-His-Gln-Phe | |
CA-1466 |
β-Amyloid(31-35) |
Ile-Ile-Gly-Leu-Met | |
CA-1467 |
β-Amyloid(32-35) |
Ile-Gly-Leu-Met | |
CA-1468 |
β-Amyloid(35-25) |
Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly | |
CA-1469 |
β-Amyloid(37-43) |
Gly-Gly-Val-Val-Ile-Ala-Thr | |
CA-1470 |
β-Amyloid(40-1) |
Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp | |
CA-1471 |
β-Amyloid/A4 Protein Precursor 770(394-410) |
Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Trp-Met | |
CA-1472 |
Amyloid β/A4 Protein Precursor770(667-676) |
Ser-Glu-Val-Lys-Met-Asp-Ala-Glu-Phe-Arg | |
CA-1473 |
Amyloid β/A4 Protein Precursor770(740-770) |
Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys-Met-Gln-Gln-Asn-Gly-Tyr-Glu-Asn-Pro-Thr-Tyr-Lys-Phe-Phe-Glu-Gln-Met-Gln-Asn | |
CA-1474 |
β-Amyloid/A4 Protein Precusor(APP)(319-335) |
Ala-Lys-Glu-Arg-Leu-Glu-Ala-Lys-His-Arg-Glu-Arg-Met-Ser-Gln-Val-Met | |
CA-1475 |
β-Amyloid/A4 Protein Precursor (APP)(328-332) |
Arg-Glu-Arg-Met-Ser | |
CA-1476 |
β-Amyloid/A4 Protein Precursor (APP) (96-110), analog |
Ac-Asn-Trp-Cys-Lys-Arg-Gly-Arg-Lys-Gln-Cys-Lys-Thr-His-Pro-His-NH2 (Disulfide bridges Cys98-Cys105 ) | |
CA-1477 |
Amyloid Bri Protein (1-23) |
Glu-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser(Disulfide bridge:Cys5-Cys22) | |
CA-1478 |
Amyloid Bri Protein (1-34) |
Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn(Disulfide bridge: Cys5-Cys22) | |
CA-1479 |
Amyloid Bri Protein (1-34) (reduced) |
Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Ser-Arg-Thr-Val-Lys-Lys-Asn-Ile-Ile-Glu-Glu-Asn | |
CA-1480 |
Amyloid Bri Protein Precursor277 (89-106) |
Cys-Gly-Ile-Lys-Tyr-Ile-Lys-Asp-Asp-Val-Ile-Leu-Asn-Glu-Pro-Ser-Ala-Asp | |
CA-1481 |
β-Amyloid (12-28) -Cys |
Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Cys | |
CA-1482 |
Amyloid Dan Protein (1-34) |
Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-TyrDisulfide bond | |
CA-1483 |
Amyloid Dan Protein (1-34) (reduced) |
Pyr-Ala-Ser-Asn-Cys-Phe-Ala-Ile-Arg-His-Phe-Glu-Asn-Lys-Phe-Ala-Val-Glu-Thr-Leu-Ile-Cys-Phe-Asn-Leu-Phe-Leu-Asn-Ser-Gln-Glu-Lys-His-Tyr | |
| CA-0463 | β-Amyloid(1-42), Human | Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | |
CA-1484 |
β-Amyloid (1-14), mouse, rat |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His | |
CA-1485 |
β-Amyloid(1-16), mouse, rat |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-NH2 | |
CA-1486 |
Amyloid P Component (33-38) amide |
Phe-Thr-Leu-Cys-Phe-Arg-NH2 | 180387-76-2 |
CA-1487 |
β-Amyloid P Component (27 -38), amide |
Glu-Lys-Pro-Leu-Gln-Asn-Phe-Thr-Leu-Cys-Phe-Arg-NH2 | |
CA-1488 |
β-Amyloid Peptide (1-42), rat |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | |
CA-1490 |
Amyloid β-Protein (1-43) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala-Thr | 134500-80-4 |
CA-1491 |
Amyloid β-Protein (20-29) |
Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly | |
CA-1492 |
Amyloid β-Protein (6-20) |
His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe | |
CA-1493 |
Amyloid β-Protein (29-40) |
Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1494 |
Amyloid β-Protein (33-42) |
Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | |
CA-1495 |
Amyloid β-Protein (42-1) |
Ala-Ile-Val-Val-Gly-Gly-Val-Met-Leu-Gly-Ile-Ile-Ala-Gly-Lys-Asn-Ser-Gly-Val-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-His-Val-Glu-Tyr-Gly-Ser-Asp-His-Arg-Phe-Glu-Ala-Asp | |
CA-1496 |
Amyloid β-Protein (25-35) amide |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-NH2 | |
CA-1497 |
β-Amyloid Protein Precursor (657 - 676) |
His-His-Gly-Val-Val-Glu-Val-Asp-Ala-Ala-Val-Thr-Pro-Glu-Glu-Arg-His-Leu-Ser-Lys | |
CA-1498 |
β-Amyloid Protein Precursor 770 (135 - 155) |
Phe-Leu-His-Gln-Glu-Arg-Met-Asp-Val-Cys-Glu-Thr-His-Leu-His-Trp-His-Thr-Val-Ala-Lys | |
CA-1499 |
β-Amyloid (1-40), rat |
Asp-Ala-Glu-Phe-Gly-His-Asp-Ser-Gly-Phe-Glu-Val-Arg-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1500 |
β-Amyloid (1-40), Ultra Pure, TFA |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1501 |
Amylin,human |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | |
CA-1502 |
Amylin (1-13) (human) |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala(Disulfide bridge:Cys2-Cys7) | |
CA-1503 |
Amylin (8-37), human |
Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-His-Ser-Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr | |
CA-1504 |
Amylin (20-29) (human) |
Ser-Asn-Asn-Phe-Gly-Ala-Ile-Leu-Ser-Ser | |
CA-1505 |
Amylin (IAPP) (Feline) |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Ile-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Ala-Ile-Leu-Ser-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2（Disulfide bridge:Cys2-Cys7） | |
CA-1506 |
Amylin, rat |
Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2(Disulfide bridge:Cys2-Cys7） | |
CA-1507 |
Amylin (8-37),rat |
Ala-Thr-Gln-Arg-Leu-Ala-Asn-Phe-Leu-Val-Arg-Ser-Ser-Asn-Asn-Leu-Gly-Pro-Val-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Tyr-NH2 | |
CA-1508 |
Anantin (linear sequence) |
Gly-Phe-Ile-Gly-Trp-Gly-Asn-Asp-Ile-Phe-Gly-His-Tyr-Ser-Gly-Asp-Phe (Peptide beta bond between Gly1-Asp8 ) | 133658-45-4 |
CA-1390 |
α-ANF(1-28), human |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bridge Cys7-Cys23) | 91917-63-4 |
CA-1509 |
Angiogenin (108-122) |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg | |
CA-1510 |
Angiogenin (108-123) |
Glu-Asn-Gly-Leu-Pro-Val-His-Leu-Asp-Gln-Ser-Ile-Phe-Arg-Arg-Pro | |
CA-1511 |
Angiotensin (1-5) |
Asp-Arg-Val-Tyr-Ile | |
CA-1512 |
Angiotensin (1-9) |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His | |
CA-1513 |
Angiotensin A |
Ala-Arg-Val-Tyr-Ile-His-Pro-Phe | |
CA-1514 |
Angiotensin I/II (1-6) |
Asp-Arg-Val-Tyr-Ile-His | |
CA-1515 |
Angiotensin I/II (3-7) |
Val-Tyr-Ile-His-Pro | |
CA-1516 |
Angiotensin I/II (5-8) |
Ile-His-Pro-Phe | |
CA-1517 |
Angiotensin, Canine, Rat |
Asp-Arg-Val-Tyr-Ile-His-Pro | |
CA-1518 |
Angiotensin Converting Enzyme Inhibitor |
Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro | |
CA-1519 |
Angiotensin I [Des-Asp1-](Human) |
Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | |
CA-1520 |
Angiotensin I, human |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | |
CA-1521 |
Angiotensin I-Converting Enzyme Substrate |
Bz-Phe-Ala-Pro | |
CA-1522 |
Angiotensin II Antipeptide |
Glu-Gly-Val-Tyr-Val-His-Pro-Val | 121379-63-3 |
CA-1523 |
Angiotensin II human |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe | |
CA-1524 |
Angiotensin III, human |
H-Arg-Val-Tyr-Ile-His-Pro-Phe | |
CA-1525 |
Angiotensin II (1-4), human |
Asp-Arg-Val-Tyr | |
CA-1526 |
Angiotensin II (3-8), human |
Val-Tyr-Ile-His-Pro-Phe | |
CA-1527 |
Angiotensin II (4-8), human |
H-Tyr-Ile-His-Pro-Phe | |
| CA-2110 | Angiotensinogen (1-13) | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His | |
CA-1528 |
Angiotensinogen (1-14),human |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Asn | |
CA-1529 |
Angiotensinogen (1-14),Porcine |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser | |
CA-1530 |
Angiotensinogen (1-14) ,Rat |
Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Tyr-Tyr-Ser | |
CA-1531 |
Angiotensin II Receptor, AT2,Amino Terminal Fragment |
Met-Lys-Asp-Asn-Phe-Ser-Phe-Ala-Ala-Thr-Ser-Arg-Asn-Ile-Thr-Ser-Ser | |
CA-1532 |
Angiotensin II [Sar1 Ile8] |
Sar-Arg-Val-Tyr-Ile-His-Pro-Ile | |
CA-1533 |
Angiotensin II Substrate |
Asp-Arg-Val-Tyr(PO3H2)-Ile-His-Pro-Phe | |
CA-1534 |
Angiotensin II type 1 receptor (181 - 187), AT1, ATE. |
Ala-Phe-His-Tyr-Glu-Ser-Gln | |
CA-1535 |
Annexin 1 (ANXA - 1; Ac 2 - 12) |
Ac-Ala-Met-Val-Ser-Glu-Phe-Leu-Lys-Gln-Ala-Trp | |
CA-1536 |
Anorexigenic Peptide |
Pyr-His-Gly | |
| CA-1618 | mini-ANP | Met-Cys-His-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Ser-Cys-Tyr-Arg-NH2 (Disulfide bond) | |
CA-1537 |
ANP (1-30), frog |
Ala-Pro-Arg-Ser-Met-Arg-Arg-Ser-Ser-Asp-Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Phe（Disulfide bridge:Cys11-Cys27） | |
CA-1538 |
ANP (1-11), rat |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg | |
CA-1539 |
Antagonist G |
Arg-D-Trp-N-Me-Phe-D-Trp-Leu-Met-NH2 | |
CA-1540 |
Antho-Rfamide |
Pyr-Gly-Arg-Phe-NH2 | 114056-25-6 |
CA-1541 |
Antho-Rwamide I |
Pyr -Ser-Leu-Arg-Trp-NH2 | |
CA-1542 |
Antho-Rwamide II |
Pyr -Gly-Leu-Arg-Trp-NH2 | |
| CA-0468 | Antide acetate | 112568-12-4 | |
CA-1543 |
Antiestrogen |
Cys-Asn-Val-Val-Pro-Leu-Tyr(PO3H2)-Asp-Leu-Leu-Leu-Glu | |
CA-1544 |
Anti-Flt1 Peptide |
Gly-Asn-Gln-Trp-Phe-Ile | |
CA-1545 |
Antifreeze Polypeptide (AFP) (HPLC-6), Winter Flounder |
Asp-Thr-Ala-Ser-Asp-Ala-Ala-Ala-Ala-Ala-Ala-Leu-Thr-Ala-Ala-Asn-Ala-Lys-Ala-Ala-Ala-Glu-Leu-Thr-Ala-Ala-Asn-Ala-Ala-Ala-Ala-Ala-Ala-Ala-Thr-Ala-Arg | |
CA-1546 |
Anti-Inflammatory Peptide 1 |
Met-Gln-Met-Lys-Lys-Val-Leu-Asp-Ser | 118850-71-8 |
CA-1547 |
Anti-Inflammatory Peptide 2 |
His-Asp-Met-Asn-Lys-Val-Leu-Asp-Leu | 118850-72-9 |
CA-1548 |
Anti-Inflammatory Peptide 3 |
Met-Gln-Met-Asn-Lys-Val-Leu-Asp-Ser | 118850-73-0 |
CA-1549 |
Anti-Kentsin |
Thr-Arg-Lys-Arg | 73430-00-9 |
CA-1550 |
Antioxidant peptide A |
Pro-His-Cys-Lys-Arg-Met | |
CA-1551 |
Antioxidant peptide B |
Thr-Arg-Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu | |
CA-1552 |
Anxiety Peptide |
Gln-Ala-Thr-Val-Gly-Asp-Val-Asn-Thr-Asp-Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys | |
CA-1553 |
Apamin |
Cys-Asn-Cys-Lys-Ala-Pro-Glu-Thr-Ala-Leu-Cys-Ala-Arg-Arg-Cys-Gln-Gln-His-NH2（Disulfide bridge:Cys1-Cys11,Cys3-Cys15） | 24345-16-2 |
CA-1554 |
Apelin-12 |
Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | |
CA-1555 |
Apelin-15 (63 - 75) |
Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met | |
CA-1556 |
Apelin-15 (63-77) |
Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | |
CA-1557 |
Apelin-36, human |
Leu-Val-Gln-Pro-Arg-Gly-Ser-Arg-Asn-Gly-Pro-Gly-Pro-Trp-Gln-Gly-Gly-Arg-Arg-Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | 252642-12-9 |
CA-1558 |
Apelin-13, human, bovine |
Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe-OH | |
CA-1559 |
[APLILSR]pPSA |
Ala-Pro-Leu-Ile-Leu-Ser-Arg-Ile-Val-Gly-Gly-Trp-Glu-Cys-Glu-Lys | |
CA-1560 |
Aquaporin-2 (254-267), human |
Arg-Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-Arg | |
CA-1561 |
Aquaporin-2 (255-271), human |
Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-Arg-Gly-Ser-Lys-Ala | |
CA-1562 |
Aquaporin-2 (255-271), rat |
Gln-Ser-Val-Glu-Leu-His-Ser-Pro-Gln-Ser-Leu-Pro-Arg-Gly-Thr-Lys-Ala | |
CA-1563 |
[Arg91, Ala96]-MBP (87-99), human |
Val-His-Phe-Phe-Arg-Asn-Ile-Val-Thr-Ala-Arg-Thr-Pro | |
CA-1564 |
[Arg3]-Amyloid β-Protein (1-40) |
Asp-Ala-Arg-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CA-1565 |
[D-Arg6,Asn10]-MCH (6-16) amide (human, mouse, rat) |
Ac-D-Arg-Cys-Met-Leu-Asn-Arg-Val-Tyr-Arg-Pro-Cys-NH2 (Disulfide bridge Cys2-Cys11) | |
CA-1566 |
[Arg15,Asp16,25,Pro18,21,23, Val22,Ile24]-Amyloid b-Protein (15-25) |
Arg-Asp-Leu-Pro-Phe-Phe-Pro-Val-Pro-Ile-Asp | |
CA-1567 |
[Arg8]-Conopressin G |
Cys-Phe-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6) | |
CA-1568 |
[Arg3,14]CTX IV (3-14) |
Arg-Asn-Arg-Leu-Ile-Pro-Pro-Phe-Trp-Lys-Thr-Arg-NH2 | |
CA-1579 |
[D-Arg2] Dermorphin (1-4), amide |
Tyr-D-Arg-Phe-Gly-NH2 |
90549-86-3 |
CA-1569 |
[D-Arg6]-Dynorphin A (1-13), porcine |
Tyr-Gly-Gly-Phe-Leu-D-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | |
CA-1570 |
[D-Arg8]-Dynorphin A (1-13), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-D-Arg-Arg-Pro-Lys-Leu-Lys | |
CA-1571 |
[Arg8,des-Gly-NH29]-Vasopressin |
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg (Disulfide bridge Cys1-Cys6) | 37552-33-3 |
CA-1572 |
[D-Arg0,Hyp3,D-Phe7]-Bradykinin |
D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg | |
CA-1573 |
[D-Arg0,Hyp2,3,D-Phe7]-Bradykinin |
D-Arg-Arg-Hyp-Hyp-Gly-Phe-Ser-D-Phe-Phe-Arg | |
CA-1574 |
[D-Arg0,Hyp3,D-Phe7,Leu8]-Bradykinin |
D-Arg-Arg-Pro-Hyp-Gly-Phe-Ser-D-Phe-Leu-Arg | |
| CA-0469 | Argiprssin acetate | 113-79-1 | |
| CA-0471 | Argireline acetate | 616204-22-9 | |
CA-1575 |
[D-Arg2]-Kyotorphin |
Tyr-D-Arg | 70904-57-3 |
CA-1576 |
[Arg14,20,21, Leu16]-PACAP (1-27), amide, human, ovine, rat |
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Arg-Gln-Leu-Ala-Val-Arg-Arg-Tyr-Leu-Ala-Ala-Val-Leu-NH2 | |
CA-1577 |
[Arg14,20,21, Leu16]-PACAP (1-27)-Gly-Lys-Arg, amide, human, ovine, rat |
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Arg-Gln-Leu-Ala-Val-Arg-Arg-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-NH2 | |
CA-1578 |
[D-Arg2,Lys4]-Dermorphin (1-4), amide |
Tyr-D-Arg-Phe-Lys-NH2 | |
CA-1580 |
[Arg0] Met-Enkephalin |
Arg-Tyr-Gly-Gly-Phe-Met | |
CA-1581 |
[Arg8]-a-Neo-Endorphin (1-8) |
Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Arg | |
CA-1582 |
[D-Arg25]-Neuropeptide Y, human, rat |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-D-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CA-1583 |
[D-Arg1,D-Phe5,D-Trp7,9,Leu11]-Substance P |
D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | 96736-12-8 |
CA-1584 |
[D-Arg1,D-Phe5,D-Trp7,11]-Substance P |
D-Arg-Pro-Lys-Pro-D-Phe-Gln-D-Trp-Phe-Gly-Leu-D-Trp-NH2 | |
CA-1585 |
[D-Arg1,D-Pro2,D-Phe7,D-His9]-Substance P |
D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-His-Leu-Met-NH2 | 115760-58-2 |
CA-1586 |
[D-Arg1,D-Pro2,D-Trp7,9,Leu11]-Substance P |
D-Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | 84676-91-5 |
CA-1587 |
[D-Arg2,Sar4]-Dermorphin (1-4) |
Tyr-D-Arg-Phe-Sar | |
CA-1588 |
[Arg3] Substance P |
Arg-Pro-Arg-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CA-1589 |
[D-Arg1,D-Trp5,7,9,Leu11]-Substance P |
D-Arg-Pro-Lys-Pro-D-Trp-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | |
CA-1590 |
[D-Arg1,D-Trp7,9,Leu11]-Substance P |
D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | |
CA-1591 |
[Arg8]-Vasopressin |
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge Cys1-Cys6) | |
CA-1592 |
[Arg8]-Vasopressin (4-9) |
Gln-Asn-Cys-Pro-Arg-Gly-NH2 | |
CA-1593 |
[Arg8]-Vasopressin (free acid) |
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly (Disulfide bridge Cys1-Cys6) | |
| CA-2111 | [Arg8]-Vasotocin | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-NH2 （Disulfide bridge Cys1-Cys6） | |
CA-1594 |
[Asn5]-Delta-Sleep Inducing Peptide |
Trp-Ala-Gly-Gly-Asn-Ala-Ser-Gly-Glu | |
CA-1595 |
[Asn670,Leu671]-Amyloid b/A4 Protein Precursor770 (667-675) |
Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe | |
CA-1596 |
[Asn670,Leu671]-Amyloid b/A4 Protein Precursor770 (667-676) |
Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg | |
CA-1597 |
[Asn10,Leu11,D-Trp12]-pTH-Related Protein (7-34) amide (human, rat) |
Leu-Leu-His-Asn-Leu-D-Trp-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | |
CA-1598 |
[Asn76] PTH (64-84), human |
Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | |
CA-1599 |
[Asn370]-Tyrosinase (368-376) |
Tyr-Met-Asn-Gly-Thr-Met-Ser-Gln-Val | |
CA-1600 |
[Asn1,Val5]-Angiotensin II |
Asn-Arg-Val-Tyr-Val-His-Pro-Phe | 20071-00-5 |
CA-1601 |
[D-Asp1]-Amyloid-β-Protein (1-42) |
D-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | |
| CA-2112 | [Asp5,6,Me-Phe8] Substance P | Asp-Asp-Phe-Me-Phe-Gly-Leu-Met-NH2 | |
CA-1602 |
(Asp371)-Tyrosinase (369-377) (human) |
Tyr-Met-Asp-Gly-Thr-Met-Ser-Gln-Val | 168650-46-2 |
CA-1603 |
AT1A, Angiotensin II receptor,(225 - 237) |
Ala-Tyr-Glu-Ile-Gln-Lys-Asn-Lys-Pro-Arg-Asn-Asp-Asp | |
| CA-0474 | Atosiban acetate | 90779-69-4 | |
CA-1604 |
Atrial Natriuretic Factor (1-29) (chicken) |
Met-Met-Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Ile-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Met-Gly-Cys-Asn-Gly-Ser-Arg-Lys-Asn(Disulfide bridge Cys7-Cys23 ) | |
CA-1605 |
Atrial Natriuretic Factor (3-28) (human) |
Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys5-Cys21 ) | |
CA-1606 |
Atrial Natriuretic Factor (4-28) (human) |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys7-Cys23 ) | 95896-08-5 |
CA-1607 |
Atrial Natriuretic Factor (1-24) (frog) |
Ser-Ser-Asp-Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe (Disulfide bond) | |
CA-1608 |
Atrial Natriuretic Peptide (1-28),rat |
Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr（Disulfide bridge:Cys7-Cys23） | |
CA-1609 |
Atrial Natriuretic Peptide (4-24),frog |
Cys-Phe-Gly-Ser-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Met-Gly-Cys-Gly-Arg-Arg-Phe(Disulfide bridge: Cys1-Cys17) | 118691-44-4 |
CA-1610 |
Atrial Natriuretic Peptide (126-149) (rat) |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg（Disulfide bridge:Cys4-Cys20） | 91421-87-3 |
CA-1611 |
Atrial Natriuretic Peptide (126-150) (rat) |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bridge: Cys4-Cys20) | 90052-57-6 |
CA-1612 |
Atrial Natriuretic Peptide Substrate, [pS6] ANF 1 – 28 |
Ser-Leu-Arg-Arg-Ser-pSer-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge 7-23) | |
CA-1613 |
Atriopeptin I (rat) |
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser(Disulfide bridge:Cys3-Cys19) | |
CA-1614 |
Atriopeptin III (rat) |
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge:Cys3-Cys19) | |
CA-1615 |
Atriopeptin II (rat, rabbit, mouse) |
Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg(Disulfide bridge:Cys3-Cys18) | |
CA-1616 |
Autocamtide-2 [KKALRRQETVDAL] |
Lys-Lys-Ala-Leu-Arg-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu | |
CA-1617 |
Autocamtide-3 [KKALHRQETVDAL] |
Lys-Lys-Ala-Leu-His-Arg-Gln-Glu-Thr-Val-Asp-Ala-Leu | |
| CA-2113 | A-VI-5 | Val-Glu-Ser-Ser-Lys | |
| CA-2114 | 2B-(A) | Biotin-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-Ala-Pro-Gln-Leu | |
CB-2328 |
Bactenecin, bovine |
Arg-Leu-Cys-Arg-Ile-Val-Val-Ile-Arg-Val-Cys-Arg(Disulfide bridge:Cys3-Cys11) | |
CB-2329 |
BAD (103-126), human |
Asn-Leu-Trp-Ala-Ala-Gln-Arg-Tyr-Gly-Arg-Glu-Leu-Arg-Arg-Met-Ser-Asp-Glu-Phe-Val-Asp-Ser-Phe-Lys | |
CB-2330 |
BAD (103-127), human |
Asn-Leu-Trp-Ala-Ala-Gln-Arg-Tyr-Gly-Arg-Glu-Leu-Arg-Arg-Met-Ser-Asp-Glu-Phe-Val-Asp-Ser-Phe-Lys-Lys | |
CB-2331 |
α-Bag Cell Peptide (1-7) |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr | |
CB-2332 |
α-Bag Cell Peptide (1-8) |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser | |
CB-2333 |
α-Bag Cell Peptide (1-9) |
Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser-Leu | |
CB-2334 |
β-Bag Cell Peptide |
Arg-Leu-Arg-Phe-His | |
CB-2335 |
γ-Bag Cell Peptide |
Arg-Leu-Arg-Phe-Asp | |
CB-2336 |
BAGE (2 - 10) |
Ala-Ala-Arg-Ala-Val-Phe-Leu-Ala-Leu | |
CB-2337 |
Bak-BH3 |
Gly-Gln-Val-Gly-Arg-Gln-Leu-Ala-Ile-Ile-Gly-Asp-Asp-Ile-Asn-Arg | |
CB-2338 |
BAM-18P |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln | |
CB-2339 |
BAM-22P |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly | |
CB-2340 |
BAM-12P (7-12) |
Arg-Val-Gly-Arg-Pro-Glu | |
CB-2341 |
BAM-12P, Bovine Adrenal Medulla Docosapeptide |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu | |
CB-2342 |
BAM 3200 Peptide E |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu | |
CB-2343 |
Band 3 Protein (547-553) (human) |
His-Pro-Leu-Gln-Lys-Thr-Tyr | |
CB-2344 |
Band 3 Protein (824-829) (human) |
Tyr-Val-Lys-Arg-Val-Lys | |
CB-2345 |
4B/5A Peptide |
Glu-Cys-Thr-Thr-Pro-Cys-Ser-Gly-Ser-Trp-Leu-Arg-Asp | |
CB-2346 |
Bax-BH3 |
Lys-Lys-Leu-Ser-Glu-Cys-Leu-Lys-Arg-Ile-Gly-Asp-Glu-Leu-Asp-Ser | |
CB-2347 |
Bax-BH3L63A |
Lys-Lys-Leu-Ser-Glu-Cys-Ala-Lys-Arg-Ile-Gly-Asp-Glu-Leu-Asp-Ser | |
| CB-3582 | BDC 2.5(A) |
Gly-Lys-Lys-Val-Ala-Ala-Pro-Ala-Trp-Ala-Arg-Met-Gly | |
CB-2348 |
2B/3, Dengue Protease Substrate |
Ac-Glu-Val-Lys-Lys-Gln-Arg-pNA | |
| CB-0652 | BEpyBr |
878-23-9 | |
CB-2349 |
bFGF Inhibitory Peptide |
Ala-Pro-Ser-Gly-His-Tyr-Lys-Gly | |
CB-2350 |
bFGF Inhibitory Peptide II |
Met-Trp-Tyr-Arg-Pro-Asp-Leu-Asp-Glu-Arg-Lys-Gln-Gln-Lys-Arg-Glu | |
CB-2351 |
bFGF (119-126), Basic Fibroblast Growth Factor,human, bovine |
Lys-Arg-Thr-Gly-Gln-Tyr-Lys-Leu | |
CB-2352 |
Bid BH3 |
Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | |
CB-2353 |
Bid BH3 Peptide |
Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | |
CB-2354 |
Bid BH3-r8 |
D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-Gly-Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | |
CB-2355 |
Bid BH3-r9 |
Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Gly-Glu-Asp-Ile-Ile-Arg-Asn-Ile-Ala-Arg-His-Leu-Ala-Gln-Val-Gly-Asp-Ser-Met-Asp-Arg | |
CB-2356 |
Big Endothelin-1 Fragment (22-38) (human) |
Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser | |
CB-2357 |
Big Endothelin-1 (1-38), human |
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser(Disulfide bridge:Cys1-Cys15,Cys3-Cys11) | |
CB-2358 |
Big Endothelin-1 (1-39),porcine |
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp-Val-Asn-Thr-Pro-Glu-His-Ile-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser (Disulfide bridge: Cys1-Cys15,Cys3-Cys11) | |
CB-2359 |
Big Endothelin-1 (22-39), rat |
Val-Asn-Thr-Pro-Glu-Arg-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Ser-Arg-Ser | |
CB-2360 |
Big Gastrin-1, human |
Pyr-Leu-Gly-Pro-Gln-Gly-Pro-Pro-His-Leu-Val-Ala-Asp-Pro-Ser-Lys-Lys-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CB-2361 |
Biotin-ACTH (1-39), human |
Biotin-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro-Asn-Gly-Ala-Glu-Asp-Glu-Ser-Ala-Glu-Ala-Phe-Pro-Leu-Glu-Phe | |
CB-2362 |
Biotin-Amyloid β-Protein (1-40) |
Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CB-2363 |
Biotin-Amyloid β-Protein (1-42) |
Biotin-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | |
CB-2364 |
Biotin-Angiotensin I/II (1-7) |
Biotin-Asp-Arg-Val-Tyr-Ile-His-Pro | |
CB-2365 |
Biotin-Angiotensin I, human |
Biotin-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu | |
CB-2366 |
Biotin-(Arg8)-Vasopressin |
Biotin-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2(Disulfide bridge:Cys1-Cys6) | |
CB-2367 |
Biotin-Atrial Natriuretic Peptide (1-28), human,porcine |
Biotin-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys7-Cys23) | |
CB-2368 |
Biotin-Bombesin |
Biotin-Glu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CB-2369 |
Biotin-Bradykinin |
Biotin-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CB-2370 |
Biotin-Calcitonin (salmon I) |
Biotin-Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7) | |
CB-2371 |
Biotin-a-CGRP (canine, mouse, rat) |
Biotin-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys6) | |
CB-2372 |
Biotin-a-CGRP (human) |
Biotin-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 (Disulfide bridge:Cys2-Cys6) | |
CB-2373 |
Biotin-CRF (human, rat) |
Biotin-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 | |
CB-2374 |
Biotin-(Cys1,Lys(biotinyl)18)-Calcitonin (human) |
Biotin-Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys(bio)-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge: Cys1-Cys6) | |
CB-2375 |
Biotin-Dynorphin A (1-17) |
Biotin-Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
CB-2376 |
Biotin-β-Endomorphin, human |
Biotin-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
CB-2377 |
Biotin-Exendin 4 |
Biotin-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | |
CB-2378 |
Biotin-Galanin, human |
Biotin-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser | |
CB-2379 |
Biotin-Gastrin (1-17) |
Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CB-2380 |
Biotin-Gastrin Releasing Peptide, human |
Biotin-Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CB-2381 |
Biotin-[Gln1]-Gastrin I (human) |
Biotin-Gln-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CB-2382 |
Biotin-[Glu1]-Gastrin I (human) (phosphorylated) |
Biotin-Glu-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-pTyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CB-2383 |
Biotin-Glucagon (1-29),bovine, human, porcine |
Biotin-His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | |
CB-2384 |
Biotin-Glucagon-Like Peptide 1 (7-36), amide,human |
Biotin-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | |
CB-2385 |
Biotin-IkB Inhibitor, amide |
Biotin-Asp-Arg-His-Asp-Ser-Gly-Leu-Asp-Ser-Met-Lys-Asp-NH2 | |
CB-2386 |
Biotin-Insulin Receptor (1142-1153) |
Biotin-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | |
CB-2387 |
Biotin-Insulin Receptor (1142-1153), amide |
Biotin-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys-NH2 | |
CB-2388 |
Biotin-Intermedin (human) |
Biotin-Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 |
|
CB-2389 |
Biotin-Intermedin (rat) |
Biotin-Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | |
CB-2390 |
Biotin-Kemptide |
Biotin-Leu-Arg-Arg-Ala-Ser-Leu-Gly | |
CB-2391 |
Biotin-Kinase Domain of Insulin Receptor (2) |
Biotin-Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | |
CB-2392 |
Biotin-Kinase Domain of Insulin Receptor (5) |
Biotin-Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-pTyr-pTyr-Arg-Lys | |
CB-2394 |
Biotin-LC-Kemptide |
Biotin-LC-Leu-Arg-Arg-Ala-Ser-Leu-Gly | |
CB-2395 |
Biotin-LC-Neurogranin (28-43) |
Biotin-LC-Ala-Ala-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Met-Ala-Arg-Lys-Lys | |
CB-2396 |
Biotin-LC-Protein Kinase G Substrate; Biotin-LC-G-Subtide |
Biotin-LC-Gln-Lys-Arg-Pro-Arg-Arg-Lys-Asp-Thr-Pro | |
CB-2397 |
Biotin-(Leu8,D-Trp22,Tyr25)-Somatostatin-28 |
Biotin-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Leu-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Tyr-Thr-Ser-Cys(Disulfide bridge:Cys17-Cys28) | |
CB-2398 |
Biotin-MBP(94-102) |
Biotin-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | |
| CB-1381 | Biotin-MBP Derivatized Peptide | Biotin-LC-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | |
CB-2399 |
Biotinyl-MCH (salmon) |
Biotin-Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val (Disulfide bridge:Cys5-Cys14) | |
CB-2400 |
Biotin-Neurokinin A |
Biotin -His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
CB-2401 |
Biotin-Neurokinin B |
Biotin-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | |
CB-2402 |
Biotin-Neuromedin B |
Biotin-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | |
CB-2403 |
Biotin-Neuromedin S (human) |
Biotin-Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CB-2404 |
Biotin-Neuromedin S (rat) |
Biotin-Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CB-2405 |
Biotin-Neuropeptide Y (human,rat) |
Biotin-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CB-2406 |
Biotin-Obestatin (human) |
Biotin-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 | |
CB-2407 |
Biotin-Obestatin (rat) |
Biotin-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 | |
CB-2408 |
Biotin-PACAP (1-38), amide,human, ovine, rat |
Biotin-His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CB-2409 |
Biotin-Pancreatic Polypeptide,human |
Biotin-Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CB-2410 |
Biotin-Parathyroid Hormone (1-34), human |
Biotin-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
CB-2411 |
Biotin-Phosphorylated MBP (94-102) |
Biotin-Ala-Pro-Arg-Thr(po3h2)-Pro-Gly-Gly-Arg-Arg | |
CB-2412 |
Biotin-RR-SRC, Insulin Receptor Tyrosine Kinase Substrate |
Biotin-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly | |
CB-2413 |
Biotin-Secretin, human |
Biotin-His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2 | |
CB-2414 |
Biotin-Somatostatin-14 |
Biotin-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide bridge:Cys3-Cys14) | |
CB-2415 |
Biotin-Substance P |
Biotin-Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CB-2416 |
Biotin-[Tyr0]-Orexin B, mouse,rat |
Biotin-Tyr-Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | |
CB-2417 |
Biotin-Tyrosine Kinase Peptide 1, amide |
Biotin-Lys-Val-Glu-Lys-Ile-Gly-Glu-Gly-Thr-Tyr-Gly-Val-Val-Tyr-Lys-NH2 | |
CB-2418 |
Biotin-VIP (human, bovine,porcine, rat) |
Biotin-His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
| CB-1080 | Bis(sulfosuccinimidyl)adipate
sodium salt |
881415-69-6 | |
| CB-1081 | Bis(sulfosuccinimidyl)oxalate sodium salt | 215597-87-8 | |
| CB-1082 | Bis(sulfosuccinimidyl)succinate sodium salt | 215597-96-9 | |
| CB-0649 | Bivalirudin trifluoroacetate | 128270-60-0 | |
CB-2419 |
BNP-32, human |
Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His(Disulfide bridge:Cys10-Cys26) | |
CB-2420 |
BNP-26 (porcine) |
Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr(Disulfide bridge:Cys4-Cys5) | |
CB-2421 |
BNP-32 ,porcine |
Ser-Pro-Lys-Thr-Met-Arg-Asp-Ser-Gly-Cys-Phe-Gly-Arg-Arg-Leu-Asp-Arg-Ile-Gly-Ser-Leu-Ser-Gly-Leu-Gly-Cys-Asn-Val-Leu-Arg-Arg-Tyr(Disulfide bridge:Cys10-Cys26) | |
CB-2422 |
BNP (1-21), Pro (Human) |
His-Pro-Leu-Gly-Ser-Pro-Gly-Ser-Ala-Ser-Asp-Leu-Glu-Thr-Ser-Gly-Leu-Gln-Glu-Gln-Arg | |
CB-2423 |
BNP-32, rat |
Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp- Gly-Leu-Arg-Leu-Phe(Disulfide bridge:Cys10-Cys26) | |
CB-2424 |
BNP-45 ,rat |
Ser-Gln-Asp-Ser-Ala-Phe-Arg-Ile-Gln-Glu-Arg-Leu-Arg-Asn-Ser-Lys-Met-Ala-His-Ser-Ser-Ser-Cys-Phe-Gly-Gln-Lys-Ile-Asp-Arg-Ile-Gly-Ala-Val-Ser-Arg-Leu-Gly-Cys-Asp-Gly-Leu-Arg-Leu-Phe(Disulfide bridge:Cys23-Cys39) | |
CB-2425 |
Boc-(Asp(OBzl)16)-Gastrin I (13-17) (human) |
Boc-Gly-Trp-Met-Asp(OBzl)-Phe-NH2 | |
CB-2426 |
Boc-Cholecystokinin Octapeptide (3-8) |
Boc-Met-Gly-Trp-Met-Asp-Phe-NH2 | 23446-11-9 |
CB-2427 |
Boc-Cholecystokinin Octapeptide (desulfated) |
Boc-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | 25687-34-7 |
CB-2428 |
Boc-FAAGRK-AMC |
Boc-Phe-Ala-Ala-Gly-Arg-Lys-AMC | |
CB-2429 |
Boc-F-L-F-L-F |
Boc-Phe-Leu-Phe-Leu-Phe | |
| CB-1351 | Boc-Gly-Pro-OH |
14296-92-5 | |
| CB-1352 | Boc-Gly-Val-OH |
28334-73-8 | |
CB-2430 |
Boc-GRR-AMC |
Boc-Gly-Arg-Arg-AMC | |
CB-2431 |
Boc-PRR-AMC |
Boc-Pro-Arg-Arg-AMC | |
CB-2432 |
Boc-RRR-AMC |
Boc-Arg-Arg-Arg-AMC | |
CB-2433 |
Bombesin |
Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CB-2434 |
Bombesin (8-14) |
Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CB-2435 |
Bombinin-like Peptide (BLP -1) |
Gly-Ile-Gly-Ala-Ser-Ile-Leu-Ser-Ala-Gly-Lys-Ser-Ala-Leu-Lys-Gly-Leu-Ala-Lys-Gly-Leu-Ala-Glu-His-Phe-Ala-Asn-NH2 | |
CB-2436 |
Bone Matrix Proteins |
Glu-Ile-Asn-Leu-Ser-His-Asn-Lys | |
| CB-0650 | BOP |
56602-33-6 | |
| CB-0651 | BOP-Cl | 68641-49-6 | |
CB-2437 |
Bovine Pineal Antireproductive Peptide |
Thr-Ser-Lys | |
CB-2438 |
BPDEtide [RKISASEFDRPLR] |
Arg-Lys-Ile-Ser-Ala-Ser-Glu-Phe-Asp-Arg-Pro-Leu-Arg | |
CB-2439 |
BPP 5a |
Pyr-Lys-Trp-Ala-Pro | 30505-63-6 |
CB-2440 |
BPP 9a |
Pyr-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro | |
| CB-2843 | 2B-(pS) | Biotin-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-pSer-Pro-Gln-Leu | |
CB-2441 |
BQ-3020 |
Ac-Leu-Met-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | |
CB-2442 |
Bradykinin |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | 6846-03-3 |
CB-2443 |
Bradykinin (1-3) |
Arg-Pro-Pro | |
CB-2444 |
Bradykinin (1-5) |
Arg-Pro-Pro-Gly-Phe | |
CB-2445 |
Bradykinin (1-6) |
Arg-Pro-Pro-Gly-Phe-Ser | |
CB-2446 |
Bradykinin (1-7) |
Arg-Pro-Pro-Gly-Phe-Ser-Pro | |
CB-2447 |
Bradykinin (2-7) |
Pro-Pro-Gly-Phe-Ser-Pro | |
CB-2448 |
Bradykinin [Des-Arg1] |
Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CB-2449 |
Bradykinin [Des-Arg9] |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe | |
CB-2450 |
Bradykinin [Hyp3] |
Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg | |
CB-2451 |
Bradykinin-Like Neuropeptide (Aplysia californica) |
Met-Lys-Arg-Ser-Arg-Gly-Pro-Ser-Pro-Arg-Arg | |
CB-2452 |
Bradykinin-Like Neuropeptide (3-11) (Aplysia californica) |
Arg-Ser-Arg-Gly-Pro-Ser-Pro-Arg-Arg | |
CB-2453 |
Bradykinin Potentiator B; Angiotensin I Converting Enzyme Inhibitor |
Pyr-Gly-Leu-Pro-Pro-Arg-Pro-Lys-Ile-Pro-Pro | |
CB-2454 |
Bradykinin Potentiator C |
Pyr-Gly-Leu-Pro-Pro-Gly-Pro-Pro-Ile-Pro-Pro | 30953-20-9 |
CB-2455 |
Brain Derived Acidic Fibroblast Growth Factor (1-11); FGF acidic (1-11) (bovine brain) |
Phe-Asn-Leu-Pro-Leu-Gly-Asn-Tyr-Lys-Lys-Pro | |
CB-2456 |
Brain Derived Acidic Fibroblast Growth Factor (102-111); FGF acidic (102-111) (bovine brain) |
His-Ala-Glu-Lys-His-Trp-Phe-Val-Gly-Leu | |
CB-2457 |
Brain Derived Basic Fibroblast Growth Factor (1-24) |
Pro-Ala-Leu-Pro-Glu-Asp-Gly-Gly-Ser-Gly-Ala-Phe-Pro-Pro-Gly-His-Phe-Lys-Asp-Pro-Lys-Arg-Leu-Tyr | |
CB-2458 |
Brain injury Derived Neurotrophic Peptide(3) BINP |
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala | |
CB-2459 |
Brain Injury Derived Neurotrophic Peptide |
Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 | |
CB-2460 |
Brevinin–1 |
Phe-Leu-Pro-Val-Leu-Ala-Gly-Ile-Ala-Ala-Lys-Val-Val-Pro-Ala-Leu-Phe-Cys-Lys-Ile-Thr-Lys-Lys-Cys(Disulfide bridge: Cys18-Cys24) | |
| CB-0653 | BroP | 50296-37-2 | |
| CB-3851 | 2B-(S) | Biotin-Arg-Arg-Ala-Ala-Glu-Glu-Leu-Asp-Ser-Arg-Ala-Gly-Ser-Pro-Gln-Leu | |
| CB-1078 | BS3 |
82436-77-9 | |
CB-2461 |
BTK derived peptide |
Lys-Lys-Val-Val-Ala-Leu-Tyr-Asp-Tyr-Met-Pro-Met-Asn-NH2 | |
CB-2462 |
BTM-P1 |
Val-Ala-Pro-Ile-Ala-Lys-Tyr-Leu-Ala-Thr-Ala-Leu-Ala-Lys-Trp-Ala-Leu-Lys-Gln-Gly-Phe-Ala-Lys-Leu-Lys-Ser | |
CB-2463 |
Buccalin |
Gly-Met-Asp-Ser-Leu-Ala-Phe-Ser-Gly-Gly-Leu-NH2 | 116786-35-7 |
CB-2465 |
Bursin |
Lys-His-Gly-NH2 | |
| CB-0605 | Buserelin acetate | 68630-75-1 | |
CC-1406 |
C3a (70-77) |
Ala-Ser-His-Leu-Gly-Leu-Ala-Arg | |
CC-1407 |
C3a (72-77) (human) |
His-Leu-Gly-Leu-Ala-Arg | |
CC-1408 |
Cadherin Peptide, avian |
Leu-Arg-Ala-His-Ala-Val-Asp-Val-Asn-Gly-NH2 | |
CC-1409 |
Caerulein (desulfated) |
Pyr-Gln-Asp-Tyr-Thr-Gly-Trp-Met-Asp-Phe-NH2 | 20994-83-6 |
CC-1410 |
Calcineurin Autoinhibitory Fragment |
Ile-Thr-Ser-Phe-Glu-Glu-Ala-Lys-Gly-Leu-Asp-Arg-Ile-Asn-Glu-Arg-Met-Pro-Pro-Arg-Arg-Asp-Ala-Met-Pro | 148067-21-4 |
CC-1412 |
Calcineurin Substrate |
Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu | |
CC-1413 |
Calcitonin, chicken |
Cys-Ala-Ser-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7） | |
| CC-1577 | Calcitonin, eel | Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro-NH2(Disulfide bridge:Cys1-Cys7) | |
CC-1414 |
Calcitonin Gene Related Peptide, chicken |
Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Asp-Phe-Leu-Ser-Arg-Ser-Gly-Gly-Val-Gly-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | |
CC-1415 |
Calcitonin Gene Related Peptide II, human |
Ala-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Met-Val-Lys-Ser-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | |
CC-1416 |
Calcitonin Gene Related Peptide (8-37), human |
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | 119911-68-1 |
CC-1417 |
Calcitonin Gene Related Peptide, rat |
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | |
CC-1418 |
Calcitonin Gene Related Peptide II, rat |
Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2(Disulfide bridge Cys2-Cys7) | |
CC-1419 |
Calcitonin Gene Related Peptide (8-37), rat |
Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CC-1420 |
Calcitonin, human |
Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Phe-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ala-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge: Cys1-Cys7) | 21215-62-3 |
CC-1421 |
Calcitonin, porcine |
Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Ser-Ala-Tyr-Trp-Arg-Asn-Leu-Asn-Asn-Phe-His-Arg-Phe-Ser-Gly-Met-Gly-Phe-Gly-Pro-Glu-Thr-Pro-NH2 (Disulfide bridge: Cys1-Cys7) | 12321-44-7 |
CC-1422 |
Calcitonin, rat |
Cys-Gly-Asn-Leu-Ser-Thr-Cys-Met-Leu-Gly-Thr-Tyr-Thr-Gln-Asp-Leu-Asn-Lys-Phe-His-Thr-Phe-Pro-Gln-Thr-Ser-Ile-Gly-Val-Gly-Ala-Pro-NH2(Disulfide bridge:Cys1-Cys7) | 11118-25-5 |
CC-1423 |
Calcitonin, salmon |
Cys-Ser-Asn-Leu-Ser-Thr-Cys-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2(Disulfide bridge Cys1-Cys7) | 47931-85-1 |
CC-1424 |
Calcitonin (8-32) (salmon I) |
Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asn-Thr-Gly-Ser-Gly-Thr-Pro-NH2 | 155069-90-2 |
CC-1425 |
Calcitonin N-Terminal Flanking Peptide, human; N-Procalcitonin |
Ala-Pro-Phe-Arg-Ser-Ala-Leu-Glu-Ser-Ser-Pro-Ala-Asp-Pro-Ala-Thr-Leu-Ser-Glu-Asp-Glu-Ala-Arg-Leu-Leu-Leu-Ala-Ala-Leu-Val-Gln-Asp-Tyr-Val-Gln-Met-Lys-Ala-Ser-Glu-Leu-Glu-Gln-Glu-Gln-Glu-Arg-Glu-Gly-Ser-Ser-Leu-Asp-Ser-Pro-Arg-Ser | |
CC-1426 |
Calcitonin C-Terminal Adjacent Peptide, rat |
Asp-Met-Ala-Lys-Asp-Leu-Glu-Thr-Asn-His-His-Pro-Tyr-Phe-Gly-Asn | |
CC-1427 |
Calcium/Calmodulin Dependent Protein Kinase II - g(345-358) |
Lys-Ser-Asp-Gly-Gly-Val-Lys-Lys-Arg-Lys-Ser-Ser-Ser-Ser | |
CC-1428 |
Calmodulin-Dependent Protein Kinase II (281-289) |
Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys | |
CC-1429 |
Calmodulin-Dependent Protein Kinase II (281-309) |
Met-His-Arg-Gln-Glu-Thr-Val-Asp-Cys-Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala | |
CC-1430 |
Calmodulin-Dependent Protein Kinase II (290-309) |
Leu-Lys-Lys-Phe-Asn-Ala-Arg-Arg-Lys-Leu-Lys-Gly-Ala-Ile-Leu-Thr-Thr-Met-Leu-Ala | |
CC-1431 |
Calcium-Like Peptide |
Lys-Ser-Asp-Gly-Gly-Val-Lys-Lys-Arg-Lys-Ser-Ser-Ser-Ser | |
CC-1432 |
Caloxin 2A1 |
Val-Ser-Asn-Ser-Asn-Trp-Pro-Ser-Phe-Pro-Ser-Ser-Gly-Gly-Gly-NH2 | |
CC-1433 |
Calpain Inhibitor Peptide |
Asp-Pro-Met-Ser-Ser-Thr-Tyr-Ile-Glu-Glu-Leu-Gly-Lys-Arg-Glu-Val-Thr-Ile-Pro-Pro-Lys-Tyr-Arg-Glu-Leu-Leu-Ala | 128578-18-7 |
CC-1434 |
cAMP Dependent PK Inhibitor (5-22), amide |
Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2 | |
CC-1435 |
cAMP Dependent PK Inhibitor (5-24) |
Thr-Thr-Tyr-Ala-Asp-Phe-Ile-Ala-Ser-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-His-Asp | |
CC-1436 |
cAMP Dependent Protein Kinase Substrate |
Arg-Arg-Lys-Ala-Ser-Gly-Pro | |
CC-1437 |
CAP-18, rabbit |
Gly-Leu-Arg-Lys-Arg-Leu-Arg-Lys-Phe-Arg-Asn-Lys-Ile-Lys-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Gln-Gly-Leu-Leu-Pro-Lys-Leu-Ala-Pro-Arg-Thr-Asp-Tyr | |
CC-1438 |
Carassin (Carrassius Auratus) |
Ser-Pro-Ala-Asn-Ala-Gln-Ile-Thr-Arg-Lys-Arg-His-Lys-Ile-Asn-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
| CC-0589 | 1,1'-Carbonyldipyrrolidine | 81759-25-3 | |
CC-1439 |
α-Casein (90-95) |
Arg-Tyr-Leu-Gly-Tyr-Leu | 83471-50-5 |
CC-1440 |
β-Casein (90-96) |
Arg-Tyr-Leu-Gly-Tyr-Leu-Glu | |
CC-1441 |
Casein Kinase II Assay Kit |
Arg-Arg-Arg-Asp-Asp-Asp-Ser-Asp-Asp-Asp | |
CC-1442 |
Casein Kinase II Receptor Peptide |
Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | |
CC-1443 |
Casein Kinase II Substrate |
Arg-Arg-Arg-Glu-Glu-Glu-Thr-Glu-Glu-Glu | |
CC-1444 |
α-Casomorphin (1-2) |
Tyr-Pro | |
CC-1445 |
β-Casomorphin (1-3) |
Tyr-Pro-Phe | |
CC-1446 |
β-Casomorphin (1-3) amide |
Tyr-Pro-Phe-NH2 | |
CC-1447 |
β-Casomorphin (1-4) amide (bovine) |
Tyr-Pro-Phe-Pro-NH2 | |
CC-1448 |
β-Casomorphin (1-5) amide (bovine) |
Tyr-Pro-Phe-Pro-Gly-NH2 | |
CC-1449 |
β-Casomorphin, bovine |
Tyr-Pro-Phe-Pro-Gly-Pro-Ile | |
CC-1450 |
β-Casomorphin (1-4) (bovine) |
Tyr-Pro-Phe-Pro | |
CC-1451 |
β-Casomorphin (1-5) (bovine) |
Tyr-Pro-Phe-Pro-Gly | |
CC-1452 |
β-Casomorphin (1-6) (bovine) |
Tyr-Pro-Phe-Pro-Gly-Pro | |
CC-1453 |
β-Casomorphin, human |
Tyr-Pro-Phe-Val-Glu-Pro-Ile | |
CC-1454 |
Caspase 3 Substrate 1m (Apopain), fluorogenic; Ac-DEVD-AMC |
Ac-Asp-Glu-Val-Asp-AMC | |
CC-1455 |
Caspase 2 Substrate,chromogenic; Ac-VDQQD-pNA |
Ac-Val-Asp-Gln-Gln-Asp-pNA | |
CC-1456 |
Caspase 3 Substrate,chromogenic; Ac-VQVD-pNA |
Ac-Val-Gln-Val-Asp-Pna | |
CC-1457 |
Caspase 3 Substrate,Colorimetric |
Ac-Asp-Glu-Val-Asp-pNA | |
CC-1458 |
Caspase 2 Substrate 1m (ICH-1), fluorogenic; Ac-VDVAD-AMC |
Ac-Val-Asp-Val-Ala-Asp-AMC | |
CC-1459 |
Caspase 1 Substrate 1m (ICE), fluorogenic; Ac-YEVD-AMC |
Ac-Tyr-Glu-Val-Asp-AMC | |
CC-1460 |
Caspase 1 Substrate 2m (ICE), fluorogenic; Ac-YVAD-AMC |
Ac-Tyr-Val-Ala-Asp-AMC | |
CC-1461 |
Caspase 1 Substrate 1 (ICE), chromogenic; Ac-YEVD-pNA |
Ac-Tyr-Glu-Val-Asp-pNA | |
CC-1462 |
Catch-Relaxing Peptide (CARP) |
Ala-Met-Pro-Met-Leu-Arg-Leu-NH2 | |
CC-1463 |
Cathepsin G (77-83) |
His-Pro-Gln-Tyr-Asn-Gln-Arg | |
CC-1464 |
Cathepsin S substrate |
Ac-Lys-Gln-Lys-Leu-Arg-AMC | |
CC-1465 |
CB-TH |
Arg-Trp-Lys-Ile-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Gly-Ser-Tyr-Cys-Asn-Arg-Arg-Thr-Gly-Lys-Cys-Gln-Arg-Met | |
CC-1466 |
CC Chemokine Receptor 3 Fragment II |
Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys | |
CC-1467 |
CC Chemokine Receptor 3 Fragment I, amide |
Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-Glu-Lys-Ala-Asp-Thr-Arg-nh2 | |
CC-1468 |
CC Chemokine Receptor 3 Fragment II, amide |
Met-Thr-Thr-Ser-Leu-Asp-Thr-Val-Glu-Thr-Phe-Gly-Thr-Thr-Ser-Tyr-Tyr-Asp-Asp-Val-Gly-Leu-Leu-Cys-NH2 | |
CC-1469 |
CDC25C |
Lys-Lys-Lys-Val-Ser-Arg-Ser-Gly-Leu-Tyr-Arg-Ser-Pro-Ser-Met-Pro-Glu-Asn-Leu-Asn-Arg-Pro-Arg | |
CC-1470 |
CD36 (93-110)-Cys |
Tyr-Arg-Val-Arg-Phe-Leu-Ala-Lys-Glu-Asn-Val-Thr-Gln-Asp-Ala-Glu-Asp-Asn-Cys | |
CC-1471 |
C. difficile Toxin B (8-16) |
Gln-Leu-Glu-Lys-Met-Ala-Asn-Val-Arg | |
CC-1472 |
C. difficile Toxin B (192-207) |
Ala-Gln-Arg-Glu-Glu-Asn-Pro-Glu-Leu-Ile-Ile-Asp-Asp-Ile-Val-Lys | |
CC-1473 |
C. difficile Toxin B (232-241) |
Ile-Thr-Gln-Asn-Ser-Gly-Asn-Asp-Val-Arg | |
CC-1474 |
C. difficile Toxin B (248-262) |
Asn-Gly-Glu-Ser-Phe-Asn-Leu-Tyr-Glu-Gln-Glu-Leu-Val-Glu-Arg | |
CC-1475 |
C. difficile Toxin B (392-401) |
Asp-Ser-Tyr-Cys-Ser-Asn-Leu-Ile-Val-Lys | |
CC-1476 |
C. difficile Toxin B (529-536) |
Ala-Gln-Phe-Glu-Glu-Tyr-Lys-Arg | |
CC-1477 |
CDPKS, Syntide analog |
Pro-Leu-Arg-Arg-Thr-Leu-Ser-Val-Ala-Ala | |
CC-1478 |
CDR-H3/C2 |
Cys-Asp-Leu-Ile-Tyr-Tyr-Asp-Tyr-Glu-Glu-Asp-Tyr-Tyr-Phe-Asp-Cys(Disulfide bridge: Cys1-Cys16) | |
CC-1479 |
CEA (605-613) |
Tyr-Leu-Ser-Gly-Ala-Asn-Leu-Asn-Leu | |
CC-1480 |
CEA, CAP-1-6-D, [Asp6] -Carcinoembryonic Antigen |
Tyr-Leu-Ser-Gly-Ala-Asp-Leu-Asn-Leu | |
CC-1481 |
CEA Related, QYSWFVNGTF |
Gln-Tyr-Ser-Trp-Phe-Val-Asn-Gly-Thr-Phe | |
CC-1482 |
CEA Related, TYACFVSNL |
Thr-Tyr-Ala-Cys-Phe-Val-Ser-Asn-Leu | |
CC-1483 |
Cecropin A |
Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Gln-Asn-Ile-Arg-Asp-Gly-Ile-Ile-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Thr-Gln-Ile-Ala-Lys-NH2 | 80451-04-3 |
CC-1484 |
Cecropin A (1-7)-Melittin A (2-9) amide |
Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-NH2 | |
CC-1485 |
Cecropin A (1-8)-Melittin (1-18) amide |
Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-NH2 | |
CC-1486 |
Cecropin B |
Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-NH2 | 80451-05-4 |
CC-1487 |
Cecropin B, Free Acid |
Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Met-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu | |
CC-1488 |
Cecropin P1 porcine |
Ser-Trp-Leu-Ser-Lys-Thr-Ala-Lys-Lys-Leu-Glu-Asn-Ser-Ala-Lys-Lys-Arg-Ile-Ser-Glu-Gly-Ile-Ala-Ile-Ala-Ile-Gln-Gly-Gly-Pro-Arg | 125667-96-1 |
CC-1489 |
CEF3 |
Ser-Ile-Ile-Pro-Ser-Gly-Pro-Leu-Lys | |
CC-1490 |
CEF4 |
Arg-Val-Leu-Ser-Phe-Ile-Lys-Gly-Thr-Lys | |
CC-1491 |
CEF6 |
Leu-Pro-Phe-Asp-Lys-Thr-Thr-Val-Met | |
CC-1492 |
CEF10 |
Cys-Leu-Gly-Gly-Leu-Leu-Thr-Met-Val | |
CC-1493 |
CFP10 (71-85) |
Glu-Ile-Ser-Thr-Asn-Ile-Arg-Gln-Ala-Gly-Val-Gln-Tyr-Ser-Arg | |
CC-1494 |
CFTR (108-117), Pseudomonas aeruginosa Inhibitor |
Ser-Tyr-Asp-Pro-Asp-Asn-Lys-Glu-Glu-Arg | |
CC-1495 |
Ceratotoxin A |
Ser-Ile-Gly-Ser-Ala-Leu-Lys-Lys-Ala-Leu-Pro-Val-Ala-Lys-Lys-Ile-Gly-Lys-Ile-Ala-Leu-Pro-Ile-Ala-Lys-Ala-Ala-Leu-Pro | |
CC-1496 |
Ceratotoxin B |
Ser-Ile-Gly-Ser-Ala-Phe-Lys-Lys-Ala-Leu-Pro-Val-Ala-Lys-Lys-Ile-Gly-Lys-Ala-Ala-Leu-Pro-Ile-Ala-Lys-Ala-Ala-Leu-Pro | |
| CC-508 | Cetrorelix acetate | 120287-85-6 | |
CC-1497 |
α-CGRP (29-37) (canine, mouse, rat) |
Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CC-1498 |
α-CGRP (30-37) (canine, mouse, rat) |
Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CC-1499 |
α-CGRP (31-37) (canine, mouse, rat) |
Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CC-1500 |
α-CGRP (32-37) (canine, mouse, porcine, rat) |
Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CC-1501 |
α-CGRP (33-37) (canine,mouse, porcine, rat) |
Gly-Ser-Glu-Ala-Phe-NH2 | |
CC-1502 |
α-CGRP (19-37), human |
Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | |
CC-1503 |
α-CGRP (23-37), human |
Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | |
CC-1504 |
Charybdotoxin |
Glp-Phe-Thr-Asn-Val-Ser-Cys-Thr-Thr-Ser-Lys-Glu-Cys-Trp-Ser-Val-Cys-Gln-Arg-Leu-His-Asn-Thr-Ser-Arg-Gly-Lys-Cys-Met-Asn-Lys-Lys-Cys-Arg-Cys-Tyr-Ser (Disulfide bridges:Cys7-Cys28,Cys13-Cys33, Cys17-Cys35 ) | 95751-30-7 |
| CC-0590 | 2-Chloro-1,3-dimethylimidazolidinium chloride | 37091-73-9 | |
CC-1505 |
Cholecystokinin-33 (10-20) (bovine, porcine) |
Ile-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His | |
CC-1506 |
Cholecystokinin Octapeptide (1-2) (desulfated) |
Asp-Tyr | |
CC-1507 |
Cholecystokinin Octapeptide (1-3) (desulfated) |
Asp-Tyr-Met | |
CC-1508 |
Cholecystokinin Octapeptide (1-4) (desulfated) |
Asp-Tyr-Met-Gly | |
CC-1509 |
Cholecystokinin Octapeptide (1-5) (desulfated) |
Asp-Tyr-Met-Gly-Trp | |
CC-1510 |
Cholecystokinin Octapeptide (1-6) (desulfated) |
Asp-Tyr-Met-Gly-Trp-Met | |
CC-1511 |
Cholecystokinin Octapeptide (2-8) (desulfated) |
Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | |
CC-1512 |
Cholecystokinin Octapeptide (desulfated) |
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 | |
CC-1513 |
Cholecystokinin Octapeptide free acid (desulfated) |
Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe | |
CC-1514 |
Cholecystokinin-33 (1-21) (porcine) |
Lys-Ala-Pro-Ser-Gly-Arg-Val-Ser-Met-Ile-Lys-Asn-Leu-Gln-Ser-Leu-Asp-Pro-Ser-His-Arg | |
CC-1515 |
Cholecystokinin Precursor (107-115) (human) (desulfated) |
Ser-Ala-Glu-Glu-Tyr-Glu-Tyr-Pro-Ser | |
CC-1516 |
Cholecystokinin Precursor (24-32) (rat) |
Val-Pro-Val-Glu-Ala-Val-Asp-Pro-Met | |
CC-1517 |
Chorionic Gonadotropin-β(109-119) amide (human) |
Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-NH2 | |
CC-1518 |
Chorionic Gonadotropin-β(109-145) (human) |
Thr-Cys-Asp-Asp-Pro-Arg-Phe-Gln-Asp-Ser-Ser-Ser-Ser-Lys-Ala-Pro-Pro-Pro-Ser-Leu-Pro-Ser-Pro-Ser-Arg-Leu-Pro-Gly-Pro-Ser-Asp-Thr-Pro-Ile-Leu-Pro-Gln | |
CC-1519 |
Chromostatin, bovine |
Ser-Asp-Glu-Asp-Ser-Asp-Gly-Asp-Arg-Pro-Gln-Ala-Ser-Pro-Gly-Leu-Gly-Pro-Gly-Pro | |
CC-1520 |
Chromogranin A (324-337), human |
Trp-Ser-Lys-Met-Asp-Gln-Leu-Ala-Lys-Glu-Leu-Thr-Ala-Glu | |
| CC-0510 | CIB | 153433-26-2 | |
CC-1521 |
[Cit5]-TRAP-5 |
Ser-Phe-Leu-Leu-Cit | |
CC-1817 |
CJC-1295 |
||
CC-1522 |
CKS-17 |
Leu-Gln-Asn-Arg-Arg-Gly-Leu-Asp-Leu-Leu-Phe-Leu-Lys-Glu-Gly-Gly-Leu | |
CC-1523 |
CKS-17 (7-12) |
Leu-Asp-Leu-Leu-Phe-Leu |
|
CC-1524 |
CK1tide |
His-Ala-Ala-Ile-Gly-Asp-Asp-Asp-Asp-Ala-Tyr-Ser-Ile-Thr-Ser-NH2 | |
CC-1525 |
CLIP(85–99) |
Lys-Pro-Val-Ser-Gln-Met-Arg-Met-Ala-Thr-Pro-Leu-Leu-Met-Arg | |
| CC-1591 | 234 CM | Lys-Tyr-Ile-Cys-Asn-Ser-Ser-Cys-Met | |
CC-1526 |
C-Myc peptide epitope |
Glu-Gln-Lys-Leu-Ile-Ser-Glu-Glu-Asp-Leu | |
CC-1527 |
Collagen Binding Fragment |
Cys-Gln-Asp-Ser-Glu-Thr-Arg-Thr-Phe-Tyr | |
CC-1528 |
Complement anaphylatoxin C5a (37-53), human |
Arg-Ala-Ala-Arg-Ile-Ser-Leu-Gly-Pro-Arg-Cys-Ile-Lys-Ala-Phe-Thr-Glu | |
CC-1529 |
Conantokin G |
Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn-NH2 | |
CC-1530 |
Conantokin G (free acid) |
Gly-Glu-Gla-Gla-Leu-Gln-Gla-Asn-Gln-Gla-Leu-Ile-Arg-Gla-Lys-Ser-Asn | |
CC-1531 |
Conantokin T, Marine snail,Conus tullpa |
Gly-Glu-Gla-Gla-Tyr-Gln-Lys-Met-Leu-Gla-Asn-Leu-Arg-Gla-Ala-Glu-Val-Lys-Lys-Asn-Ala-NH2 | |
CC-1532 |
Conopressin S |
Cys-Ile-Ile-Arg-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge: Cys1-Cys6) | |
CC-1533 |
α-Conotoxin EI |
Arg-Asp-Hyp-Cys-Cys-Tyr-His-Pro-Thr-Cys-Asn-Met-Ser-Asn-Pro-Gln-Ile-Cys- NH2 | |
CC-1534 |
α-Conotoxin GI |
Glu-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Arg-His-Tyr-Ser-Cys-NH2 (Disulfide bridge: Cys2-Cys7, Cys3-Cys13） | |
CC-1535 |
α-Conotoxin GS |
Ala-Cys-Ser-Gly-Arg-Gly-Ser-Arg-Cys-Hyp-Hyp-Gln-Cys-Cys-Met-Gly-Leu-Arg-Cys-Gly-Arg-Gly-Asn-Pro-Gln-Lys-Cys-Ile-Gly-Ala-His-Gla-Asp-Val | |
CC-1536 |
α-Conotoxin IMI |
Gly-Cys-Cys-Ser-Asp-Pro-Arg-Cys-Ala-Trp-Arg-Cys- NH2 （Disulfide bridge: Cys2-Cys8,Cys3-Cys12） | 156467-85-5 |
CC-1537 |
α-Conotoxin MI |
Gly-Arg-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Tyr-Ser-Cys-NH2 | |
CC-1538 |
α-Conotoxin SI |
Ile-Cys-Cys-Asn-Pro-Ala-Cys-Gly-Pro-Lys-Tyr-Ser-Cys- NH2 (Disulfide bridges Cys2-Cys7, Cys3-Cys13 ) | |
CC-1539 |
α-Conotoxin SIA |
Tyr-Cys-Cys-His-Pro-Ala-Cys-Gly-Lys-Asn-Phe-Asp-Cys-NH2 (Disulfide bridge: Cys2 -Cys7,Cys3 - Cys13) | |
CC-1540 |
Contraceptive Tetrapeptide |
Thr-Pro-Arg-Lys | |
CC-1541 |
Corazonin, American Cockroach, Periplaneta americana |
Pyr-Thr-Phe-Gln-Tyr-Ser-Arg-Gly-Trp-Thr-Asn-NH2 | |
CC-1542 |
Corticostatin, human |
Val-Cys-Ser-Cys-Arg-Leu-Val-Phe-Cys-Arg-Arg-Thr-Glu-Leu-Arg-Val-Gly-Asn-Cys-Leu-Ile-Gly-Gly-Val-Ser-Phe-Thr-Tyr-Cys-Cys-Thr-Arg-Val | |
CC-1543 |
Corticostatin, rabbit |
Gly-Ile-Cys-Ala-Cys-Arg-Arg-Arg-Phe-Cys-Pro-Asn-Ser-Glu-Arg-Phe-Ser-Gly-Tyr-Cys-Arg-Val-Asn-Gly-Ala-Arg-Tyr-Val-Arg-Cys-Cys-Ser-Arg-Arg | |
| CC-0509 | Corticotrophin | 9002-60-2 | |
CC-1544 |
Corticotropin Releasing Factor, bovine |
Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Asn-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2 | |
CC-1545 |
Corticotropin Releasing Factor, human, rat |
Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 | |
CC-1546 |
Corticotropin Releasing Factor, ovine |
Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2 | |
CC-1547 |
Cortistatin 17, human |
Asp-Arg-Met-Pro-Cys-Arg-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys (Disulfide bridge Cys5-Cys16) | |
CC-1548 |
Cortistatin 14 (mouse, rat) |
Pro-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Ser-Ser-Cys-Lys(Disulfide bridge Cys2-Cys13) | |
CC-1549 |
C-Peptide, dogs |
Glu-Val-Glu-Asp-Leu-Gln-Val-Arg-Asp-Val-Glu-Leu-Ala-Gly-Ala-Pro-Gly-Glu-Gly-Gly-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ala-Leu-Gln | |
CC-1550 |
C-Peptide (57-87), human |
Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln | |
CC-1551 |
C3 Peptide P16 |
Lys-Asn-Arg-Trp-Glu-Asp-Pro-Gly-Lys-Gln-Leu-Tyr-Asn-Val-Glu-Ala | |
CC-1552 |
C-Peptide 1 (rat) |
Glu-Val-Glu-Asp-Pro-Gln-Val-Pro-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Glu-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln | |
CC-1553 |
C-Peptide 2 (rat) |
Glu-Val-Glu-Asp-Pro-Gln-Val-Ala-Gln-Leu-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Asp-Leu-Gln-Thr-Leu-Ala-Leu-Glu-Val-Ala-Arg-Gln | |
CC-1554 |
CREB327 (113-126) |
Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg-Lys-Ile-Leu-Asn-Asp | |
CC-1555 |
CREBtide |
Lys-Arg-Arg-Glu-Ile-Leu-Ser-Arg-Arg-Pro-Ser-Tyr-Arg | |
CC-1556 |
CRF (6-33) (human, rat) |
Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser | |
CC-1557 |
Cripto-1, CR-1 |
Cys-Pro-Pro-Ser-Phe-Tyr-Gly-Arg-Asn-Cys-Glu-His-Asp-Val-Arg-Lys-Glu | |
CC-1558 |
C-Reactive Protein (CRP) (77-82) |
Val-Gly-Gly-Ser-Glu-Ile | |
CC-1559 |
C-Reactive Protein (CRP) (174-185) |
Ile-Tyr-Leu-Gly-Gly-Pro-Phe-Ser-Pro-Asn-Val-Leu | |
CC-1560 |
C-Reactive Protein (CRP) (201-206) |
Lys-Pro-Gln-Leu-Trp-Pro | |
CC-1561 |
Crustacean Cardioactive Peptide, CCAP |
Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys (Disulfide bridge Cys3-Cys9) | |
CC-1562 |
Crustacean Cardioactive Peptide (CCAP), amide |
Pro-Phe-Cys-Asn-Ala-Phe-Thr-Gly-Cys-NH2 | |
CC-1563 |
Crustacean Erythrophore Concentrating Hormone |
Pyr-Leu-Asn-Phe-Ser-Pro-Gly-Trp-NH2 | |
| CC-2062 | Crystalline | Trp-Gly | |
CC-1564 |
CTAP |
D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2(Disulfide bridge Cys2-Pen7) | |
CC-1565 |
C-Type Natriuretic Peptide,Chicken |
Gly-Leu-Ser-Arg-Ser-Cys-Phe-Gly-Val-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22) | |
CC-1566 |
C-Type Natriuretic Peptide (1-22), human |
Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys6-Cys22) | |
CC-1567 |
C-Type Natriuretic Peptide (1-53) (human) |
Asp-Leu-Arg-Val-Asp-Thr-Lys-Ser-Arg-Ala-Ala-Trp-Ala-Arg-Leu-Leu-Gln-Glu-His-Pro-Asn-Ala-Arg-Lys-Tyr-Lys-Gly-Ala-Asn-Lys-Lys-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys(Disulfide bridge:Cys37-Cys54) | |
CC-1568 |
C-telopeptide |
Glu-Lys-Ala-His-Asp-Gly-Gly-Arg | |
CC-1569 |
C-terminal Proghrelin Isoform Peptide, mouse |
Arg-Arg-Gln-Leu-Thr-Ser-Asn-His-Gly-Gln-Ala | |
CC-1570 |
CTX IV (6-12) |
Leu-Ile-Pro-Pro-Phe-Trp-Lys-NH2 | |
| CC-2063 | 234 CW | Lys-Tyr-Met-Cys-Asn-Ser-Ser-Cys-Met | |
CC-0202 |
Cyclopentyl succinimidyl carbonate |
128595-07-3 |
|
CC-1571 |
[Cys(Acm)2,7]-a-CGRP (human) |
Ala-Cys(Acm)-Asp-Thr-Ala-Thr-Cys(Acm)-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 | |
CC-1572 |
[Cys(Acm)20,31]-EGF (20-31) |
Cys(Acm)-Met-His-Ile-Glu-Ser-Leu-Asp-Ser-Tyr-Thr-Cys(Acm) | |
CC-1573 |
Cys-β-Amyloid (1-40) |
Cys-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CC-1574 |
Cys-β-Amyloid (12-28) |
Cys-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | |
CC-1575 |
[D-Cys6,Asn7,D-Ala11,Cys14]-Bombesin (6-14) |
D-Cys-Asn-Trp-Ala-Val-D-Ala-His-Leu-Cys-NH2 (Disulfide bridge Cys1-Cys9) | |
CC-1576 |
[Cys18]-Atrial Natriuretic Factor (4-18) amide (rat) |
Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Cys-NH2 (Disulfide bridge Cys7-Cys18) | |
CC-1578 |
[CysCys21] Atrial Natriuretic Factor (3-28), Rat |
Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr (Disulfide bridge Cys7-Cys23 ) | |
CC-1579 |
Cys-CD36 (139-155) |
Cys-Asn-Leu-Ala-Val-Ala-Ala-Ala-Ser-His-Ile-Tyr-Gln-Asn-Gln-Phe-Val-Gln | |
CC-1580 |
[Cys8,13]-Dynorphin A (1-13) amide |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Cys-Arg-Pro-Lys-Leu-Cys-NH2 (Disulfide bridge Cys8-Cys13) | |
CC-1581 |
Cys-Gly-His-Gly-Asn-Lys-Ser-Amyloid ß -Protein (33-40) |
Cys-Gly-His-Gly-Asn-Lys-Ser-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CC-1582 |
Cys-Gly-Lys-Arg-Amyloid ß Protein (1-42) |
Cys-Gly-Lys-Arg-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | |
CC-1583 |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (33-40) |
Cys-Gly-Lys-Lys-Gly-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CC-1584 |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (35-40) |
Cys-Gly-Lys-Lys-Gly-Met-Val-Gly-Gly-Val-Val | |
CC-1585 |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (36-42) |
Cys-Gly-Lys-Lys-Gly-Val-Gly-Gly-Val-Val-I le-Ala | |
CC-1586 |
Cys-Gly-Lys-Lys-Gly-Amyloid ß -Protein (37-42) |
Cys-Gly-Lys-Lys-Gly-Gly-Gly-Val-Val-Ile-Ala | |
CC-1587 |
Cys-GM-CSF (17-31) |
Cys-Asn-Ala-Ile-Gln-Glu-Ala-Arg-Arg-Leu-Leu-Asn-Leu-Ser-Arg-Asp | |
CC-1588 |
[Cys0]-GTP-Binding Protein Gsa (28-42); GTP-Binding Protein Fragment, Gs alpha |
Cys-Lys-Gln-Leu-Gln-Lys-Asp-Lys-Gln-Val-Tyr-Arg-Ala-Thr-His-Arg | |
CC-1589 |
[Cys2, Tyr3, Orn5, Pen7-amide]-Somatostatin 14 (7-14) |
D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 | |
CC-1590 |
[Cys3, 6, Tyr8, Pro10]-Substance P |
Arg-Pro-Cys-Pro-Gln-Cys-Phe-Tyr-Gly-Pro-Met-NH2 (Disulfide bridge: 3-6) | |
| CD-0248 | DAGO | Tyr-D-Ala-Gly-N-Me-Phe-Gly-OL | |
CD-1437 |
Dansyl-Y-V-G |
Dansyl-Tyr-Val-Gly | |
CD-1438 |
DAP10 Signaling Fragment |
Pro-Ala-Gln-Glu-Asp-Gly-Lys-Val-Tyr-Ile-Asn-Met-Pro-Gly-Arg-Gly | |
| CD-0892 | DCG04 | 314263-42-8 | |
CD-0261 |
DCI |
1122-28-7 |
|
| CD-0258 | D-D-D-D-D | Asp-Asp-Asp-Asp-Asp | |
| CD-0286 | D-D-D-D-D-D | Asp-Asp-Asp-Asp-Asp-Asp | |
CD-1439 |
Decorsin, Leech |
Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | |
CD-1440 |
α-Defensin-1, human |
Asp-His-Tyr-Asn-Cys-Val-Ser-Ser-Gly-Gly-Gln-Cys-Leu-Tyr-Ser-Ala-Cys-Pro-Ile-Phe-Thr-Lys-Ile-Gln-Gly-Thr-Cys-Tyr-Arg-Gly-Lys-Ala-Lys-Cys-Cys-Lys (Disulfide bridge: Cys 5- Cys 34, Cys 12- Cys 27, Cys 17- Cys 35) | |
CD-1441 |
β-Defensin-3, human |
Gly-Ile-Ile-Asn-Thr-Leu-Gln-Lys-Tyr-Tyr-Cys-Arg-Val-Arg-Gly-Gly-Arg-Cys-Ala-Val-Leu-Ser-Cys-Leu-Pro-Lys-Glu-Glu-Gln-Ile-Gly-Lys-Cys-Ser-Thr-Arg-Gly-Arg-Lys-Cys-Cys-Arg-Arg-Lys-Lys (Disulfide bridge: Cys11-Cys40, Cys18-Cys33, Cys23-Cys41) | |
CD-1442 |
β-Defensin-4, human |
Glu-Leu-Asp-Arg-Ile-Cys-Gly-Tyr-Gly-Thr-Ala-Arg-Cys-Arg-Lys-Lys-Cys-Arg-Ser-Gln-Glu-Tyr-Arg-Ile-Gly-Arg-Cys-Pro-Asn-Thr-Tyr-Ala-Cys-Cys-Leu-Arg-Lys(Disulfide bridge: Cys6-Cys33; Cys13-Cys27; Cys17-Cys34) | |
CD-1443 |
Defensin-1 (human) HNP-1 |
Ala-Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Disulfide bridges Cys2-Cys30,Cys4-Cys19, and Cys 9-29) | |
CD-1444 |
Defensin (human) HNP-2 |
Cys-Tyr-Cys-Arg-Ile-Pro-Ala-Cys-Ile-Ala-Gly-Glu-Arg-Arg-Tyr-Gly-Thr-Cys-Ile-Tyr-Gln-Gly-Arg-Leu-Trp-Ala-Phe-Cys-Cys(Disulfide bridge: 1-29, 3-18, 8-28) | |
CD-1445 |
Delicious Peptide |
Lys-Gly-Asp-Glu-Glu-Ser-Leu-Ala | |
CD-1446 |
Dendroaspis Natriuretic Peptide |
Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Arg-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala(Disulfide bridge Cys7-Cys23) | |
| CD-0646 | DEPBT | 165534-43-0 | |
CD-1447 |
Dermenkephalin |
Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2 | |
| CD-414 | Dermorphin | Tyr-D-Ala-Phe-Gly-Tyr-Pro-Ser-NH2 | 77614-16-5 |
CD-1448 |
Dermorphin Analog |
Tyr-D-Arg-Phe-Sar-Tyr-Pro-Ser-NH2 | |
CD-1449 |
[Des-Ala1,des-Gly2,His4,5,D-Trp8]-Somatostatin-14 |
Cys-His-His-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys1-Cys12) | |
CD-1450 |
[Des-Acetyl]-a-MSH |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val- NH2 | |
CD-1451 |
[Des-Arg30,Des-Pro31]-Dendroaspis Natriuretic Peptide |
Glu-Val-Lys-Tyr-Asp-Pro-Cys-Phe-Gly-His-Lys-Ile-Asp-Arg-Ile-Asn-His-Val-Ser-Asn-Leu-Gly-Cys-Pro-Ser-Leu-Arg-Asp-Pro-Asn-Ala-Pro-Ser-Thr-Ser-Ala (Disulfide bridge Cys7-Cys23) | |
CD-1452 |
[Des-Asp10]Decorsin, Leech |
Ala-Pro-Arg-Leu-Pro-Gln-Cys-Gln-Gly-Asp-Gln-Glu-Lys-Cys-Leu-Cys-Asn-Lys-Asp-Glu-Cys-Pro-Pro-Gly-Gln-Cys-Arg-Phe-Pro-Arg-Gly-Asp-Ala-Asp-Pro-Tyr-Cys-Glu | |
CD-1453 |
[Des-Asp187]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) |
Ile-Thr-Gln-Val-Pro-Phe-Ser-Val | |
CD-1454 |
[Des-Asp187,Met186]-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse) |
Ile-Met-Gln-Val-Pro-Phe-Ser-Val | |
CD-1455 |
[Des-Gln16]-PACAP (6-27), amide, human, ovine, rat |
Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 | |
CD-1456 |
[Des-Gly10,Dleu6, ProNHEt9], LH-RH, Leuprolide |
Pyr-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt | |
CD-1457 |
[Des-Gly77,His78] Myelin, Basic Protein (68-84), bovine |
Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ala-Gln-Arg-Pro-Gln-Asp-Glu-Asn | |
CD-1458 |
[Des-His1, Glu9]-Glucagon (1- 29), amide |
Ser-Gln-Gly-Thr-Phe-Thr-Ser-Glu-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-NH2 | |
CD-1459 |
[Des-Leu26,Cys(Acm)20,31]-EGF (20-31) |
Cys(Acm)-Met-His-Ile-Glu-Ser-Asp-Ser-Tyr-Thr-Cys(Acm) | |
CD-1460 |
[Des-Leu9]-Kinetensin |
Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe | |
CD-1461 |
[Des-octanoyl]-Ghrelin, human |
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg | |
CD-1462 |
[Des-octanoyl]-Ghrelin, rat |
Gly-Ser-Ser-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg | |
CD-1463 |
[Des-Pro2]Bradykinin |
Arg-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CD-1464 |
[Des-Ser1] Cerebellin |
Gly-Ser-Ala-Lys-Val-Ala-Phe-Ser-Ala-Ile-Arg-Ser-Thr-Asn-His | |
CD-1465 |
[Des-Thr5]-Glucagon |
His-Ser-Gln-Gly-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | |
CD-1466 |
[Des-Thr7]-Glucagon |
His-Ser-Gln-Gly-Thr-Phe-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | |
CD-1467 |
[Des-Tyr1] Dynorphin A (1-8) |
Gly-Gly-Phe-Leu-Arg-Arg-Ile | |
CD-1468 |
[Des-Tyr1]-g-Endorphin |
Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | |
CD-1469 |
[Des-Tyr1]-β-Endorphin, human |
Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
CD-1470 |
[Des-Tyr1] Leu-Enkephalin |
Gly-Gly-Phe-Leu | |
CD-1471 |
[Des-Tyr1] Met-Enkephalin |
Gly-Gly-Phe-Met | |
| CD-0648 | DFIH | 164298-27-5 | |
CD-1472 |
Diazepam-Binding Inhibitor Fragment, human |
Gln-Ala-Thr-Val-Gly-Asp-Ile-Asn-Thr-Glu-Arg-Pro-Gly-Met-Leu-Asp-Phe-Thr-Gly-Lys | |
CD-1759 |
N,N'-Di-Boc-1H-pyrazole-1-carboxamidine |
152120-54-2 |
|
| CD-0617 | 5'-O-Dimethoxytrityl-deoxythymidine
|
40615-39-2 | |
| CD-0513 | N-[3-(Dimethylamino)propyl]-N'-ethylcarbodiimide
methiodide |
22572-40-3 | |
| CD-0647 | DMTMM | 3945-69-5 | |
CD-1473 |
Doc-6 (130-145) |
Gly-Val-Gln-Arg-Glu-Gln-Asn-Glu-Arg-Phe-Asn-Val-Tyr-Leu-Met-Pro | |
CD-1474 |
Dok-4 (130-145) |
Gly-Val-Gln-Cys-Glu-Gln-Thr-Asp-Arg-Phe-Asn-Val-Phe-Leu-Leu-Pro | |
CD-1475 |
Dok-4 (263-275) |
Leu-Pro-Arg-Ser-Ala-Tyr-Trp-His-His-Ile-Thr-Gly-Ser | |
CD-1476 |
Dok-5 (263-275) |
Leu-Pro-Arg-Ser-Ala-Tyr-Trp-Gln-His-Ile-Thr-Arg-Gln | |
CD-1477 |
Dok-6 (263-275) |
Leu-Pro-Arg-Ser-Ala-Tyr-Trp-His-His-Ile-Thr-Arg-Gln | |
| CD-1478 | DYKDDDDK | Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys | |
| CD-0645 | Dynorphin A(1-13) acetate | ||
CD-1479 |
Dynorphin A amide, porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 | |
CD-1480 |
Dynorphin A (1-10), amide,porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-NH2 | |
CD-1481 |
Dynorphin A (1-13), amide,porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-NH2 | |
CD-1482 |
Dynorphin A (1-6), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg | |
CD-1483 |
Dynorphin A (1-7), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg | |
CD-1484 |
Dynorphin A (1-10), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro | |
CD-1485 |
Dynorphin A (1-11), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys | |
CD-1486 |
Dynorphin A (1-12), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu | |
CD-1487 |
Dynorphin A (1-13), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | |
CD-1488 |
Dynorphin A (2-12), porcine |
Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu | |
CD-1489 |
Dynorphin A (2-13), porcine |
Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | |
CD-1490 |
Dynorphin (2-17), amide,porcine |
Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-NH2 | |
CD-1491 |
Dynorphin A (1-8), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile | |
CD-1492 |
Dynorphin A (1-9), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg | |
CD-1493 |
Dynorphin A (2-17), porcine |
Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
CD-1494 |
Dynorphin A (3-8), porcine |
Gly-Phe-Leu-Arg-Arg-Ile | |
CD-1495 |
Dynorphin A (3-13), porcine |
Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys | |
CD-1496 |
Dynorphin A (6-17), porcine |
Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
CD-1497 |
Dynorphin A (7-17), porcine |
Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
CD-1498 |
Dynorphin A (8-17), porcine |
Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
CD-1499 |
Dynorphin A (9-17), porcine |
Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
CD-1500 |
Dynorphin A (13-17), porcine |
Lys-Trp-Asp-Asn-Gln | |
CD-1501 |
Dynorphin A (1-17),(Prodynorphin 209-225), Porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln | |
| CD-0429 | Dynorphin B (1-9) | Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe | |
CE-0431 |
Eα (52-68) |
Ala-Ser-Phe-Glu-Ala-Gln-Gly-Ala-Leu-Ala-Asn-Ile-Ala-Val-Asp-Lys-Ala | |
CE-0432 |
Ecdysis-Triggering Hormone (Manduca sexta) ; Mas-ETH |
Ser-Asn-Glu-Ala-Ile-Ser-Pro-Phe-Asp-Gln-Gly-Met-Met-Gly-Tyr-Val-Ile-Lys-Thr-Asn-Lys-Asn-Ile-Pro-Arg-Met-NH2 | 60731-46-6 |
CE-0125 |
EEDQ |
16357-59-8 |
|
CE-0433 |
EGFR-derived peptide |
Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Lys | |
CE-0434 |
EGF Receptor (988-993) (phosphorylated) (human) |
Asp-Ala-Asp-Glu-pTyr-Leu-NH2 | |
CE-0435 |
EGF Receptor Substrate 1 |
Asp-Ala-Asp-Glu-pTyr-Leu-Ile-Pro-Gln-Gln-Gly-Phe-Phe | |
CE-0436 |
EGF Receptor Substrate 2 |
Asp-Ala-Asp-Glu-pTyr-Leu-Ile-Pro-Gln-Gln-Gly | |
CE-0437 |
Egg Laying Hormone of Aplysia |
Ile-Ser-Ile-Asn-Gln-Asp-Leu-Lys-Ala-Ile-Thr-Asp-Met-Leu-Leu-Thr-Glu-Gln-Ile-Arg-Glu-Arg-Gln-Arg-Tyr-Leu-Ala-Asp-Leu-Arg-Gln-Arg-Leu-Leu-Glu-Lys-NH2 | |
CE-0438 |
Eglin c (41-49) |
Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr | |
CE-0439 |
Eglin c (60-63)-methyl ester |
Thr-Asn-Val-Val-Ome | |
CE-0440 |
E75, Her - 2/neu (369 - 377) |
Lys-Ile-Phe-Gly-Ser-Leu-Ala-Phe-Leu | |
CE-0441 |
E-I-L-D-V, human, bovine, rat |
Glu-Ile-Leu-Asp-Val | |
CE-0442 |
E-I-L-E-V-P-S-T |
Glu-Ile-Leu-Glu-Val-Pro-Ser-Thr | |
CE-0140 |
Elcatonin acetate |
Ser-Asn-Leu-Ser-Thr-Asu-Val-Leu-Gly-Lys-Leu-Ser-Gln-Glu-Leu-His-Lys-Leu-Gln-Thr-Tyr-Pro-Arg-Thr-Asp-Val-Gly-Ala-Gly-Thr-Pro (Ser----Asu) | 60731-46-6 |
CE-0443 |
Eledoisin |
Pyr-Pro-Ser-Lys-Asp-Ala-Phe-Ile-Gly-Leu-Met-NH2 | |
CE-0444 |
Eledoisin Related Peptide |
Lys-Phe-Ile-Gly-Leu-Met-NH2 | |
CE-0445 |
EMP-1 (Epithelial Membrane Protein) |
Gly-Gly-Thr-Tyr-Ser-Cys-His-Phe-Gly-Pro-Leu-Thr-Trp-Val-Cys-Lys-Pro-Gln-Gly-Gly | |
CE-0446 |
Endokinin A/B |
Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CE-0447 |
Endokinin C (Human) |
Lys-Lys-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu-NH2 | |
CE-0448 |
Endokinin D (Human) |
Val-Gly-Ala-Tyr-Gln-Leu-Glu-His-Thr-Phe-Gln-Gly-Leu-Leu-NH2 | |
CE-0449 |
Endomorphin-1 |
Tyr-Pro-Trp-Phe-NH2 | |
CE-0450 |
Endomorphin-2 |
Tyr-Pro-Phe-Phe-NH2 | |
CE-0451 |
Endonuclease Antigenic Site |
Glu-Thr-Gly-Gln-Glu-Thr-Ala-Tyr-Phe-Leu-Leu-Lys-Leu-Ala-Gly-Arg-Trp-Pro-Val-Lys | |
| CE-0755 | α-Endorphin | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr | |
| CE-0756 | δ–Endorphin | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu | |
| CE-0757 | β-Endorphin, camel | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | |
| CE-0758 | β-Endorphin (1-27), camel,bovine, ovine | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His | |
| CE-0759 | β-Endorphin, equine | Tyr-Gly-Gly-Phe-Met-Ser-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | |
| CE-0760 | β-Endorphin, human | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
| CE-0761 | β-Endorphin (1-26), human | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala | |
| CE-0762 | β-Endorphin (1-27), human | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr | |
| CE-0763 | β-Endorphin (6-31), human | Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
| CE-0764 | β-Endorphin (18-31) (human) | Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
| CE-0765 | β-Endorphin (27-31) (human) | Tyr-Lys-Lys-Gly-Glu | |
| CE-0766 | β-Endorphin (30-31) (human) | Gly-Glu | |
| CE-0767 | β-Endorphin (1-5) + (16-31),human | Tyr-Gly-Gly-Phe-Met-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Ala-Tyr-Lys-Lys-Gly-Glu | |
| CE-0768 | β-Endorphin, porcine | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Val-Lys-Asn-Ala-His-Lys-Lys-Gly-Gln | |
| CE-0769 | β-Endorphin, rat | H-Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser-Gln-Thr-Pro-Leu-Val-Thr-Leu-Phe-Lys-Asn-Ala-Ile-Ile-Lys-Asn-Val-His-Lys-Lys-Gly-Gln | |
CE-0452 |
Endothelin (16-21) |
His-Leu-Asp-Ile-Ile-Trp | |
CE-0453 |
Endothelin-1 (11-21) |
Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys5) | |
CE-0454 |
Endothelin-1 (1-15), amide,human |
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-NH2 | |
CE-0455 |
Endothelin-1, human |
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr- Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys15,Cys3-Cys11) | 117399-94-7 |
CE-0456 |
Endothelin-1 (1-15), human |
Cys-Ser-Cys-Ser-Ser-Leu-Met-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys | |
CE-0457 |
Endothelin 2 (human, canine) |
Cys-Ser-Cys-Ser-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys15,Cys3-Cys11) | |
CE-0458 |
Endothelin 3, human, rat |
Cys-Thr-Cys-Phe-Thr-Tyr-Lys-Asp-Lys-Glu-Cys-Val-Tyr-Tyr-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge Cys1-Cys15,Cys3-Cys11) | |
CE-0459 |
Endotoxin Inhibitor |
Lys-Thr-Lys-Cys-Lys-Phe-Leu-Lys-Lys-Cys(Disulfide bridge Cys4-Cys10 ) | |
| CE-0142 | Enfuvirtide acetate | 159519-65-0 | |
CE-0460 |
ent-Amyloid b-Protein (1-42) |
D-Asp-D-Ala-D-Glu-D-Phe-D-Arg-D-His-D-Asp-D-Ser-Gly-D-Tyr-D-Glu-D-Val-D-His-D-His-D-Gln-D-Lys-D-Leu-D-Val-D-Phe-D-Phe-D-Ala-D-Glu-D-Asp-D-Val-Gly-D-Ser-D-Asn-D-Lys-Gly-D-Ala-D-Ile-D-Ile-Gly-D-Leu-D-Met-D-Val-Gly-Gly-D-Val-D-Val-D-Ile-D-Ala | |
CE-0461 |
Entero-Hylambatin |
Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | |
CE-0462 |
Enterostatin, human |
Ala-Pro-Gly-Pro-Arg | |
CE-0463 |
Enterostatin (pig, rat) |
Val-Pro-Asp-Pro-Arg | 117137-85-6 |
CE-0464 |
Eosinophilotactic Peptide |
Val-Gly-Ser-Glu | |
CE-0465 |
Eosinophilotactic Tetrapeptides |
Ala-Gly-Ser-Glu | |
CE-0466 |
Ep-CAM (263-271) |
Gly-Leu-Lys-Ala-Gly-Val-Ile-Ala-Val | |
CE-0467 |
Epidermal Growth Factor Receptor Peptide (985-996) |
Asp-Val-Val-Asp-Ala-Asp-Glu-Tyr-Leu-Ile-Pro-Gln | |
CE-0468 |
Epidermal Mitosis Inhibiting Pentapeptide |
Pyr-Glu-Asp-Ser-Gly | |
| CE-0144 | Eptifibatide acetate | Map-Har-Gly-Asp-Trp-Pro-Cys-NH2(Disulfide bridge, Map1-Cys6) | 148031-34-9 |
| CE-0469 | ERKtide | Ala-Thr-Gly-Pro-Leu-Ser-Pro-Gly-Pro-Phe-Gly-Arg-Arg | |
| CE-0470 | Erythromycin resistance peptide | Met-Arg-Leu-Phe-Val | |
CE-0471 |
Exendin 3 |
His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | |
CE-0472 |
Exendin 4 |
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | |
CE-0770 |
Exendin (5-39) |
Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | |
CE-0473 |
Exendin (9-39) |
Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | |
CE-0474 |
Exendin 4 (1-8) |
His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-NH2 | |
| CE-0475 | Exendin 9 (3-39) | Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2 | 196109-31-6 |
CE-0476 |
Experimental Allergic Encephalitogenic Peptide (human) |
Phe-Ser-Trp-Gly-Ala-Glu-Gly-Gln-Arg | |
CE-0477 |
Experimental Autoimmune Encephalomyelitis Complementary Peptide |
Val-Phe-Ile-Leu-Gly-Pro-Leu-Arg-Leu-Leu-Gly | |
| CE-0145 | Exenatide acetate | 141732-76-5 | |
CF-1056 |
Fas C-Terminal Tripeptide |
Ac-Ser-Leu-Val | |
CF-1057 |
FDC-SP (30-85), human |
Ser-Ile-Ser-Asp-Ser-Asp-Glu-Leu-Ala-Ser-Gly-Phe-Phe-Val-Phe-Pro-Tyr-Pro-Tyr-Pro-Phe-Arg-Pro-Leu-Pro-Pro-Ile-Pro-Phe-Pro-Arg-Phe-Pro-Trp-Phe-Arg-Arg-Asn-Phe-Pro-Ile-Pro-Ile-Pro-Glu-Ser-Ala-Pro-Thr-Thr-Pro-Leu-Pro-Ser-Glu-Lys | |
CF-1058 |
FDC-SP (61-85), human |
Phe-Pro-Trp-Phe-Arg-Arg-Asn-Phe-Pro-Ile-Pro-Ile-Pro-Glu-Ser-Ala-Pro-Thr-Thr-Pro-Leu-Pro-Ser-Glu-Lys | |
CF-1059 |
FGF basic (119-126) (human,bovine, ovine, rabbit) |
Arg-Thr-Gly-Gln-Tyr-Lys-Leu | |
CF-1060 |
Fibrinogen Binding Inhibitory Peptide |
His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val | |
CF-1061 |
Fibrinogen-Binding Peptide |
Glu-His-Ile-Pro-Ala | |
CF-1062 |
Fibrinogen β-Chain (24-42) |
Glu-Glu-Ala-Pro-Ser-Leu-Arg-Pro-Ala-Pro-Pro-Pro-Ile-Ser-Gly-Gly-Gly-Tyr-Arg | |
CF-1063 |
Fibrinogen γ-Chain (117-133) |
Asn-Asn-Gln-Lys-Ile-Val-Asn-Leu-Lys-Glu-Lys-Val-Ala-Gln-Leu-Glu-Ala | |
CF-1064 |
Fibrinogen Related Peptide |
Gly-Gln-Gln-His-His-Leu-Gly-Gly-Ala-Lys-Gln-Ala-Gly-Asp-Val | |
CF-1065 |
Fibrinolysis Inhibitng Factor |
Gly-Pro-Arg-Pro | |
CF-1066 |
Fibrinopeptide A, human |
Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg | |
CF-1067 |
Fibrinopeptide B |
Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | |
CF-1068 |
Fibrinopeptide B, Bovine |
Gln-Phe-Pro-Thr-Asp-Tyr-Asp-Glu-Gly-Gln-Asp-Asp-Arg-Pro-Lys-Val-Gly-Leu-Gly-Ala-Arg | |
CF-1069 |
Fibrinopeptide B, human |
Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | |
CF-1070 |
Fibronectin Adhesion-Promoting Peptide |
Trp-Gln-Pro-Pro-Arg-Ala-Arg-Ile | |
CF-1071 |
Fibronectin Analog |
Gly-Arg-Ala-Asp-Ser-Pro-Lys | |
CF-1072 |
Fibronectin-Binding Protein |
Phe-Asn-Lys-His-Thr-Glu-Ile-Ile-Glu-Glu-Asp-Thr-Asn-Lys-Asp-Lys-Pro-Ser-Tyr-Gln-Phe-Gly-Gly-His-Asn-Ser-Val-Asp-Phe-Glu-Glu-Asp-Thr-Leu-Pro-Lys-Val | |
CF-1073 |
Fibronectin CS-1 Peptide |
Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr | |
CF-1074 |
Fibronectin Type III Connecting Segment (1-25) |
Asp-Glu-Leu-Pro-Gln-Leu-Val-Thr-Leu-Pro-His-Pro-Asn-Leu-His-Gly-Pro-Glu-Ile-Leu-Asp-Val-Pro-Ser-Thr | |
CF-1075 |
FITC-LC-Myelin Basic Protein Peptide Substrate |
FITC-LC-Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | |
CF-1076 |
F-L-E-E-V |
Phe-Leu-Glu-Glu-Val | |
CF-1077 |
FluM1 A2 (58-66) |
Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu | |
CF-1241 |
Fmoc-AEA |
260367-12-2 |
|
CF-1242 |
Fmoc-AEEA |
166108-71-0 |
|
CF-1243 |
Fmoc-AEEEA |
139338-72-0 |
|
CF-1244 |
Fmoc-AEEP |
872679-70-4 |
|
| CF-1245 | Fmoc-AEP | 1654740-73-4 | |
CF-1078 |
[Fmoc-Glu70,Ala71,72,Lys74]-C3a (70-77) |
Fmoc-Glu-Ala-Ala-Leu-Lys-Leu-Ala-Arg | |
| CF-1043 | Fmoc-hydrazide | 35661-51-9 | |
CF-1079 |
Fmoc-Lys(Boc)-Leu-Lys(Boc) |
Fmoc-Lys(Boc)-Leu-Lys(Boc) | |
CF-1080 |
Fmoc-Mating Factor a |
Fmoc-Trp-His-Trp-Leu-Gln-Leu-Lys-Pro-Gly-Gln-Pro-Met-Tyr | |
| CF-0314 | Fmoc-NH2 | 84418-43-9 | |
| CF-0629 | Fmoc-Pro-Pro-OH | 129223-22-9 | |
CF-1081 |
F-M-R-F |
Phe-Met-Arg-Phe | |
CF-1082 |
FMRF amide Molluscan Cardioexcitatory Peptide |
Phe-Met-Arg-Phe-NH2 | |
CF-1083 |
FMRF-like Neuropeptide; SchistoFLRFamide |
Pro-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 | |
CF-1084 |
FMRF-related peptide,Lymnaea heptapeptide |
Gly-Asp-Pro-Phe-Leu-Arg-Phe-NH2 | |
CF-1085 |
FMRF-related peptide, Pyr -DPFLRFM-NH2 |
Pyr-Asp-Pro-Phe-Leu-Arg-Phe-NH2 | |
CF-1086 |
FMRF-related peptide,SDPFLRF-NH2 |
Ser-Asp-Pro-Phe-Leu-Arg-Phe-NH2 | |
CF-1087 |
Forkhead derived peptide, Woodtide |
Lys-Lys-Ile-Ser-Gly-Arg-Leu-Ser-Pro-Ile-Met-Thr-Glu-Gln-NH2 | |
CF-1088 |
Formyl-LHRH (2-10) |
For-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 | |
CF-1089 |
N-Formyl-Met-Ala-Ser |
For-Met-Ala-Ser | |
CF-1090 |
N-Formyl-Met-Leu-Phe |
For-Met-Leu-Phe | |
CF-1091 |
N-Formyl-Met-Leu-Phe-Lys |
For-Met-Leu-Phe-Lys | |
CF-1092 |
N-Formyl-Nle-Leu-Phe-Nle-Tyr-Lys |
For-Nle-Leu-Phe-Nle-Tyr-Lys | |
CF-1093 |
F1 Peptide, lobster |
Thr-Asn-Arg-Asn-Phe-Leu-Arg-Phe-NH2 | |
CG-0074 |
G250.A2 |
His-Leu-Ser-Thr-Ala-Phe-Ala-Arg-Val | |
CG-0075 |
GAD65 (78-97) |
Lys-Pro-Cys-Asn-Cys-Pro-Lys-Gly-Asp-Val-Asn-Tyr-Ala-Phe-Leu-His-Ala-Thr-Asp-Leu | |
CG-0076 |
GAD65 (206-220) |
Thr-Tyr-Glu-Ile-Ala-Pro-Val-Phe-Val-Leu-Leu-Glu-Tyr-Val-Thr | |
CG-0077 |
Galanin (2-11) |
Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-NH2 | |
CG-0078 |
Galanin, human |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser | |
CG-0079 |
Galanin-Lys(Biotin), human |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Val-Gly-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-Asn-Gly-Leu-Thr-Ser-Lys(Biotin) | |
CG-0080 |
Galanin Message Associated Peptide (44-59) amide |
Leu-Pro-Gly-Leu-Pro-Ser-Ala-Ala-Ser-Ser-Glu-Asp-Ala-Gly-Gln-Ser-NH2 | |
CG-0081 |
Galanin Message Associated Peptide (1-41), amide; GMAP (1-41), amide; Preprogalanin (65-105), amide |
Glu-Leu-Glu-Pro-Glu-Asp-Glu-Ala-Arg-Pro-Gly-Gly-Phe-Asp-Arg-Leu-Gln-Ser-Glu-Asp-Lys-Ala-Ile-Arg-Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH2 | |
CG-0082 |
Galanin (1-13)-Neuropeptide Y (25-36), amide (M32) |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CG-0083 |
Galanin, porcine |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-His-Asp-Lys-Tyr-Gly-Leu-Ala-NH2 | 88813-36-9 |
CG-0084 |
Galanin (1-16), porcine, rat |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile | |
CG-0085 |
Galanin, rat |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-NH2 | 114547-31-8 |
CG-0086 |
Galanin (1-13)-Spantide I |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-D-Arg-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Leu-NH2 | |
CG-0087 |
Galantide |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CG-0192 |
mini-gastrin I (human) |
Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CG-0088 |
Gastric Inhibitory Peptide (GIP), human |
Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | |
CG-0089 |
Gastric Inhibitory Polypeptide (6-30) amide (human) |
Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH2 | |
CG-0090 |
Gastric Inhibitory Polypeptide (1-30) (porcine) |
Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys | |
CG-0102 |
Gastric Juice Peptide Fragmentc |
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | |
CG-0103 |
Gastrin, chicken |
Phe-Leu-Pro-His-Val-Phe-Ala-Glu-Leu-Ser-Asp-Arg-Lys-Gly-Phe-Val-Gln-Gly-Asn-Gly-Ala-Val-Glu-Ala-Leu-His-Asp-Phe-Tyr-Pro-Asp-Trp-Met-Asp-Phe-NH2 | |
CG-0104 |
Gastrin-1, human |
Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CG-0101 |
Gastrin I (1-14) (human) |
Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp | 100940-57-6 |
CG-0105 |
Gastrin I (rat) |
Pyr-Arg-Pro-Pro-Met-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH2 | |
CG-0106 |
Gastrin Releasing Peptide,human |
Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CG-0091 |
Gastrin Releasing Peptide (1-16), human |
Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro | |
CG-0092 |
Gastrin Releasing Peptide-Lys(Biotin), human |
Val-Pro-Leu-Pro-Ala-Gly-Gly-Gly-Thr-Val-Leu-Thr-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-Lys(Biotin) | |
CG-0093 |
Gastrin Releasing Peptide,procine |
Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CG-0094 |
Gastrin Tetrapeptide |
Trp-Met-Asp-Phe-NH2 | |
| CG-0001 | G-A-Y | Gly-Ala-Tyr | |
| CG-0015 | G-F-R | Gly-Phe-Arg | |
| CG-0062 | GHK | Gly-His-Lys | 72957-37-0 |
CG-0095 |
Ghrelin (human) |
Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Arg-Val-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro-Arg | |
CG-0096 |
Ghrelin (Rat) |
Gly-Ser-Ser(n-octanoyl)-Phe-Leu-Ser-Pro-Glu-His-Gln-Lys-Ala-Gln-Gln-Arg-Lys-Glu-Ser-Lys-Lys-Pro-Pro-Ala-Lys-Leu-Gln-Pro- Arg | |
CG-0097 |
GHRF (1-44), human |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH2 | |
CG-0098 |
GHRF, mouse |
His-Val-Asp-Ala-Ile-Phe-Thr-Thr-Asn-Tyr-Arg-Lys-Leu-Leu-Ser-Gln-Leu-Tyr-Ala-Arg-Lys-Val-Ile-Gln-Asp-Ile-Met-Asn-Lys-Gln-Gly-Glu-Arg-Ile-Gln-Glu-Gln-Arg-Ala-Arg-Leu-Ser | |
CG-0099 |
GHRF, ovine |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Ile-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Lys-Val-Arg-Leu-NH2 | |
CG-0100 |
GHRF, rat |
His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Arg-Ser-Arg-Phe-Asn | |
| CG-0041 | GHRP-2 acetate | D-Ala-D-2-Nal-Ala-Trp-D-Phe-Lys-NH2 | 158861-67-7 |
| CG-0042 | GHRP-6 acetate | 87616-84-0 | |
CG-0107 |
GIP (1 - 30), porcine, amide |
Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-NH2 | |
CG-0108 |
GIP (3 - 42), human |
Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-His-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | |
CG-0109 |
GIP, mouse, rat |
Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | |
CG-0110 |
GIP, porcine |
Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Ser-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | |
| CG-0045 | α-Gliadin (57-73) | Gln-Leu-Gln-Pro-Phe-Pro-Gln-Pro-Glu-Leu-Pro-Tyr-Pro-Gln-Pro-Gln-Ser | |
CG-0111 |
Gliadin (43-49)(Gliadorphin) Alpha |
Tyr-Pro-Gln-Pro-Gln-Pro-Phe | |
CG-0112 |
[Gln11]-β-Amyloid (1-16) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys | |
CG-0113 |
[Gln11]-β-Amyloid (1-28) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys | |
CG-0114 |
[Gln11]-β-Amyloid (1-40) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CG-0115 |
[Gln22]-β-Amyloid (1-40) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CG-0116 |
[Gln22]-25359-Amyloid (6-40) |
His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gln-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CG-0117 |
[Gln9]-Amyloid β-Protein (1-40) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gln-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CG-0118 |
[Gln8] LH-RH, chicken |
Pyr-His-Trp-Ser-Tyr-Gly-Leu-Gln-Pro-Gly-NH2 | |
CG-0119 |
[Gln4] Neurotensin |
Pyr-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | 61445-54-3 |
CG-0120 |
[Gln18]-Platelet Factor 4 (15-22) (human) |
Thr-Thr-Ser-Gln-Val-Arg-Pro-Arg | |
CG-0121 |
[Gln144]-PLP(139-151), Q144-PLP(139-151) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Gln-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
| CG-0065 | GLP-1(7-36) acetate | 107444-51-9 | |
CG-0122 |
GLP-1 (7-36) amide (chicken,common turkey) |
His-Ala-Glu-Gly-Thr-Tyr-Thr-Ser-Asp-Ile-Thr-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Asn-Gly-Arg-NH2 | |
CG-0123 |
GLP-1 (9-36) amide (human,bovine, guinea pig, mouse,porcine, rat) |
Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | |
CG-0124 |
GLP-2 (1-33) (human) |
His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp | |
CG-0125 |
GLP-2 (1-34) (human) |
His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Ala-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp-Arg | |
CG-0126 |
GLP-1 (1-37) (human, bovine,guinea pig, mouse, rat) |
His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly | |
CG-0127 |
GLP-1 (7-36)-Lys(biotinyl) amide (human, bovine, guinea pig, mouse, rat) |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Lys(bio) -NH2 | |
CG-0128 |
GLP-2 (rat) |
His-Ala-Asp-Gly-Ser-Phe-Ser-Asp-Glu-Met-Asn-Thr-Ile-Leu-Asp-Asn-Leu-Ala-Thr-Arg-Asp-Phe-Ile-Asn-Trp-Leu-Ile-Gln-Thr-Lys-Ile-Thr-Asp | |
CG-0129 |
[Glu10] - ACTH (1 - 17) |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Glu-Lys-Pro-Val-Gly-Lys-Lys-Arg | |
CG-0130 |
Glucagon (1-29), bovine,human, porcine |
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | |
CG-0131 |
Glucagon (19-29), bovine,human, porcine |
Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr | |
| CG-0044 | Glucagon 1-29 acetate | 16941-32-5 | |
CG-0132 |
Glucagon (1-37), porcine; Oxyntomodulin, porcine |
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Lys-Asn-Asn-Ile-Ala | |
CG-0133 |
Glucagon-Like Peptide 1 (7-37) |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly | |
CG-0134 |
Glucagon-Like Peptide I (7-36),amide, human |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | |
CG-0135 |
Glucagon-Like Peptide 1 (7 -17)-Cys, GLP - 1 (7-17) -Cys |
His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Cys | |
CG-0136 |
Glucagon-Like Peptide 1, (GLP-1) amide, human |
His-Asp-Glu-Phe-Glu-Arg-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | |
CG-0137 |
[Glu3,4,7,10,14]-Conantokin G |
Gly-Glu-Glu-Glu-Leu-Gln-Glu-Asn-Gln-Glu-Leu-Ile-Arg-Glu-Lys-Ser-Asn-NH2 | |
CG-0138 |
Gluten Exorphin A5 |
Gly-Tyr-Tyr-Pro-Thr | |
CG-0139 |
Gluten Exorphin B5 |
Tyr-Gly-Gly-Trp-Leu | |
CG-0140 |
Gluten Exorphin C |
Tyr-Pro-Ile-Ser-Leu | |
CG-0141 |
[Glu1] Fibrinopeptide B, human |
Glu-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg | |
CG-0142 |
[Glu2]-TRH |
Pyr-Glu-Pro-NH2 | |
CG-0143 |
[D-Glu5,D-Trp7,9,10]-Substance P (5-11) |
D-Glu-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 | |
CG-0144 |
[Gly22]-β-Amyloid (1-40) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CG-0145 |
[Gly22]-Amyloid b-Protein (1-42) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Gly-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-I le-Ala | |
CG-0146 |
Glycogen Synthase-derived peptide |
Lys-Lys-Leu-Asn-Arg-Thr-Leu-Ser-Val-Ala | |
CG-0147 |
Glycoprotein Hormone a (32-46) amide |
Cys-Phe-Ser-Arg-Ala-Tyr-Pro-Thr-Pro-Leu-Arg-Ser-Lys-Lys-Thr-NH2 | |
CG-0148 |
Glycoprotein IIb Fragment (300-312) |
Gly-Asp-Gly-Arg-His-Asp-Leu-Leu-Val-Gly-Ala-Pro-Leu | |
CG-0149 |
Glycoprotein IIb Fragment (656-667) |
Gly-Ala-His-Tyr-Met-Arg-Ala-Leu-Ser-Asn-Val-Glu | |
CG-0150 |
[Gly30,Cys31]- β-Amyloid (13-31) |
His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Gly-Cys | |
CG-0151 |
[Gly28,Cys30]-Amyloid b-Protein (1-30) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Gly-Gly-Cys-NH2 | |
| CG-0022 | Gly-Gly-Ile |
69242-40-6 | |
| CG-0023 | Gly-Gly-Leu | 14857-82-0 | |
| CG-0024 | Gly-Gly-Val | 20274-89-9 | |
| CG-0006 | Gly-Ile | 19461-38-2 | |
| CG-0018 | Gly-Tyr | 658-79-7 | |
| CG-0008 | Gly-Val | 1963-21-9 | |
CG-0152 |
[Gly1,Ser3,22,Gln4,34,Thr6,Ala19,Tyr21,Ala23,31, Aib32]-Pancreatic Polypeptide (human) |
Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | |
CG-0153 |
[Gly11] Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Gly-NH2 | |
CG-0154 |
GMAP (16-41), amide |
Leu-Gln-Ser-Glu-Asp-Lys-Ala-Ile-Arg-Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH2 | |
CG-0155 |
GMAP (25-41), amide |
Thr-Ile-Met-Glu-Phe-Leu-Ala-Phe-Leu-His-Leu-Lys-Glu-Ala-Gly-Ala-Leu-NH2 | |
CG-0156 |
GM-CSF (17-31) |
Asn-Ala-Ile-Gln-Glu-Ala-Arg-Arg-Leu-Leu-Asn-Leu-Ser-Arg-Asp | |
CG-0157 |
GM-CSF (96-112) |
Cys-Ala-Thr-Gln-Ile-Ile-Thr-Phe-Glu-Ser-Phe-Lys-Glu-Asn-Leu-Lys-Asp | |
CG-0158 |
Gn-RH Associated Peptide (GAP) (1-13), human |
Asp-Ala-Glu-Asn-Leu-Ile-Asp-Ser-Phe-Gln-Glu-Ile-Val | |
CG-0159 |
GnT-V (nt38 - 67) |
Val-Leu-Pro-Asp-Val-Phe-Ile-Arg-Cys-Val | |
| CG-0046 | Gonadorelin acetate | 71447-49-9 | |
| CG-0048 | Goserelin acetate | 145781-92-6 | |
CG-0160 |
G154; gp100 (154-162) |
Lys-Thr-Trp-Gly-Gln-Tyr-Trp-Gln-Val | |
CG-0161 |
G209-2M; gp100 (209-217) |
Ile-Met-Asp-Gln-Val-Pro-Phe-Ser-Val | |
| CG-0047 | gp 38 | Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys（Disulfide bridge:Cys20-Cys26） | |
CG-0162 |
gp100 (177-186) |
Ala-Met-Leu-Gly-Thr-His-Thr-Met-Glu-Val | |
CG-0163 |
gp100 (178-187) |
Met-Leu-Gly-Thr-His-Thr-Met-Glu-Val | |
CG-0164 |
gp100 (457-466) |
Leu-Leu-Asp-Gly-Thr-Ala-Thr-Leu-Arg-Leu | |
CG-0165 |
gp100 (476-485) |
Val-Leu-Tyr-Arg-Tyr-Gly-Ser-Phe-Ser-Val | |
CG-0166 |
gp100 (570-579) |
Ser-Leu-Ala-Asp-Thr-Asn-Ser-Leu-Ala-Val | |
CG-0167 |
gp100 (614–622) |
Leu-Ile-Tyr-Arg-Arg-Arg-Leu-Met-Lys | |
CG-0168 |
gp100 (619–627) |
Arg-Leu-Met-Lys-Gln-Asp-Phe-Ser-Val | |
CG-0169 |
gp100 (639–647) |
Arg-Leu-Pro-Arg-Ile-Phe-Cys-Ser-Cys | |
CG-0170 |
GPC3 (144-152) |
Phe-Val-Gly-Glu-Phe-Phe-Thr-Asp-Val | |
CG-0171 |
GPC3 (298-306), mouse |
Glu-Tyr-Ile-Leu-Ser-Leu-Glu-Glu-Leu | |
CG-0172 |
gp120, HIV-1 MN |
Tyr-Asn-Ala-Lys-Arg-Lys-Arg-Ile-His-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Tyr-Thr-Thr-Lys-Asn-Ile-Ile | |
| CG-0194 | G-P-R | Gly-Pro-Arg | |
| CG-0195 | G-Q | Gly-Gln | |
CG-0173 |
Granuliberin R |
Phe-Gly-Phe-Leu-Pro-Ile-Tyr-Arg-Arg-Pro-Ala-Ser-NH2 | |
CG-0174 |
Grb2 SH2 Domain Ligand |
Tyr(PO3H2)-Val-Asn-Val | |
| CG-0013 | GRF (1-29) | Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Al a-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 |
863288-34-0 |
CG-0175 |
GRF (1-29) amide (rat) |
His-Ala-Asp-Ala-Ile-Phe-Thr-Ser-Ser-Tyr-Arg-Arg-Ile-Leu-Gly-Gln-Leu-Tyr-Ala-Arg-Lys-Leu-Leu-His-Glu-Ile-Met-Asn-Arg-NH2 | |
CG-0176 |
GRF (free acid) (human) |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu | |
CG-0177 |
GRF, porcine |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Arg-Val-Arg-Leu-NH2 | |
CG-0178 |
G-R-G-D-S-P |
Gly-Arg-Gly-Asp-Ser-Pro | |
CG-0179 |
G-R-G-D-T-P |
Gly-Arg-Gly-Asp-Thr-Pro | |
CG-0180 |
G-R-G-E-S-P (Inactive control) |
Gly-Arg-Gly-Glu-Ser-Pro | |
CG-0181 |
G-R-G-E-T-P |
Gly-Arg-Gly-Glu-Thr-Pro | |
CG-0182 |
GRPP (human) |
Arg-Ser-Leu-Gln-Asp-Thr-Glu-Glu-Lys-Ser-Arg-Ser-Phe-Ser-Ala-Ser-Gln-Ala-Asp-Pro-Leu-Ser-Asp-Pro-Asp-Gln-Met-Asn-Glu-Asp | |
CG-0183 |
Growth Hormone Releasing Factor, GRF (1-29), amide,human |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 | |
CG-0184 |
Growth Hormone Releasing Factor, GRF (1-40), amide,human |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-NH2 | |
CG-0185 |
Growth Hormone Releasing Factor, GRF, (1-40), human |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala | |
CG-0186 |
Growth Hormone Releasing Factor, GRF (1-44), amide,bovine |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Asn-Arg-Gln-Gln-Gly-Glu-Arg-Asn-Gln-Glu-Gln-Gly-Ala-Lys-Val-Arg-Leu-NH2 | |
CG-0187 |
GRP (14-27) (human, porcine,canine) |
Met-Tyr-Pro-Arg-Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CG-0188 |
GRP (1-16) (porcine) |
Ala-Pro-Val-Ser-Val-Gly-Gly-Gly-Thr-Val-Leu-Ala-Lys-Met-Tyr-Pro | |
CG-0189 |
GSK3 Peptide Substrate |
Gly-Arg-Pro-Arg-Thr-Thr-Ser-Phe-Ala-Glu | |
| CG-0196 | GSP | Glu-Met-Arg-Leu-Ser-Lys-Phe-Phe-Arg-Asp-Phe-Ile-Leu-Gln-Arg-Lys-Lys | |
CG-0190 |
Guanylin, human |
Pro-Gly-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys(Disulfide bridge: Cys4-Cys12,Cys7-Cys15) | |
CG-0191 |
Guanylin, rat, mouse |
Pro-Asn-Thr-Cys-Glu-Ile-Cys-Ala-Tyr-Ala-Ala-Cys-Thr-Gly-Cys(Disulfide bridge: Cys4-Cys12,Cys7-Cys15) | |
| CH-0426 | H-Ala-Phe-OH |
3061-90-3 | |
CH-0677 |
HA Peptide |
Tyr-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala | |
CH-0678 |
HBcAg (HBV) (18 - 27) |
Phe-Leu-Pro-Ser-Asp-Phe-Phe-Pro-Ser-Val | |
| CH-0259 | HBPipU | 190849-64-0 | |
CH-0679 |
HBV core (107 - 115) |
Cys-Leu-Thr-Phe-Gly-Arg-Glu-Thr-Val | |
CH-0680 |
HBV core14, (HBA31) |
Ser-Thr-Leu-Pro-Glu-Thr-Thr-Val-Val-Arg-Arg | |
CH-0681 |
HBV core protein (128-140) |
Thr-Pro-Pro-Ala-Tyr-Arg-Pro-Pro-Asn-Ala-Pro-Ile-Leu | |
CH-0682 |
HBV env (183–191) |
Phe-Leu-Leu-Thr-Arg-Ile-Leu-Thr-Ile | |
CH-0683 |
HBV env (335 - 343) |
Trp-Leu-Ser-Leu-Leu-Val-Pro-Phe-Val | |
CH-0684 |
HBVpol502, HBV polymerase (502 - 510) |
Lys-Leu-His-Leu-Tyr-Ser-His-Pro-Ile | |
CH-0685 |
HBVpol655, HBV polymerase (655 - 663) |
Ala-Leu-Met-Pro-Leu-Tyr-Ala-Cys-Ile | |
CH-0686 |
HBV polymerase (455 - 463) |
Gly-Leu-Ser-Arg-Tyr-Val-Ala-Arg-Leu | |
| CH-0312 | HBPyU | 105379-24-6 | |
| CH-0256 | HCTU | 330645-87-9 | |
CH-0687 |
HCV Core Protein (19-25) |
Pro-Gln-Asp-Val-Lys-Phe-Pro | |
CH-0688 |
HCV Core Protein (59-68) |
Arg-Gly-Arg-Arg-Gln-Pro-Ile-Pro-Lys-Ala | |
CH-0689 |
HCV Core Protein (107-114) |
Trp-Gly-Pro-Asn-Asp-Pro-Arg-Arg | |
CH-0690 |
HCV-1 e2 Protein (484 - 499) |
Pro-Tyr-Cys-Trp-His-Tyr-Pro-Pro-Lys-Pro-Cys-Gly-Ile-Val-Pro-Ala | |
CH-0691 |
HCV-1 e2 Protein (554 - 569) |
Trp-Met-Asn-Ser-Thr-Gly-Phe-Thr-Lys-Val-Cys-Gly-Ala-Pro-Pro-Cys | |
CH-0692 |
HCV NS4A Protein (22-33) (FDA strain) |
Cys-Val-Val-I le-Val-Gly-Arg-I le-Val-Leu-Ser-Gly | |
CH-0693 |
HCV NS4A Protein (22-34) (H strain) |
Cys-Val-Val-I le-Val-Gly-Arg-Val-Val-Leu-Ser-Gly-Lys | |
CH-0694 |
HCV NS4A Protein (21-34) (JT strain) |
Gly-Ser-Val-Val-I le-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg | |
CH-0695 |
HCV Nucleoprotein (88-96) |
Asn-Glu-Gly-Leu-Gly-Trp-Ala-Gly-Trp | |
| CH-0261 | HDBTU | 125700-68-7 | |
CH-0696 |
Head activator |
Pyr-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe | |
CH-0108 |
L-His-ala |
16874-75-2 | |
CH-0109 |
L-His-gly |
2578-58-7 | |
CH-0697 |
Head activator (7-11) |
Lys-Val-Ile-Leu-Phe | |
CH-0698 |
α-Helical CRF (9-41) |
Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 | |
CH-0699 |
α-Helical CRF (12-41) |
Phe-His-Leu-Leu-Arg-Glu-Met-Leu-Glu-Met-Ala-Lys-Ala-Glu-Gln-Glu-Ala-Glu-Gln-Ala-Ala-Leu-Asn-Arg-Leu-Leu-Leu-Glu-Glu-Ala-NH2 | |
CH-0700 |
Helodormin |
His-Ser-Asp-Ala-Ile-Phe-Thr-Gln-Gln-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Ala-Ser-Ile-Leu-Gly-Ser-Arg-Thr-Ser-Pro-Pro-Pro-NH2 | |
CH-0701 |
Helospectin I |
His-Ser-Asp-Ala-Thr-Phe-Thr-Ala-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Glu-Ser-Ile-Leu-Gly-Ser-Ser-Thr-Ser-Pro-Arg-Pro-Pro-Ser-Ser | |
CH-0702 |
Helospectin II |
His-Ser-Asp-Ala-Thr-Phe-Thr-Ala-Glu-Tyr-Ser-Lys-Leu-Leu-Ala-Lys-Leu-Ala-Leu-Gln-Lys-Tyr-Leu-Glu-Ser-Ile-Leu-Gly-Ser-Ser-Thr-Ser-Pro-Arg-Pro-Pro-Ser | |
CH-0703 |
He-LWamide II |
Lys-Pro-Pro-Gly-Leu-Trp-NH2 | |
CH-0704 |
Hemagglutinin (48-68) /Influenza virus |
Thr-Gly-Lys-Ile-Cys-Asn-Asn-Pro-His-Arg-Ile-Leu-Asp-Gly-Ile-Asp-Cys-Thr-Leu-Ile-Asp | |
CH-0705 |
Hemoglobin (Hb) (64 - 76) |
Gly-Lys-Lys-Val-Ile-Thr-Ala-Phe-Asn-Glu-Gly-Leu-Lys | |
CH-0706 |
Hemokinin 1 (human) |
Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CH-0707 |
Hemokinin 1 (mouse, rat) |
Arg-Ser-Arg-Thr-Arg-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | |
CH-0708 |
Hemorphin-7 |
Tyr-Pro-Trp-Thr-Gln-Arg-Phe | |
CH-0709 |
Hepatitus B Virus Pre-S Region (120-145) |
Met-Gln-Trp-Asn-Ser-Thr-Thr-Phe-His-Gln-Thr-Leu-Gln-Asp-Pro-Arg-Val-Arg-Gly-Leu-Tyr-Phe-Pro-Ala-Gly-Gly | |
CH-0710 |
Hepatitis B Virus Receptor Binding Fragment |
Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro-Ala-Phe-Gly-Ala-Asn-Ser-Asn-Asn-Pro-Asp-Trp-Asp-Phe-Asn-Pro | |
CH-0711 |
Hepatitis Virus C NS3 Protease Inhibitor 1 |
Ac-Asp-Glu-Met-Glu-Glu-Cys | |
CH-0712 |
HER2/neu (869-877) |
Leu-Leu-Asp-Ile-Asp-Glu-Thr-Glu-Tyr | |
CH-0713 |
HER2/neu(654-662) GP2 |
Ile-Ile-Ser-Ala-Val-Val-Gly-Ile-Leu | |
CH-0714 |
Herpes Virus Inhibitor 1 |
Tyr-Ala-Gly-Ala-Val-Val-Asn-Asp-Leu | |
CH-0715 |
Hexa His |
His-His-His-His-His-His | |
CH-0716 |
Hexa -Tyrosine |
Tyr-Tyr-Tyr-Tyr-Tyr-Tyr | |
| CH-0253 | Hexarelin acetate | 140703-51-1 | |
CH-0717 |
Hirudin (54-65) (desulfated) |
Gly-Asp-Phe-Glu-Glu-Ile-Pro-Glu-Glu-Tyr-Leu-Gln | |
CH-0718 |
[His1, Lys6]-GHRP, GHRP-6 |
His-D-Trp-Ala-Trp-D-Phe-Lys-NH2 | |
CH-0719 |
[D-His26]-Neuropeptide Y, human, rat; [D-His26]-NPY, human, rat |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-D-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CH-0720 |
[His11]Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-His-NH2 | |
CH-0721 |
Histatin 3 (H3) |
Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr-Arg-Ser-Asn-Tyr-Leu-Tyr-Asp-Asn | |
CH-0722 |
Histatin 5 (H5) |
Asp-Ser-His-Ala-Lys-Arg-His-His-Gly-Tyr-Lys-Arg-Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr | |
CH-0723 |
Histatin-8 [Hemagglutination -Inhibiting Peptide (HIP)] |
Lys-Phe-His-Glu-Lys-His-His-Ser-His-Arg-Gly-Tyr | |
CH-0724 |
Histone H3 (1-25),amide |
Ala-Arg-Thr-Lys-Gln-Thr-Ala-Arg-Lys-Ser-Thr-Gly-Gly-Lys-Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala--NH2 | |
CH-0725 |
Histone H3 (116-136), C116-136 |
Lys-Arg-Val-Thr-Ile-Met-Pro-Lys-Asp-Ile-Gln-Leu-Ala-Arg-Arg-Ile-Arg-Gly-Glu-Arg-Ala | |
CH-0726 |
Histone H1 - derived peptide |
Gly-Gly-Gly-Pro-Ala-Thr-Pro-Lys-Lys-Ala-Lys-Lys-Leu | |
CH-0727 |
Histone H3 (116–136), N15-39 |
Ala-Pro-Arg-Lys-Gln-Leu-Ala-Thr-Lys-Ala-Ala-Arg-Lys-Ser-Ala-Pro-Ala-Thr-Gly-Gly-Val-Lys-Lys-Pro-His | |
| CH-0255 | Histrelin acetate | 220810-26-4 | |
CH-0728 |
HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) |
Ala-Val-Gly-Ile-Gly-Ala-Leu-Phe-Leu-Gly-Phe-Leu-Gly-Ala-Ala-Gly-Ser-Thr-Met-Gly-Ala-Arg-Ser-NH2 | |
CH-0729 |
HIV-1 env Protein gp120 (278-292) (strains BH10, BH8,HXB2, HXB3, PV22) |
Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys | |
CH-0730 |
HIV-1 gag Protein p24 (137-154) |
Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Ser-Pro-Thr-Ser-Ile-Leu-Asp-Ile-Arg | |
CH-0731 |
HIV-1 gag Protein p24 (194-210) |
Ala-Asn-Pro-Asp-Cys-Lys-Thr-Ile-Leu-Lys-Ala-Leu-Gly-Pro-Ala-Ala-Thr | |
CH-0732 |
HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) |
Ala-Met-Gln-Met-Leu-Lys-Asp-Thr-Ile | |
CH-0733 |
HIV -gp120- Antigenic Peptide |
Cys-Gly-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg | |
CH-0734 |
HIV-gp41-Antigenic Peptide 5 |
Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys-His-Thr-Thr-Val-Pro-Trp-Val-Asn-Asp-Ser-NH2(Disulfide bridge: Cys20-Cys26) | |
CH-0735 |
HIV-gp120-41-C |
Val-Pro-Trp-Asn-Ser-Ser-Trp-Ser-Asn-Lys-Leu-Asp-Arg-Ile-Trp-Asn-Asn-Met-Thr-Trp | |
CH-0736 |
HIV-gp41-Fragment |
Ala-Val-Gly-Ile-Gly-Ala | |
CH-0737 |
HIV -gp120- Fragment (254-274) |
Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu | |
CH-0738 |
HIV-gp120- Fragment (308-331) |
Asn-Asn-Thr-Arg-Lys-Ser-Ile-Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys-Ile-Gly | |
CH-0739 |
HIV-gp120-Fragment (318-327) |
Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile | |
CH-0740 |
HIV -gp120- Fragment (421-438) |
Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly-Lys-Ala-Met-Tyr-Ala-Pro-Pro | |
CH-0741 |
HIV-gp120-41-N-A |
Leu-Trp-Val-Thr-Val-Tyr-Tyr-Gly-Val-Pro-Val-Trp-Lys-Lys-Val-Val | |
CH-0742 |
HIV-gp120-41-N-B |
Ile-Glu-Pro-Leu-Gly-Ile-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg | |
CH-0743 |
HIV-1, HIV-2 Protease Substrate |
Ala-Thr-Leu-Asn-Phe-Pro-Ile-Ser-Pro-Trp | |
CH-0744 |
HIV Integrase Protein Inhibitor(1) |
His-Cys-Lys-Phe-Trp-Trp | |
CH-0745 |
HIV Nef(90 - 100) |
Phe-Leu-Lys-Glu-Lys-Gly-Gly-Leu-Glu-Gly-Leu | |
CH-0746 |
HIV Protease Substrate |
Ac-Ala-Arg-Val-Leu-Ala-Glu-Ala-NH2 | |
CH-0747 |
HIV QK10 |
Gln-Val-Pro-Leu-Arg-Met-Thr-Tyr-Lys | |
CH-0748 |
HIV-1 rev Protein (34-50) |
Thr-Arg-Gln-Ala-Arg-Arg-Asn-Arg-Arg-Arg-Arg-Trp-Arg-Glu-Arg-Gln-Arg | |
CH-0749 |
HIV-1 tat Protein (1-9) |
Met-Asp-Pro-Val-Asp-Pro-Asn-Ile-Glu | |
CH-0750 |
HIV-1 tat Protein (47-57) |
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg | |
CH-0751 |
HIV-1 tat Protein (49-57) |
Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg | |
CH-0752 |
HJ Inhibitor Peptide 2 |
Lys-Trp-Trp-Cys-Arg-Trp | |
| CH-0262 | HNTU | 208462-94-6 | |
| CH-0263 | HOCt | 137156-41-3 | |
| CH-0257 | HOOBt |
28230-32-2 | |
| CH-0311 | HPD-OSu | 443305-32-6 | |
| CH-0264 | HPTDP | 366821-61-6 | |
CH-0753 |
HPV-E6-C |
Pro-Leu-Cys-Pro-Glu-Glu-Lys-Gln-Arg-His-Leu-Asp-Lys-Lys-Gln-Arg-Phe-His-Asn-Ile | |
CH-0754 |
HPV-E7-C |
Ser-Ser-Glu-Glu-Glu-Asp-Glu-Ile-Asp-Gly-Pro-Ala-Gly-Gln-Ala-Glu-Pro-Asp-Arg-Ala | |
CH-0755 |
HPV-E6-M |
Ser-Glu-Tyr-Pro-His-Tyr-Cys-Tyr-Ser-Leu-Tyr-Gly-Thr-Thr-Leu-Glu-Gln-Gln-Tyr-Asn | |
CH-0756 |
HPV-E6-N |
Asp-Pro-Gln-Glu-Arg-Pro-Arg-Lys-Leu-Pro-Gln-Leu-Cys-Thr-Glu | |
CH-0757 |
HPV-E7-N |
Tyr-Met-Leu-Asp-Leu-Gln-Pro-Glu-Thr-Thr-Asp-Leu-Tyr-Cys-Tyr-Glu-Gln-Leu-Asn-Asp | |
CH-0758 |
Hsp Heat shock protein (3–13) |
Lys-Thr-Ile-Ala-Tyr-Asp-Glu-Glu-Ala-Arg-Arg | |
| CH-0260 | HSPyU | 207683-26-9 | |
| CH-0258 | HSTU | 265651-18-1 | |
CH-0759 |
HSV-1-amide UL 26 Open Reading Frame (242-255) |
His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Met-Trp-Gly-NH2 | |
CH-0760 |
HSV-1 Glycoprotein (gB) (497-507) |
Thr-Ser-Ser-Ile-Glu-Phe-Ala-Arg-Leu-Gln-Phe | |
CH-0761 |
HSV-gB2 (498 - 505) |
Ser-Ser-Ile-Glu-Phe-Ala-Arg-Leu | |
CH-0762 |
Human CMV Assemblin Protease Substrate (M-site) |
Arg-Gly-Val-Val-Asn-Ala-Ser-Ser-Arg-Leu-Ala-Lys | |
CH-0763 |
Human CMV pp65 (495-503) |
Asn-Leu-Val-Pro-Met-Val-Ala-Thr-Val | |
CH-0764 |
Human Follicular Conadotropin Releasing Peptide (Hf-GRP) |
Thr-Asp-Thr-Ser-His-His-Asp-Gln-Asp-His-Pro-Thr-Phe-Asn | |
CH-0765 |
Human Growth Hormone (1-43) |
Phe-Pro-Thr-Ile-Pro-Leu-Ser-Arg-Leu-Phe-Asp-Asn-Ala-Met-Leu-Arg-Ala-His-Arg-Leu-His-Gln-Leu-Ala-Phe-Asp-Thr-Tyr-Gln-Glu-Phe-Glu-Glu-Ala-Tyr-Ile-Pro-Lys-Glu-Gln-Lys-Tyr-Ser | |
CH-0766 |
Human IgE Pentapeptide HEPP |
Asp-Ser-Asp-Pro-Arg | |
CH-0767 |
Humanin (human) |
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | |
CH-0768 |
Human Papillomavirus E7 protein (49 - 57) |
Arg-Ala-His-Tyr-Asn-Ile-Val-Thr-Phe | |
| CH-0435 | H-Val-Pro-Pro-OH | 58872-39-2 | |
| CH-0769 | Hydrin 1 | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-Arg (Disulfide bridge: Cys1-Cys6) | 122842-47-1 |
CH-0770 |
Hydrin 2 |
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly(Disulfide bridge:C1-C6) | |
| CH-0302 | 4-(Hydroxymethyl)phenoxyacetic acid | 68858-21-9 | |
| CH-0303 | 3-Hydroxy-9H-xanthen-9-one | 3722-51-8 | |
CH-0771 |
Hylambatin |
Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 | |
CH-0772 |
Hypercalcemia Malignancy Factor (1-40) |
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser | |
CH-0773 |
Hypercalcemia Malignancy Factor (1-34), amide, human |
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | |
CH-0774 |
Hypercalcemia Malignancy Factor (7-34), amide, human |
Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-NH2 | |
CH-0775 |
Hypercalcemia Malignancy Factor (1-34), human |
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala | |
CH-0776 |
Hypertrehalosaemic Neuropeptide, Heliothis zea |
Pyr-Leu-Thr-Phe-Ser-Ser-Gly-Trp-Gly-Asn-NH2 | |
CH-0777 |
Hypertrehalosaemic Neuropeptide, Nauphoeta cinerea |
Pyr-Val-Asn-Phe-Ser-Pro-Gly-Trp-Gly-Thr-NH2 | |
CH-0778 |
Hypocretin (70-98) (human) |
Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Gly | |
CI-0320 |
IELLQAR Selectin Binding Peptide |
Ile-Glu-Leu-Leu-Gln-Ala-Arg | |
CI-0321 |
IGF-I (1-3) |
Gly-Pro-Glu | |
CI-0322 |
IGF-I (24-41) |
Tyr-Phe-Asn-Lys-Pro-Thr-Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr | |
CI-0323 |
IGF-I (30-41) |
Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr | |
CI-0324 |
IGF-II (33-40) |
Ser-Arg-Val-Ser-Arg-Arg-Ser-Arg | |
CI-0325 |
IGF-I Analog |
Cys-Tyr-Ala-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Cys | |
| CI-0200 | IGF-1 LR3 | ||
CI-0326 |
I-309 (human) |
Lys-Ser-Met-Gln-Val-Pro-Phe-Ser-Arg-Cys-Cys-Phe-Ser-Phe-Ala-Glu-Gln-Glu-Ile-Pro-Leu-Arg-Ala-Ile-Leu-Cys-Tyr-Arg-Asn-Thr-Ser-Ser-Ile-Cys-Ser-Asn-Glu-Gly-Leu-Ile-Phe-Lys-Leu-Lys-Arg-Gly-Lys-Glu-Ala-Cys-Ala-Leu-Asp-Thr-Val-Gly-Trp-Val-Gln-Arg-His-Arg-Lys-Met-Leu-Arg-His-Cys-Pro-Ser-Lys-Arg-Lys | |
CI-0327 |
IL-8 (-5 to +5) |
Ala-Val-Leu-Pro-Arg-Ser-Ala-Lys-Glu-Leu | |
CI-0328 |
IL-1a (223-250) (human) |
Phe-Phe-Tyr-Glu-Thr-His-Gly-Thr-Lys-Asn-Tyr-Phe-Thr-Ser-Val-Ala-His-Pro-Asn-Leu-Phe-Ile-Ala-Thr-Lys-Gln-Asp-Tyr | |
CI-0329 |
IL-1b (178-207) (human) |
Leu-Lys-Glu-Lys-Asn-Leu-Tyr-Leu-Ser-Cys-Val-Leu-Lys-Asp-Asp-Lys-Pro-Thr-Leu-Gln-Leu-Glu-Ser-Val-Asp-Pro-Lys-Asn-Tyr-Pro | |
CI-0330 |
IL-1b (208-240) (human) |
Lys-Lys-Lys-Met-Glu-Lys-Arg-Phe-Val-Phe-Asn-Lys-Ile-Glu-Ile-Asn-Asn-Lys-Leu-Glu-Phe-Glu-Ser-Ala-Gln-Phe-Pro-Asn-Trp-Tyr-Ile-Ser-Thr | |
CI-0331 |
[Ile34]-β- Amyloid (25-34) |
Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Ile | |
CI-0332 |
[Ile161]MAGE-A2 (157 -166) |
Tyr-Leu-Gln-Leu-Ile-Phe-Gly-Ile-Glu-Val | |
CI-0333 |
[Ile8]-Oxytocin |
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Ile-Gly-NH2 (Disulfide bridge Cys1-Cys6) | |
CI-0334 |
[Ile-Ser] - Bradykinin (T-Kinin) |
Ile-Ser-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CI-0335 |
[Ile76]-TNF-a (70-80) (human) |
Pro-Ser-Thr-His-Val-Leu-Ile-Thr-His-Thr-Ile | |
CI-0336 |
[Ile12, Val15] MUC5AC Analog 3 |
Gly-Thr-Thr-Pro-Ser-Pro-Val-Pro-Thr-Thr-Ser-Ile-Thr-Ser-Val-Pro | |
CI-0337 |
IL-6 (88-121) (human) |
Ile-Ile-Thr-Gly-Leu-Leu-Glu-Phe-Glu-Val-Tyr-Leu-Glu-Tyr-Leu-Gln-Asn-Arg-Phe-Glu-Ser-Ser-Glu-Glu-Gln-Ala-Arg-Ala-Val-Gln-Met-Ser-Thr-Lys | |
CI-0338 |
IL-8 Inhibitor |
Ac-Arg-Arg-Trp-Trp-Cys-Arg-NH2 | |
CI-0339 |
IL-8ra (9-29) |
Ac-Met-Trp-Asp-Phe-Asp-Asp-Leu-Asn-Phe-Thr-Gly-Met-Pro-Pro-Ala-Asp-Glu-Asp-Tyr-Ser-Pro-NH2 | |
CI-0340 |
IL-1 Receptor Peptide (human) |
Lys-Ile-Cys-Ile-Arg-Ile-Gln-Ile-Ser | |
CI-0341 |
Indolicidin |
Ile-Leu-Pro-Trp-Lys-Trp-Pro-Trp-Trp-Pro-Trp-Arg-Arg-NH2 | |
CI-0342 |
Influenza A M2 coat protein (22- 46) |
Ser-Ser-Asp-Pro-Leu-Val-Val-Ala-Ala-Ser-Ile-Ile-Gly-Ile-Leu-His-Leu-Ile-Leu-Trp-Ile-Leu-Asp-Arg-Leu | |
CI-0343 |
Influenza A NP (366-374) |
Ala-Ser-Asn-Glu-Met-Asn-Asp-Ala-Met | |
CI-0344 |
Influenza A NP (366-374) Strain A/NT/60/68 |
Ala-Ser-Asn-Glu-Asn-Met-Asp-Ala-Met | |
CI-0345 |
Influenza A NP (366-374) Strain A/PR/8/35 |
Ala-Ser-Asn-Glu-Asn-Met-Glu-Thr-Met | |
CI-0346 |
Influenza HA (110-119) |
Ser-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys | |
CI-0347 |
Influenza HA (110-120) |
Ser-Phe-Glu-Arg-Phe-Glu-Ile-Phe-Pro-Lys-Glu | |
CI-0348 |
Influenza HA (204-212) |
Leu-Tyr-Gln-Asn-Val-Gly-Thr-Tyr-Val | |
CI-0349 |
Influenza HA (210-219) |
Thr-Tyr-Val-Ser-Val-Gly-Thr-Ser-Thr-Leu | |
CI-0350 |
Influenza HA (307-319) |
Pro-Lys-Tyr-Val-Lys-Gln-Asn-Thr-Leu-Lys-Leu-Ala-Thr | |
CI-0351 |
Influenza HA (518-526) |
Ile-Tyr-Ser-Thr-Val-Ala-Ser-Ser-Leu | |
CI-0352 |
Influenza HA (529-537) |
Ile-Tyr-Ala-Thr-Val-Ala-Gly-Ser-Leu | |
CI-0353 |
Influenza NP (50-57) |
Ser-Asp-Tyr-Glu-Gly-Arg-Leu-Ile | |
CI-0354 |
Influenza NP (147-155) |
Thr-Tyr-Gln-Arg-Thr-Arg-Ala-Leu-Val | |
CI-0355 |
Influenza NP (482-489) |
Ser-Asn-Glu-Gly-Ser-Tyr-Phe-Phe | |
CI-0356 |
Insulin B (9-23) |
Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly | |
CI-0357 |
Insulin-like Growth Factor I (57-70) |
Ala-Leu-Leu-Glu-Thr-Tyr-Cys-Ala-Thr-Pro-Ala-Lys-Ser-Glu | |
CI-0358 |
Insulin-Like Growth Factor II (69-84) |
Asp-Val-Ser-Thr-Pro-Pro-Thr-Val-Leu-Pro-Asp-Asn-Phe-Pro-Arg-Tyr | |
CI-0359 |
Insulin Receptor (1142-1153) |
Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | |
CI-0360 |
Insulin Receptor (1142-1153), Amide |
Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys-NH2 | |
CI-0361 |
Insulin Receptor (1142-1153),pTyr1150, Biotinylated |
Biotin-Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-pTyr-Tyr-Arg-Lys | |
CI-0362 |
Interleukin II (60-70) |
Leu-Thr-Phe-Lys-Phe-Tyr-Met-Pro-Lys-Lys-Ala | |
| CI-0529 | β-Interleukin II (44-56) | Ile-Leu-Asn-Gly-Ile-Asn-Asn-Tyr-Lys-Asn-Pro-Lys-Leu | |
CI-0363 |
Interleukin-1β Convertase Substrate |
Asn-Glu-Ala-Tyr-Val-His-Asp-Ala-Pro-Val-Arg-Ser-Leu-Asn | |
| CI-0530 | β-Interleukin I (163-171),human | Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys | |
CI-0364 |
Interleukin-6 Receptor (partial) |
Thr-Ser-Leu-Pro-Val-Gln-Asp-Ser-Ser-Ser-Val-Pro | |
CI-0365 |
Intermedin (human) |
Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | |
CI-0366 |
Intermedin-53 (human) |
His-Ser-Gly-Pro-Arg-Arg-Thr-Gln-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Met-Gly-Pro-Ala-Gly-Arg-Gln-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | |
CI-0367 |
Intermedin (rat) |
Pro-His-Ala-Gln-Leu-Leu-Arg-Val-Gly-Cys-Val-Leu-Gly-Thr-Cys-Gln-Val-Gln-Asn-Leu-Ser-His-Arg-Leu-Trp-Gln-Leu-Val-Arg-Pro-Ser-Gly-Arg-Arg-Asp-Ser-Ala-Pro-Val-Asp-Pro-Ser-Ser-Pro-His-Ser-Tyr-NH2 | |
CI-0368 |
Invertebrate Tachykinin-I,OctTK-I |
Lys-Pro-Pro-Ser-Ser-Ser-Glu-Phe-Ile-Gly-Leu-Met-NH2 | |
| CI-0304 | Ipamorelin | Aib-His-D-2-Nal-D-Phe-Lys-NH2 |
170851-70-4 |
CI-0369 |
IP3R-derived Peptide |
Gly-Arg-Arg-Glu-Ser-Leu-Thr-Ser-Phe-Gly-NH2 | |
CI-0370 |
IRL-1038 |
Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp | |
CI-0371 |
IRL-1720 |
Ac-Asp-Lys-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | |
CI-0372 |
IRS1-derived peptide |
Lys-Lys-Ser-Arg-Gly-Asp-Tyr-Met-Thr-Met-Gln-Ile-Gly-NH2 | |
| CI-0373 | IV9 (476-484), HIV-1 RT Epitope | Ile-Leu-Lys-Glu-Pro-Val-His-Gly-Val | |
| CJ-0001 | JAG-1 (188 - 204), Jagged -1 (188-204), Notch Ligand | Cys-Asp-Asp-Tyr-Tyr-Tyr-Gly-Phe-Gly-Cys-Asn-Lys-Phe-Cys-Arg-Pro-Arg | |
CK-0012 |
Kallikrein Inhibitor |
Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 | |
CK-0013 |
Kassinin |
Asp-Val-Pro-Lys-Ser-Asp-Gln-Phe-Val-Gly-Leu-Met-NH2 | |
CK-0014 |
Katacalcin |
Asp-Met-Ser-Ser-Asp-Leu-Glu-Arg-Asp-His-Arg-Pro-His-Val-Ser-Met-Pro-Gln-Asn-Ala-Asn | |
CK-0015 |
KEEAE |
Lys-Glu-Glu-Ala-Glu | |
CK-0016 |
Kemptamide |
Lys-Lys-Arg-Pro-Gln-Arg-Ala-Thr-Ser-Asn-Val-Phe-Ser-NH2 | |
CK-0017 |
Kemptide |
Leu-Arg-Arg-Ala-Ser-Leu-Gly | |
CK-0018 |
Kemptide Negative Control |
Leu-Arg-Arg-Ala-Ala-Leu-Gly | |
CK-0019 |
Ketolide resistance Peptide MRFFV |
Met-Arg-Phe-Phe-Val | |
CK-0020 |
K-G-D-S |
Lys-Gly-Asp-Ser | |
CK-0021 |
KGF Receptor Peptide |
His-Ser-Gly-Ile-Asn-Ser-Ser-Asn-Ala-Glu-Val-Leu-Ala-Leu-Phe-Asn-Val-Thr-Glu-Met-Asp-Ala-Gly-Glu-Tyr | |
CK-0022 |
Kinase Domain of Insulin Receptor (1) |
Tyr-Glu-Thr-Asp-pTyr-Tyr-Arg-Lys-Gly-Gly-Lys-Gly-Leu | |
CK-0023 |
Kinase Domain of Insulin Receptor (2) |
Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-Tyr-Tyr-Arg-Lys | |
CK-0024 |
Kinase Domain of Insulin Receptor (3) |
Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-pTyr-Tyr-Arg-Lys | |
CK-0025 |
Kinase Domain of Insulin Receptor (4) |
Thr-Arg-Asp-Ile-Tyr-Glu-Thr-Asp-Tyr-pTyr-Arg-Lys | |
CK-0026 |
Kinase Domain of Insulin Receptor (5) |
Thr-Arg-Asp-Ile-pTyr-Glu-Thr-Asp-pTyr-pTyr-Arg-Lys | |
CK-0027 |
Kinase Domain of Pyruvate Kinase, porcine liver |
Leu-Arg-Arg-Ala-pSer-Leu-Gly | |
CK-0028 |
Kinetensin |
Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe-Leu | |
CK-0029 |
Kisspeptin-13 (human) |
Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | |
CK-0030 |
Kisspeptin-13 (4-13) (human) |
Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | |
CK-0031 |
Kisspeptin-54 (27-54) (human) |
Ile-Pro-Ala-Pro-Gln-Gly-Ala-Val-Leu-Val-Gln-Arg-Glu-Lys-Asp-Leu-Pro-Asn-Tyr-Asn-Trp-Asn-Ser-Phe-Gly-Leu-Arg-Phe-NH2 | |
CK-0032 |
KK4A |
Lys-Lys-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Val-Leu-Ser-Gly-Lys | |
CK-0033 |
KL-1 |
Leu-Pro-Pro-Val-Ala-Ala-Ser-Ser-Leu-Arg-Asn-Asp | |
CK-0034 |
K-R-Q-H-P-G |
Lys-Arg-Gln-His-Pro-Gly | |
CK-0035 |
Kyotorphin |
Tyr-Arg | |
CL-0026 |
Laminin (925-933) |
Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg | |
CL-0027 |
Laminin (929-933) |
Tyr-Ile-Gly-Ser-Arg | |
CL-0028 |
Laminin A Chain (2091-2108) |
Cys-Ser-Arg-Ala-Arg-Lys-Gln-Ala-Ala-Ser-Ile-Lys-Val-Ala-Val-Ser-Ala-Asp-Arg | |
CL-0029 |
Laminin Nonapeptide, amide |
Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 | |
CL-0030 |
Laminin Penta Peptide, amide |
Tyr-Ile-Gly-Ser-Arg-NH2 | |
CL-0031 |
Lamprey PQRFamide |
Ser-Trp-Gly-Ala-Pro-Ala-Glu-Lys-Phe-Trp-Met-Arg-Ala-Met-Pro-Gln-Arg-Phe-NH2 | |
CL-0032 |
LEAP-2 (38-77) (Human) |
Met-Thr-Pro-Phe-Trp-Arg-Gly-Val-Ser-Leu-Arg-Pro-Ile-Gly-Ala-Ser-Cys-Arg-Asp-Asp-Ser-Glu-Cys-Ile-Thr-Arg-Leu-Cys-Arg-Lys-Arg-Arg-Cys-Ser-Leu-Ser-Val-Ala-Gln-Glu | |
CL-0033 |
Leptin (93-105) (human) |
Asn-Val-Ile-Gln-Ile-Ser-Asn-Asp-Leu-Glu-Asn-Leu-Arg | |
CL-0034 |
Leptin (22-56), human; OBGRP(22-56), human |
Val-Pro-Ile-Gln-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val-Thr-Arg-Ile-Asn-Asp-Ile-Ser-His-Thr-Gln-Ser-Val-Ser-Ser-Lys-Gln-Lys | |
CL-0035 |
Leptin (116-130), mouse |
Ser-Cys-Ser-Leu-Pro-Gln-Thr-Ser-Gly-Leu-Gln-Lys-Pro-Glu-Ser | |
CL-0036 |
Leptin Receptor Precursor |
Pro-Phe-Val-Lys-pTyr-Ala-Thr-Leu-Ile-Ser-Asn | |
CL-0037 |
[Leu144,Arg147]-Myelin Proteolipid Protein(139-151) |
Ser-His-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe | |
CL-0038 |
[Leu144, Arg147]-PLP (139-151), [L144, R147-PLP(139-151)] |
His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-Arg-Pro-Asp-Lys-Phe | |
CL-0039 |
Leucokinin I |
Asp-Pro-Ala-Phe-Asn-Ser-Trp-Gly-NH2 | |
CL-0040 |
Leucokinin II |
Asp-Pro-Gly-Phe-Ser-Ser-Trp-Gly-NH2 | |
| LeucokininIII | Asp-Gln-Gly-Phe-Asn-Ser-Trp-Gly-NH2 | ||
CL-0041 |
Leucokinin IV |
Asp-Ala-Ser-Phe-His-Ser-Trp-Gly-NH2 | |
CL-0042 |
Leucokinin V |
Gly-Ser-Gly-Phe-Ser-Ser-Trp-Gly-NH2 | |
CL-0043 |
Leucokinin VII |
Asp-Pro-Ala-Phe-Ser-Ser-Trp-Gly-NH2 | |
CL-0044 |
Leucokinin VIII |
Gly-Ala-Ser-Phe-Tyr-Ser-Trp-Gly-NH2 | |
CL-0045 |
Leucomyosuppressin (lms) |
Pyr-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 | |
CL-0046 |
Leucopyrokinin (LPK) |
PYR-Thr-Ser-Phe-Thr-Pro-Arg-Leu-NH2 | |
CL-0047 |
Leucopyrokinin (4-8); Pheromonotropic Pentapeptide |
Phe-Thr-Pro-Arg-Leu-NH2 | |
CL-0048 |
[Leu8, Des-Arg9]-Bradykinin |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu | |
CL-0049 |
Leu-Enkephalin |
Tyr-Gly-Gly-Phe-Leu | |
CL-0050 |
Leu-Enkephalin, amide |
Tyr-Gly-Gly-Phe-Leu-NH2 | |
CL-0051 |
[Leu15]-Gastrin I (human) |
Pyr-Gly-Pro-Trp-Leu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Leu-Asp-Phe-NH2 | |
| CH-0434 | Leu-Leu-Leu | Leu-Leu-Leu | 10329-75-6 |
CL-0052 |
[D-Leu2]-Melanocyte-Stimulating Hormone-Release Inhibiting Factor |
Pro-D-Leu-Gly-NH2 | |
CL-0053 |
[Leu13] Motilin, human, porcine |
Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Leu-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | |
CL-0054 |
[Leu144]-PLP (139-151), L144-PLP(139-151) |
His-Ser-Leu-Gly-Lys-Leu-Leu-Gly-His-Pro-Asp-Lys-Phe | |
CL-0055 |
[Leu116]-Prepro-Neuromedin U (104-136) (human) |
Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Leu-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu | |
CL-0056 |
[Leu31,Pro34]-Neuropeptide Y (human, rat) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CL-0057 |
[Leu31,Pro34]-Neuropeptide Y (13-36) (human, rat) |
Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CL-0058 |
[Leu31,Pro34]-Neuropeptide Y (porcine) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CL-0059 |
[Leu31,Pro34]-Peptide YY (human) |
Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
| CL-0014 | Leuprorelin acetate | 74381-53-6 | |
CL-0060 |
[Leu8,D-Trp22,Tyr25]-Somatostatin-28 |
Ser-Ala-Asn-Ser-Asn-Pro-Ala-Leu-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Tyr-Thr-Ser-Cys (Disulfide bridge Cys17-Cys28) | |
CL-0061 |
Leu-Valorphin-Arg |
Leu-Val-Val-Tyr-Pro-Trp-Thr-Gln-Arg | |
CL-0062 |
Levitide |
Pyr-Gly-Met-Ile-Gly-Thr-Leu-Thr-Ser-Lys-Arg-Ile-Lys-Gln-NH2 | |
CL-0063 |
LF 20 Consensus Peptide. Anthrax Related Lethal Factor |
Met-Leu-Ala-Arg-Arg-Lys-Lys-Val-Tyr-Pro-Tyr-Pro-Met-Glu-Pro-Thr-Ile-Ala-Glu-Gly-NH2 | |
CL-0064 |
LHRH (4-10) |
Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 | |
| CL-0003 | LHRH (1-5) (free acid) | Pyr-Glu-His-Trp-Ser-Tyr-OH | 52434-75-0 |
CL-0065 |
LHRH-Ⅲ, lamprey |
Pyr-His-Trp-Ser-His-Asp-Trp-Lys-Pro-Gly-NH2 | |
CL-0066 |
LHRH, salmon |
Pyr-His-Trp-Ser-Tyr-Gly-Trp-Leu-Pro-Gly-NH2 | |
| CL-0015 | Lipopeptide acetate | 171263-26-6 | |
| CL-0006 | β-Lipotropin (61-64) | Tyr-Gly-Gly-Phe | |
| CL-0112 | β-Lipotropin (61-69) | Tyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys | |
| CL-0113 | β-Lipotropin (88-91) | Lys-Lys-Gly-Glu | |
| CL-0114 | β-Lipotropin (1-10), porcine | Glu-Leu-Ala-Gly-Ala-Pro-Pro-Glu-Pro-Ala | |
CL-0067 |
Litorin |
Pyr-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2 | |
CL-0068 |
LKRApYLG-NH2 |
Leu-Lys-Arg-Ala-pTyr-Leu-Gly-NH2 | |
CL-0069 |
LL-37, Antimicrobial Peptide,human |
Leu-Leu-Gly-Asp-Phe-Phe-Arg-Lys-Ser-Lys-Glu-Lys-Ile-Gly-Lys-Glu-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asp-Phe-Leu-Arg-Asn-Leu-Val-Pro-Arg-Thr-Glu-Ser | |
CL-0070 |
LL-37 pentamide |
Leu-Leu-Gly-Asn-Phe-Phe-Arg-Lys-Ser-Lys-Gln-Lys-Ile-Gly-Lys-Gln-Phe-Lys-Arg-Ile-Val-Gln-Arg-Ile-Lys-Asn-Phe-Phe-Arg-Asn-Leu-Val-Pro-Arg-Thr-Gln-Ser | |
CL-0071 |
LL-37, reverse sequence |
Ser-Glu-Thr-Arg-Pro-Val-Leu-Asn-Arg-Leu-Phe-Asp-Lys-Ile-Arg-Gln-Val-Ile-Arg-Lys-Phe-Glu-Lys-Gly-Ile-Lys-Glu-Lys-Ser-Lys-Arg-Phe-Phe-Asp-Gly-Leu-Leu | |
CL-0072 |
LMP1 (156-164), IAL |
Ile-Ala-Leu-Tyr-Leu-Gln-Gln-Asn-Trp | |
CL-0073 |
LMP2 (236-244) , RRR |
Arg-Arg-Arg-Trp-Arg-Arg-Leu-Thr-Val | |
CL-0074 |
LMP1, TDD |
Thr-Asp-Asp-Ser-Gly-His-Glu-Ser-Asp-Ser-Asn-Ser-Asn-Glu-Gly-Arg-His | |
CL-0075 |
LMP2 (419-427), TYG |
Thr-Tyr-Gly-Pro-Val-Phe-Met-Cys-Leu | |
CL-0076 |
Locustachykinin I |
Gly-Pro-Ser-Gly-Phe-Tyr-Gly-Val-Arg-NH2 | |
CL-0077 |
Locustachykinin II |
Ala-Pro-Leu-Ser-Gly-Phe-Tyr-Gly-Val-Arg-NH2 | |
CL-0078 |
Luteinizing Hormone Releasing Hormone LH-RH |
Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 | |
CL-0079 |
Luteinizing Hormone-Releasing Hormone, free acid, human; LH-RH, free acid, human |
Glp-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-Cys | |
CL-0080 |
[D-Lys16]-ACTH（1-24） |
Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-d-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CL-0081 |
Lys-(Ala3)-Bradykinin |
Lys-Arg-Pro-Ala-Gly-Phe-Ser-Pro-Phe-Arg | |
CL-0082 |
[Lys15]-Amyloid b-Protein(15-21) |
Lys-Lys-Leu-Val-Phe-Phe-Ala | |
CL-0083 |
[Lys8,Asn9] Neurotensin LANT-6 (8-13) |
Lys-Asn-Pro-Tyr-Ile-Leu | |
CL-0084 |
Lys(Boc)-Leu-Lys(Boc)-OBzl |
Lys(Boc)-Leu-Lys(Boc)-OBzl | |
CL-0085 |
[Lys3]-Bombesin |
Pyr -Gln-Lys-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CL-0086 |
[Lys0]-Bradykinin (Kallidin) |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CL-0087 |
Lys-Bradykinin-Ser-Val-Gln-Val-Ser |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-Ser-Val-Gln-Val-Ser | |
CL-0088 |
[Lys8]-Conopressin S |
Cys-Ile-Ile-Arg-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge Cys1-Cys6) | |
CL-0089 |
Lys-(Des-Arg9)-Bradykinin |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe | |
CL-0090 |
Lys-(Des-Arg9,Leu8)-Bradykinin |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Leu | |
CL-0091 |
[D-Lys3] - GHRP – 6 |
His-D-Trp-D-Lys-Trp-D-Phe-Lys-NH2 | |
CL-0092 |
Lys-(Hyp3)-Bradykinin |
Lys-Arg-Pro-Hyp-Gly-Phe-Ser-Pro-Phe-Arg | |
| CL-0017 | Lysipressin acetate | 50-57-7 | |
CL-0093 |
[Lys6] Leu-Enkephalin |
Tyr-Gly-Gly-Phe-Leu-Lys | |
CL-0094 |
Lys-Lys-IRS-1 (891-902) (dephosphorylated) (human) |
Lys-Lys-Lys-Ser-Pro-Gly-Glu-Tyr-Val-Asn-Ile-Glu-Phe-Gly | |
CL-0095 |
[Lys8,Lys9]-Neurotensin (8-13) |
Lys-Lys-Pro-Tyr-Ile-Leu | |
CL-0096 |
Lymphocyte Activating Pentapeptide |
Leu-Pro-Pro-Ser-Arg | |
CL-0097 |
[Lys0] g-1-MSH, amide |
Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 | |
CL-0098 |
[Lys0]-γ-1-MSH (41-58), amide |
Lys-Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | |
CL-0099 |
[Lys3, Phe10, Tyr13] -Autocamtide - 2 - RelatedInhibitory Peptide (AIP) Analog |
Lys-Lys-Lys-Leu-Arg-Arg-Gln-Glu-Ala-Phe-Asp-Ala-Tyr | |
CL-0100 |
[Lys4] Sarafotoxin S6c |
Cys-Thr-Cys-Lys-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp [Disulfide bridge Cys1-15,3-11] | |
CL-0101 |
[Lys1015,1024]-Thrombospondin-1 (1015-1024)(human, bovine, mouse) |
Lys-Arg-Phe-Tyr-Val-Val-Met-Trp-Lys-Lys | |
CL-0102 |
Lys-(Tyr8)-Bradykinin |
Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg | |
CL-0103 |
[Lys8] Vasopressin |
Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Lys-Gly-NH2 (Disulfide bridge Cys1-Cys6） | |
CL-0104 |
[Lys8]-Vasotocin (free acid) |
Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Lys-Gly (Disulfide bridge Cys1-Cys6） | |
CL-0105 |
Lytic Peptide, SB-37 |
Met-Pro-Lys-Trp-Lys-Val-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Arg-Asn-Ile-Arg-Asn-Gly-Ile-Val-Lys-Ala-Gly-Pro-Ala-Ile-Ala-Val-Leu-Gly-Glu-Ala-Lys-Ala-Leu-Gly | |
CL-0106 |
Lytic Peptide, Shiva-1 |
Met-Pro-Arg-Leu-Phe-Arg-Arg-Ile-Asp-Arg-Val-Gly-Lys-Gln-Gly-Ile-Leu-Arg-Ala-Gly-Pro-Ala-Ile-Ala-Leu-Val-Gly-Asp-Ala-Arg-Ala-Val-Gly | |
CM-1342 |
M35 |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-NH2 | |
CM-1343 |
M40 |
Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-Pro-Pro-Ala-Leu-Ala-Leu-Ala-NH2 | |
CM-1344 |
Macrophage Inhibitory Peptide |
Thr-Lys-Pro | |
CM-1345 |
Magainin 1 |
Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Gly-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Lys-Ser | |
CM-1346 |
Magainin 2 |
Gly-Ile-Gly-Lys-Phe-Leu-His-Ser-Ala-Lys-Lys-Phe-Gly-Lys-Ala-Phe-Val-Gly-Glu-Ile-Met-Asn-Ser | |
CM-1347 |
Magainin Spacer Peptide |
Asp-Ala-Glu-Ala-Val-Gly-Pro-Glu-Ala-Phe-Ala-Asp-Gln-Asp-Leu-Asp-Glu-Arg-Glu-Val-Arg | |
CM-1348 |
Mage-1 Antigen (161-169),human |
Glu-Ala-Asp-Pro-Thr-Gly-His-Ser-Tyr | |
CM-1349 |
Mage-3 Antigen (167-176),human |
Met-Glu-Val-Asp-Pro-Ile-Gly-His-Leu-Tyr | |
CM-1350 |
Mage-3 Antigen (271-279),human |
Phe-Leu-Trp-Gly-Pro-Arg-Ala-Leu-Val | |
CM-1351 |
Malantide |
Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile | |
CM-1352 |
MAP Kinase Substrate; EGF-R (661-681) |
Lys-Arg-Glu-Leu-Val-Glu-Pro-Leu-Thr-Pro-Ser-Gly-Glu-Ala-Pro-Asn-Gln-Ala-Leu-Leu-Arg | |
CM-1353 |
MARCKS Protein (151-175) |
Lys-Lys-Lys-Lys-Lys-Arg-Phe-Ser-Phe-Lys-Lys-Ser-Phe-Lys-Leu-Ser-Gly-Phe-Ser-Phe-Lys-Lys-Asn-Lys-Lys | |
CM-1354 |
MARCKS Protein (159-165) |
Phe-Lys-Lys-Ser-Phe-Lys-Leu | |
CM-1355 |
MARCKS PSD-Derived Peptide, PKC Substrate |
Lys-Lys-Arg-Phe-Ser-Phe-Lys-Lys-Ser-Phe-Lys-Leu | |
CM-1356 |
MARCKS Substrate (151-175) |
Lys-Lys-Lys-Lys-Lys-Arg-Phe-pSer-Phe-Lys-Lys-pSer-Phe-Lys-Leu-Ser-Gly-Phe-pSer-Phe-Lys-Lys-Asn-Lys-Lys | |
CM-1357 |
MART-1 (26-35) (human) |
Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val | |
CM-1358 |
MART-1 (27-35) (human) |
Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val | |
CM-1359 |
Mas8 |
Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Arg-Leu-Leu-NH2 | |
CM-1360 |
Mas17 |
Ile-Asn-Leu-Lys-Ala-Lys-Ala-Ala-Leu-Ala-Lys-Lys-Leu-Leu-NH2 | |
CM-1361 |
Mast Cell Degranulating (MCD) Peptide |
Ile-Lys-Cys-Asn-Cys-Lys-Arg-His-Val-Ile-Lys-Pro-His-Ile-Cys-Arg-Lys-Ile-Cys-Gly-Lys-Asn-NH2(Disulfide bridge Cys3-Cys15,Cys5-Cys19) | |
CM-1362 |
Mast Cell Degranulating (MCD) Peptide HR-1 |
Ile-Asn-Leu-Lys-Ala-Ile-Ala-Ala-Leu-Val-Lys-Lys-Val-Leu-NH2 | |
CM-1363 |
Mast Cell Degranulating (MCD) Peptide HR-2 |
Phe-Leu-Pro-Leu-Ile-Leu-Gly-Lys-Leu-Val-Lys-Gly-Leu-Leu-NH2 | |
CM-1364 |
Mastoparan |
Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Lys-Ile-Leu-NH2 | |
CM-1365 |
Mastoparan 7 |
Ile-Asn-Leu-Lys-Ala-Leu-Ala-Ala-Leu-Ala-Lys-Ala-Leu-Leu-NH2 | |
CM-1366 |
Mastoparan X |
Ile-Asn-Trp-Lys-Gly-Ile-Ala-Ala-Met-Ala-Lys-Lys-Leu-Leu-NH2 | |
| CM-0075 | α-Mating Factor (1-6) | Trp-His-Trp-Leu-Gln-Leu | |
CM-1367 |
Mating Factor aSK2 |
Trp-His-Trp-Leu-Ser-Phe-Ser-Lys-Gly-Glu-Pro-Met-Tyr | |
CM-1368 |
MBP (1 - 17) |
Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu-Ala-Thr-Ala-Ser | |
CM-1369 |
MBP (90-106) |
AC-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | |
CM-1370 |
MBP (68-82), gulinea pig; Myelin Basic Protein(68-82),guinea pig |
Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn | |
CM-1371 |
MBP (74-85), guinea pig |
Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn-Pro-Val | |
CM-1372 |
MBP (1-11), human |
Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His-Gly | |
CM-1373 |
MBP (87-99), human; Myelin Basic Protein (87-99),guinea pig, human |
Val-His-Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr-Pro | |
CM-1374 |
MBP MAPK Substrate |
Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg | |
CM-1375 |
MBP (1-11), mouse |
Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys | |
CM-1376 |
MBP (90-106), phosphorylated |
Phe-Phe-Lys-Asn-Ile-Val-Thr-Pro-Arg-Thr(PO3H2)-Pro-Pro-Pro-Ser-Gln-Gly-Lys-NH2 | |
CM-1377 |
MCH-Gene-Overprinted-Polypeptide-14 (rat) |
Thr-Ile-His-Cys-Lys-Trp-Arg-Glu-Lys-Pro-Leu-Met-Leu-Met | |
CM-1378 |
MCH-Gene-Overprinted-Polypeptide-27 (rat) |
Ser-Asp-Thr-Cys-Trp-Ser-Thr-Thr-Ser-Phe-Gln-Lys-Lys-Thr-Ile-His-Cys-Lys-Trp-Arg-Glu-Lys-Pro-Leu-Met-Leu-Met(Disulfide bridge: Cys4-Cys17) | |
CM-1379 |
mCRAMP, mouse |
Gly-Leu-Leu-Arg-Lys-Gly-Gly-Glu-Lys-Ile-Gly-Glu-Lys-Leu-Lys-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Asn-Phe-Phe-Gln-Lys-Leu-Val-Pro-Gln-Pro-Glu-Gln | |
CM-1380 |
Melanin Concentrating Hormone, human, mouse, rat MCH, human, mouse, rat |
Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide bridge Cys7-Cys16) |
|
CM-1381 |
Melanin Concentrating Hormone, salmon MCH,salmon |
Asp-Thr-Met-Arg-Cys-Met-Val-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Glu-Val(Disulfide bridge Cys5-Cys14) |
|
CM-1382 |
Melanocyte Associated Antigen gp100 |
Ala-Leu-Asn-Phe-Pro-Gly-Ser-Gln-Lys |
|
CM-1383 |
Melanocyte Associated Antigen gp 100 (17-25) |
Ala-Leu-Leu-Ala-Val-Gly-Ala-Thr-Lys |
|
CM-1384 |
Melanocyte Protein PMEL 17 (185-193) (human, bovine,mouse) |
Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val |
|
CM-1385 |
Melanocyte Protein PMEL 17 (256-264) (human, bovine,mouse) |
Tyr-Leu-Glu-Pro-Gly-Pro-Val-Thr-Ala |
|
CM-1386 |
Melanocyte Protein PMEL 17 (44-59) (human, bovine,mouse) |
Trp-Asn-Arg-Gln-Leu-Tyr-Pro-Glu-Trp-Thr-Glu-Ala-Gln-Arg-Leu-Asp |
|
| CM-2048 | α-Melanocyte Stimulating Hormone (11-13)(MSHa) |
Lys-Pro-Val-NH2 | |
| CM-2049 | α-Melanocyte Stimulating Hormone, acetylated-[D-Val13] (11-13) (MSHa) | Ac-Lys-Pro-D-Val-NH2 | |
| CM-2050 | α-Melanocyte Stimulating Hormone [Acetyl-D-Lys11, D-Val13] (11-13) (MSHa) | Ac-D-Lys-Pro-D-Val-NH2 | |
| CM-2051 | α-Melanocyte Stimulating Hormone [Met5, Pro6, D-Phe7,D-Trp9, Phe10] (5-13) (MSHa) | Met-Pro-D-Phe-Arg-D-Trp-Phe-Lys-Pro-Val-NH2 | |
CM-1387 |
Melanoma-associated antigen peptide; MART-1(27-35), human |
Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val |
|
CM-1388 |
Melanostatin, frog |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Lys-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 |
|
| CM-0504 | Melanotan I acetate | Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | 75921-69-6 |
| CM-0505 | Melanotan II acetate | Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys-NH2 (Lactam bridge Asp2-Lys7) | 121062-08-6 |
| CM-0603 | Melittin from honey bee venom | Gly-Ile-Gly-Ala-Val-Leu-Lys-Val-Leu-Thr-Thr-Gly-Leu-Pro-Ala-Leu-Ile-Ser-Trp-Ile-Lys-Arg-Lys-Arg-Gln-Gln-NH2 | 37231-28-0 |
CM-1389 |
Men 10376 |
Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Lys-NH2 | |
CM-1390 |
Metamorphosin A |
Pyr-Gln-Pro-Gly-Leu-Trp-NH2 | |
CM-1391 |
[Met5,Arg6] Enkephalin |
Tyr-Gly-Gly-Phe-Met-Arg | |
CM-1392 |
[Met5,Arg6] Enkephalin-Arg |
Tyr-Gly-Gly-Phe-Met-Arg-Arg | |
CM-1393 |
[Met5,Arg6,Gly7,Leu8] Enkephalin |
Tyr-Gly-Gly-Phe-Met-Arg-Gly-Leu | |
CM-1394 |
[Met5,Arg6,Phe7] Enkephalin |
Tyr-Gly-Gly-Phe-Met-Arg-Phe | |
CM-1395 |
[Met5,Arg6,Phe7] Enkephalin, amide |
Tyr-Gly-Gly-Phe-Met-Arg-Phe-NH2 | |
CM-1396 |
[Met5,Arg6,7,Val8,Gly9] Enkephalin |
Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly | |
CM-1397 |
[Met2]-Deltorphin |
Tyr-Met-Phe-His-Leu-Met-Asp-NH2 | |
CM-1398 |
Met-Enkephalin |
Tyr-Gly-Gly-Phe-Met | |
CM-1399 |
Met-Enkephalin, amide |
Tyr-Gly-Gly-Phe-Met-NH2 | |
CM-1400 |
[Met5, Lys6, Arg7] a-Neo-Endorphin (1-7) |
Tyr-Gly-Gly-Phe-Met-Lys-Arg | |
CM-1401 |
Met-Lys-Bradykinin |
Met-Lys-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CM-1402 |
[Met5, Lys6] a-Neo-Endorphin (1-6) |
Tyr-Gly-Gly-Phe-Met-Lys | |
CM-1403 |
[Met5, Lys6,7] a-Neo-Endorphin (1-7) |
Tyr-Gly-Gly-Phe-Met-Lys-Lys | |
CM-1404 |
[D-Met2,Pro5] Enkephalin, amide |
Tyr-D-Met-Gly-Phe-Pro-NH2 | |
CM-1405 |
MGP-pNA |
Met-Gly-Pro-pNA | |
CM-1406 |
MIF-1 Tyr |
Tyr-Pro-Leu-Gly-NH2 | |
CM-1407 |
Miraculin (1-20) |
Asp-Ser-Ala-Pro-Asn-Pro-Val-Leu-Asp-Ile-Asp-Gly-Glu-Lys-Leu-Arg-Thr-Gly-Thr-Asn | |
CM-1408 |
MKKp2 |
Ser-Lys-Gly-Lys-Ser-Lys-Arg-Lys-Lys-Asp-Leu-Arg-Ile-Ser-Cys-Asn-Ser-Lys | |
CM-1409 |
MLC-derived peptide |
Lys-Lys-Arg-Pro-Gln-Arg-Arg-Tyr-Ser-Asn-Val-Phe | |
CM-1410 |
MMP Biotinylated Substrate I |
Biotin-LC-Pro-Leu-Gly-Leu-Arg-Ala-Tyr-NH2 | |
CM-1411 |
MMP-3 Inhibitor I |
Ac-Arg-Cys-Gly-Val-Pro-Asp-NH2 | |
CM-1412 |
MMP-2/MMP-9 Inhibitor III |
Cys-Thr-Thr-His-Trp-Gly-Phe-Thr-Leu-Cys | |
CM-1413 |
MMP-2/MMP-9 Substrate I,fluorogenic |
Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg | |
CM-1414 |
MMP Substrate I, fluorogenic |
Dnp-Pro-Leu-Gly-Leu-Trp-Ala-D-Arg-NH2 | |
CM-1415 |
MMP-3 Substrate I,fluorogenic |
Dnp-Pro-Tyr-Ala-Tyr-Trp-Met-Arg | |
CM-1416 |
MMP-7 Substrate I,fluorogenic |
Dnp-Arg-Pro-Leu-Ala-Leu-Trp-Arg-Ser | |
CM-1417 |
MMP-8 Substrate, fluorogenic |
Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg | |
CM-1418 |
MMP-1 Substrate I, fluorogenic |
Dnp-Pro-Leu-Ala-Leu-Trp-Ala-Arg | |
| CM-0508 | MMTM | 293311-03-2 | |
CM-1419 |
Morphine Modulating Peptide, C-Terminal Fragment |
Pro-Gln-Arg-Phe-NH2 | |
CM-1420 |
Motilin, canine |
Phe-Val-Pro-Ile-Phe-Thr-His-Ser-Glu-Leu-Gln-Lys-Ile-Arg-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | 85490-53-5 |
CM-1421 |
Motilin, porcine |
Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Met-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | |
| CM-2052 | α-MSH | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | |
| CM-2053 | δ-MSH | Ser-Met-Glu-Val-Arg-Gly-Trp | 100930-04-9 |
| CM-2054 | γ2-MSH | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly | 72711-43-4 |
| CM-2055 | γ3-MSH | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-Arg-Arg-Asn-Gly-Ser-Ser-Ser-Ser-Gly-Val-Gly-Gly-Ala-Ala-Gln | |
| CM-2056 | γ-MSH (3-8) | Met-Gly-His-Phe-Arg-Trp | |
| CM-2057 | δ1-MSH, amide | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-NH2 | |
| CM-2058 | γ2-MSH (41-58),amide | Tyr-Val-Met-Gly-His-Phe-Arg-Trp-Asp-Arg-Phe-Gly-NH2 | |
| CM-2059 | α-MSH, Free Acid | Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val | |
| CM-2060 | β-MSH, human | Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | |
| CM-2061 | β-MSH, monkey | Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | |
| CM-2062 | β- MSH, porcine | Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | |
CM-1423 |
MSH Release Inhibiting Factor, amide |
Pro-Leu-Gly-NH2 | |
| CM-0507 | MSNT |
74257-00-4 | |
CM-1422 |
MSP-1 P2, Malaria Merozoite Surface Peptide – 1 |
Gly-Tyr-Arg-Lys-Pro-Leu-Asp-Asn-Ile-Lys-Asp-Asn-Val-Gly-Lys-Met-Glu-Asp-Tyr-Ile-Lys-Lys | |
CM-1424 |
MSP-1 (20-39), Merozoite Surface Peptide 1 |
Val-Thr-His-Glu-Ser-Tyr-Gln-Glu-Leu-Val-Lys-Lys-Leu-Glu-Ala-Leu-Glu-Asp-Ala-Val | |
CM-1425 |
Murine CMV pp 89 (168-176) |
Tyr-Pro-His-Phe-Met-Pro-Thr-Asn-Leu | |
CM-1426 |
Murine CMV pp 89 (170-174) |
His-Phe-Met-Pro-Thr | |
CM-1427 |
Myelin Oligodendrocyte Glycoprotein(35-55), rat MOG(35-55) |
Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys | |
CM-1428 |
Myelopeptide-2 (MP-2) |
Leu-Val-Val-Tyr-Pro-Trp | |
CM-1429 |
Myomodulin |
Pro-Met-Ser-Met-Leu-Arg-Leu-NH2 | |
CM-1430 |
Myosin Kinase Inhibiting Peptide |
Lys-Lys-Arg-Ala-Ala-Arg-Ala-Thr-Ser-NH2 | |
CM-1431 |
Myristoylated ADP -Ribosylation Factor 1, myr-ARF1 (2-17) |
myr-Gly-Asn-Ile-Phe-Ala-Asn-Leu-Phe-Lys-Gly-Leu-Phe-Gly-Lys-Lys-Glu | |
CM-1432 |
Myristoylated ADP -Ribosylation Factor 6, myr-ARF6 (2-13) |
myr-Gly-Lys-Val-Leu-Ser-Lys-Ile-Phe-Gly-Asn-Lys-Glu | |
CM-1433 |
Myristoylated Protein Kinase C (19-31) |
Myristoyl-Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val | |
| CN-0156 | Nafarelin acetate | 76932-56-4 | |
CN-0518 |
NAP |
Asn-Ala-Pro-Val-Ser-Ile-Pro-Gln | |
CN-0519 |
Necrofibrin, human |
Gly-Ala-Val-Ser-Thr-Ala | |
CN-0520 |
Necrofibrin, rat |
Trp-Thr-Val-Pro-Thr-Ala | |
| CN-0022 | β-Neo-Endorphin | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro | |
| CN-0029 | α-Neo-Endorphin (1-7) | Tyr-Gly-Gly-Phe-Leu-Arg-Lys | |
| CN-0035 | α-Neo-Endorphin (1-8) | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr | |
| CN-0039 | α-Neo-Endorphin Analog | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Arg-Pro-Lys-NH2 | |
| CN-0044 | α-Neo-Endorphin, porcine | Tyr-Gly-Gly-Phe-Leu-Arg-Lys-Tyr-Pro-Lys | |
CN-0521 |
Neo-Kyotorphin |
Thr-Ser-Lys-Tyr-Arg | |
CN-0158 |
NEPIS |
4156-16-5 |
|
CN-0522 |
Nesfatin-1 (human) |
Val-Pro-Ile-Asp-Ile-Asp-Lys-Thr-Lys-Val-Gln-Asn-Ile-His-Pro-Val-Glu-Ser-Ala-Lys-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Asp-Val-Leu-Glu-Thr-Asp-Lys-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Lys-Ser-Gly-Arg-Leu-Ser-Lys-Glu-Leu-Asp-Leu-Val-Ser-His-His-Val-Arg-Thr-Lys-Leu-Asp-Glu-Leu | |
CN-0523 |
Nesfatin-1 (mouse) |
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Thr-Glu-Pro-Val-Glu-Asn-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu | |
CN-0524 |
Nesfatin-1 (rat) |
Val-Pro-Ile-Asp-Val-Asp-Lys-Thr-Lys-Val-His-Asn-Val-Glu-Pro-Val-Glu-Ser-Ala-Arg-Ile-Glu-Pro-Pro-Asp-Thr-Gly-Leu-Tyr-Tyr-Asp-Glu-Tyr-Leu-Lys-Gln-Val-Ile-Glu-Val-Leu-Glu-Thr-Asp-Pro-His-Phe-Arg-Glu-Lys-Leu-Gln-Lys-Ala-Asp-Ile-Glu-Glu-Ile-Arg-Ser-Gly-Arg-Leu-Ser-Gln-Glu-Leu-Asp-Leu-Val-Ser-His-Lys-Val-Arg-Thr-Arg-Leu-Asp-Glu-Leu | |
| CN-0157 | Nesiritide acetate | 114471-18-0 | |
CN-0525 |
NES Topoisomerase II alpha (1017-1028) |
Asp-Ile-Leu-Arg-Asp-Phe-Phe-Glu-Leu-Arg-Leu-Lys | |
CN-0526 |
Neurogranin (28-43) |
Ala-Ala-Lys-Ile-Gln-Ala-Ser-Phe-Arg-Gly-His-Met-Ala-Arg-Lys-Lys | |
CN-0527 |
Neurokinin A (4-10) |
Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
CN-0528 |
Neurokinin A; Substance K; Neuromedin L; NKA |
His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
CN-0529 |
Neurokinin B |
Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | |
CN-0530 |
Neurokinin Receptor (393-407), rat |
Lys-Thr-Met-Thr-Glu-Ser-Ser-Phe-Tyr-Ser-Asn-Met-Leu-Ala | |
CN-0531 |
Neuromedin (B-30) |
Leu-Ser-Trp-Asp-Leu-Pro-Glu-Pro-Arg-Ser-Arg-Ala-Gly-Lys-Ile-Arg-Val-His-Pro-Arg-Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | |
CN-0532 |
Neuromedin B, porcine |
Gly-Asn-Leu-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | |
CN-0533 |
Neuromedin C, porcine GRP(18-27) |
Gly-Asn-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CN-0534 |
Neuromedin N |
Lys-Ile-Pro-Tyr-Ile-Leu | |
CN-0535 |
Neuromedin S (human) |
Ile-Leu-Gln-Arg-Gly-Ser-Gly-Thr-Ala-Ala-Val-Asp-Phe-Thr-Lys-Lys-Asp-His-Thr-Ala-Thr-Trp-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CN-0536 |
Neuromedin S (rat) |
Leu-Pro-Arg-Leu-Leu-His-Thr-Asp-Ser-Arg-Met-Ala-Thr-Ile-Asp-Phe-Pro-Lys-Lys-Asp-Pro-Thr-Thr-Ser-Leu-Gly-Arg-Pro-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CN-0537 |
Neuromedin (U25), human |
Phe-Arg-Val-Asp-Glu-Glu-Phe-Gln-Ser-Pro-Phe-Ala-Ser-Gln-Ser-Arg-Gly-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CN-0538 |
Neuromedin (U8), porcine |
Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CN-0539 |
Neuromedin (U25), porcine |
Phe-Lys-Val-Asp-Glu-Glu-Phe-Gln-Gly-Pro-Ile-Val-Ser-Gln-Asn-Arg-Arg-Tyr-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CN-0540 |
Neuromedin U, rat |
Tyr-Lys-Val-Asn-Glu-Tyr-Gln-Gly-Pro-Val-Ala-Pro-Ser-Gly-Gly-Phe-Phe-Leu-Phe-Arg-Pro-Arg-Asn-NH2 | |
CN-0541 |
Neuron Specific Peptide |
Asp-Val-Ser-Asp-Gly-Ser-Ala-Glu-Arg-Arg-Pro-Tyr-Thr-Arg-Met-Gly-Ser-Gly-Gly-Leu-Lys-Leu-His-Cys-Val-His-Pro-Ala-Asn-Cys-Pro-Gly-Gly-Leu-Met-Val-Thr | |
CN-0542 |
Neuropeptide AF (hNPAF),Human |
Ala-Gly-Glu-Gly-Leu-Asn-Ser-Gln-Phe-Trp-Ser-Leu-Ala-Ala-Pro-Gln-Arg-Phe-NH2 | |
CN-0543 |
Neuropeptide EI-Gly-Arg-Arg-MCH (human, mouse, rat) |
Glu-Ile-Gly-Asp-Glu-Glu-Asn-Ser-Ala-Lys-Phe-Pro-Ile-Gly-Arg-Arg-Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Cys-Trp-Gln-Val(Disulfide bridge:C23-C32) | |
CN-0544 |
Neuropeptide EI (human,mouse, rat) |
Glu-Ile-Gly-Asp-Glu-Glu-Asn-Ser-Ala-Lys-Phe-Pro-Ile-NH2 | |
CN-0545 |
Neuropeptide F |
Pro-Asp-Lys-Asp-Phe-Ile-Val-Asn-Pro-Ser-Asp-Leu-Val-Leu-Asp-Asn-Lys-Ala-Ala-Leu-Arg-Asp-Tyr-Leu-Arg-Gln-Ile-Asn-Glu-Tyr-Phe-Ala-Ile-Ile-Gly-Arg-Pro-Arg-Phe-NH2 | |
CN-0546 |
Neuropeptide FF Morphine Modulating Neuropeptide F-8-F-NH2 |
Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 | |
CN-0547 |
Neuropeptide K, porcine |
Asp-Ala-Asp-Ser-Ser-Ile-Glu-Lys-Gln-Val-Ala-Leu-Leu-Lys-Ala-Leu-Tyr-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
| CN-0054 | γ-Neuropeptide, rabbit | Asp-Ala-Gly-His-Gly-Gln-Ile-Ser-His-Lys-Arg-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
CN-0548 |
Neuropeptide W-30 (human) |
Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ala-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp | |
CN-0549 |
Neuropeptide W-30 (rat) |
Trp-Tyr-Lys-His-Val-Ala-Ser-Pro-Arg-Tyr-His-Thr-Val-Gly-Arg-Ala-Ser-Gly-Leu-Leu-Met-Gly-Leu-Arg-Arg-Ser-Pro-Tyr-Leu-Trp | |
CN-0550 |
Neuropeptide Y (18-36) |
Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0551 |
Neuropeptide Y (22-36) |
Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0552 |
Neuropeptide Y (1-24) amide (human, rat) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-NH2 | |
CN-0553 |
Neuropeptide Y (2-36), amide,porcine |
Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0554 |
Neuropeptide Y (free acid) (human) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr | |
CN-0555 |
Neuropeptide Y (3-36), human |
Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0556 |
Neuropeptide Y (13-36),human |
Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0557 |
Neuropeptide Y, human, rat |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0558 |
Neuropeptide Y (2-36) (human,rat) |
Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0559 |
Neuropeptide Y-Lys(Biotin),human, rat; NPY-Lys(Biotin),human, rat |
Biotin-Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-Lys | |
CN-0560 |
Neuropeptide Y (porcine) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0561 |
Neuropeptide Y (3-36) (porcine) |
Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CN-0562 |
Neuropeptide Y (13-36) (porcine) |
Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
| CN-0062 | β-Neuroprotectin | D-Ala-Asp-Leu-Ile-Ala-Tyr-Leu-NH2 | |
CN-0563 |
Neurotensin |
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu | 39379-15-2 |
CN-0564 |
Neurotensin (1-8) |
Pyr--Leu-Tyr-Glu-Asn-Lys-Pro-Arg | |
CN-0565 |
Neurotensin (1-11) |
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr | |
CN-0566 |
Neurotensin (8-13) |
Arg-Arg-Pro-Tyr-Ile-Leu | |
CN-0567 |
Neurotensin (8-13), N-Acetyl |
Ac-Arg-Arg-Pro-Tyr-Ile-Leu | |
CN-0568 |
Neurotensin (9-13) |
Arg-Pro-Tyr-Ile-Leu | |
CN-0569 |
Neurotensin (Frog) |
Pyr-Ser-His-Ile-Ser-Lys-Ala-Arg-Arg-Pro-Tyr-Ile-Leu-NH2 | |
CN-0570 |
Neurotensin, guinea pig |
Pyr-Leu-Tyr-Glu-Asn-Lys-Ser-Arg-Arg-Pro-Tyr-Ile-Leu | |
CN-0571 |
Neurotrophic Factor for Retinal Cholinergic Neurons |
Tyr-Leu-Leu-Pro-Ala-Gln-Val-Asn-Ile-Asp | |
CN-0572 |
[Nle27]-GRF (1-29) amide (human) |
Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Nle-Ser-Arg- NH2 | |
CN-0573 |
[Nle13, Glu14] Motilin, human,porcine |
Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Nle-Glu-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | |
CN-0574 |
[Nle253]-HSV-1 UL 26 Open Reading Frame (238-257) |
Gly-Ile-Ala-Gly-His-Thr-Tyr-Leu-Gln-Ala-Ser-Glu-Lys-Phe-Lys-Nle-Trp-Gly-Ala-Glu | |
CN-0575 |
[Nle13]-Motillin |
Phe-Val-Pro-Ile-Phe-Thr-Tyr-Gly-Glu-Leu-Gln-Arg-Nle-Gln-Glu-Lys-Glu-Arg-Asn-Lys-Gly-Gln | |
CN-0576 |
[Nle4] a-MSH, amide |
Ac-Ser-Tyr-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | |
CN-0577 |
[Nle10]-Neurokinin A (4-10) |
Asp-Ser-Phe-Val-Gly-Leu-Nle-NH2 | |
CN-0578 |
[Nle4,D-Phe7] a-MSH, amide; Melanotan Ⅰ |
Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | |
CN-0579 |
[Nle11] Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Nle-NH2 | |
CN-0580 |
[Nle21,Tyr32] Corticotropin Releasing Factor, ovine |
Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-Tyr-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala- NH2 | |
CN-0581 |
[Nle8’18,Tyr34]-pTH (1-34) amide (bovine) |
Ala-Val-Ser-Glu-Ile-Gln-Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr- NH2 | |
CN-0582 |
[Nle8’18,Tyr34]-pTH (3-34) amide (bovine) |
Ser-Glu-Ile-Gln-Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr- NH2 | |
CN-0583 |
[Nle8’18,Tyr34]-pTH (7-34) amide (bovine) |
Phe-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Nle-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | |
CN-0584 |
[Nle8’21,Tyr34]-pTH (1-34)amide (rat) |
Ala-Val-Ser-Glu-Ile-Gln-Leu-Nle-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Nle-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr- NH2 | |
CN-0585 |
Nociceptin (1-13) amide |
Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2 | |
CN-0586 |
Nocistatin |
Glu-Gln-Lys-Gln-Leu-Gln | |
CN-0587 |
Non-Ab Component of Alzheimer's Disease Amyloid |
Glu-Gln-Val-Thr-Asn-Val-Gly-Gly-Ala-Val-Val-Thr-Gly-Val-Thr-Ala-Val-Ala-Gln-Lys-Thr-Val-Glu-Gly-Ala-Gly-Ser-Ile-Ala-Ala-Ala-Thr-Gly-Phe-Val | |
CN-0588 |
N-10 Region of TRAP |
Asp-Glu-Ile-Lys-Tyr-Ser-Glu-Glu-Val-Cys | |
CN-0589 |
NPF |
Lys-Arg-Ser-Tyr(PO3H2)-Glu-Glu-His-Ile-Pro | |
CN-0590 |
NPV |
Phe-Gln-Gln-Leu-Phe-Leu-Asn-Thr-Leu | |
CN-0591 |
NS2(114 - 121), Influenza |
Arg-Thr-Phe-Ser-Phe-Gln-Leu-Ile | |
CN-0592 |
NTB (Naltriben) |
D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 （Disulfide bridge: Cys2-Pen7） | |
CN-0593 |
NTproBNP(1-76) |
His-Pro-Leu-Gly-Ser-Pro-Gly-Ser-Ala-Ser-Asp-Leu-Glu-Thr-Ser-Gly-Leu-Gln-Glu-Gln-Arg-Asn-His-Leu-Gln-Gly-Lys-Leu-Ser-Glu-Leu-Gln-Val-Glu-Gln-Thr-Ser-Leu-Glu-Pro-Leu-Gln-Glu-Ser-Pro-Arg-Pro-Thr-Gly-Val-Trp-Lys-Ser-Arg-Glu-Val-Ala-Thr-Glu-Gly-Ile-Arg-Gly-His-Arg-Lys-Met-Val-Leu-Tyr-Thr-Leu-Arg-Ala-Pro-Arg | |
CN-0594 |
NubO (68–75), Ndufa4 (68–75) |
Val-Asn-Val-Asp-Tyr-Ser-Lys-Leu | |
CN-0595 |
Nuclear Export Signal, NES, Dok - 1 (348 - 359) |
Leu-Leu-Lys-Ala-Lys-Leu-Thr-Asp-Pro-Lys-Glu-Asp | |
CN-0596 |
Nuclear Export Signal, NES, PKI |
Glu-Leu-Ala-Leu-Lys-Leu-Ala-Gly-Leu-Asp-Ile-Asn | |
CO-0077 |
Obestatin, human |
Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 | |
CO-0078 |
Obestatin, rat, mouse |
Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 | |
CO-0079 |
Octaneuropeptide |
Arg-Pro-Gly-Leu-Leu-Asp-Leu-Lys | |
CO-0080 |
Opioid receptor antagonist |
Ac-Arg-Phe-Met-Trp-Met-Lys-NH2 | |
CO-0081 |
Orexin A, bovine, human,mouse, rat |
Pyr-Pro-Leu-Pro-Asp-Cys-Cys-Arg-Gln-Lys-Thr-Cys-Ser-Cys-Arg-Leu-Tyr-Glu-Leu-Leu-His-Gly-Ala-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Leu-NH2 （Disulfide bridge: Cys6-Cys12,Cys7-Cys14） | |
CO-0082 |
Orexin B, canine |
Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | |
CO-0083 |
Orexin B, human |
Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | |
CO-0084 |
Orexin B, rat, mouse |
Arg-Pro-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Asn-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-NH2 | |
| CO-0023 | Ornipressin acetate | 3397-23-7 | |
CO-0085 |
Orn8, Urotensin II, human |
Glu-Thr-Pro-Asp-Cys-Phe-Trp-Orn-Tyr-Cys-Val | |
CO-0086 |
Orphanin FQ, (Nociceptin) |
Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln | |
CO-0087 |
Osteogenic Growth Peptide |
Ala-Leu-Lys-Arg-Gln-Gly-Arg-Thr-Leu-Tyr-Gly-Phe-Gly-Gly | |
CO-0088 |
Osteocalcin (1-49) (human) |
Tyr-Leu-Tyr-Gln-Trp-Leu-Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Gla-Pro-Arg-Arg-Gla-Val-Cys-Gla-Leu-Asn-Pro-Asp-Cys-Asp-Glu-Leu-Ala-Asp-His-Ile-Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val(Disulfide bridge Cys23-Cys29) | |
CO-0089 |
Osteocalcin (7-19) (human) |
Gly-Ala-Pro-Val-Pro-Tyr-Pro-Asp-Pro-Leu-Glu-Pro-Arg | |
CO-0090 |
Osteocalcin (37-49) (human) |
Gly-Phe-Gln-Glu-Ala-Tyr-Arg-Arg-Phe-Tyr-Gly-Pro-Val | |
CO-0091 |
Osteocalcin (45-49) (human) |
Phe-Tyr-Gly-Pro-Val | |
CO-0092 |
Osteostatin amide (human) |
Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg-NH2 | |
CO-0093 |
Osteostatin (1-5) amide (human, bovine, dog, horse,mouse, rabbit, rat) |
Thr-Arg-Ser-Ala-Trp-NH2 | |
CO-0094 |
Osteostatin (human) |
Thr-Arg-Ser-Ala-Trp-Leu-Asp-Ser-Gly-Val-Thr-Gly-Ser-Gly-Leu-Glu-Gly-Asp-His-Leu-Ser-Asp-Thr-Ser-Thr-Thr-Ser-Leu-Glu-Leu-Asp-Ser-Arg | |
CO-0095 |
Osteostatin (1-5) (human,bovine, dog, horse, mouse,rabbit, rat) |
Thr-Arg-Ser-Ala-Trp | |
CO-0096 |
Ovalbumin(257-264) antigen peptide |
Ser-Ile-Ile-Asn-Phe-Glu-Lys-Leu | |
CO-0097 |
OVA(323-339) |
Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg | |
CO-0098 |
OVA Peptide |
Ile-Ser-Gln-Ala-Val-His-Ala-Ala-His-Ala-Glu-Ile-Asn-Glu-Ala-Gly-Arg-NH2 | |
CO-0099 |
OV-1, Sheep |
Lys-Asn-Leu-Arg-Arg-Ile-Ile-Arg-Lys-Ile-Ile-His-Ile-Ile-Lys-Lys-Tyr-Gly | |
CO-0100 |
OV-2, Sheep |
Leu-Arg-Arg-Ile-Ile-Arg-Lys-Ile-Ile-His-Ile-Ile-Lys-Lys-NH2 | |
CO-0101 |
Oxyntomodulin (human,mouse, rat) |
His-Ser-Gln-Gly-Thr-Phe-Thr-Ser-Asp-Tyr-Ser-Lys-Tyr-Leu-Asp-Ser-Arg-Arg-Ala-Gln-Asp-Phe-Val-Gln-Trp-Leu-Met-Asn-Thr-Lys-Arg-Asn-Arg-Asn-Asn-Ile-Ala | |
| CO-0025 | Oxytocin acetate | Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH2(Disulfide bridge Cys1-Cys6) | 50-56-6 |
CP-0610 |
P1 |
Gly-Ser-Phe-Leu-Val-Arg-Glu-Ser | |
CP-0611 |
PACAP-38, amide, frog |
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Ile-Lys-Asn-Lys-NH2 | |
CP-0612 |
PACAP-27 (6-27) (human,chicken, mouse, ovine,porcine, rat) |
Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 | |
CP-0613 |
PACAP-38 (6-38) (human,chicken, mouse, ovine,porcine, rat) |
Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CP-0614 |
PACAP-38 (16-38) (human,chicken, mouse, ovine,porcine, rat) |
Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CP-0615 |
PACAP-38 (28-38) (human,chicken, mouse, ovine,porcine, rat) |
Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CP-0616 |
PACAP-38 (31-38) (human,chicken, mouse, ovine,porcine, rat) |
Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CP-0617 |
PACAP-27 (human, mouse,ovine, porcine, rat) |
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2 | |
CP-0618 |
PACAP (1-38), human, ovine,rat |
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-NH2 | |
CP-0619 |
PACAP(1-38)-Lys(Biotin),amide, human, ovine, rat |
His-Ser-Asp-Gly-Ile-Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-Gly-Lys-Arg-Tyr-Lys-Gln-Arg-Val-Lys-Asn-Lys-Lys(Bio)-NH2 | |
CP-0620 |
PACAP-Related Peptide (PRP), human |
Asp-Val-Ala-His-Gly-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Gly-Lys-His-Leu-Gln-Ser-Leu-Val-Ala | |
CP-0621 |
PACAP-Related Peptide (1-29) (rat) |
Asp-Val-Ala-His-Glu-Ile-Leu-Asn-Glu-Ala-Tyr-Arg-Lys-Val-Leu-Asp-Gln-Leu-Ser-Ala-Arg-Lys-Tyr-Leu-Gln-Ser-Met-Val-Ala | |
CP-0622 |
PA (224-233), Influenza |
Ser-Ser-Leu-Glu-Asn-Phe-Arg-Ala-Tyr-Val | |
| CP-0387 | PAL-KTTKS | 214047-00-4 | |
CP-0623 |
PAKtide |
Arg-Arg-Arg-Leu-Ser-Phe-Ala-Glu-Pro-Gly | |
CP-0624 |
Pancreastatin, porcine |
Gly-Trp-Pro-Gln-Ala-Pro-Ala-Met-Asp-Gly-Ala-Gly-Lys-Thr-Gly-Ala-Glu-Glu-Ala-Gln-Pro-Pro-Glu-Gly-Lys-Gly-Ala-Arg-Glu-His-Ser-Arg-Gln-Glu-Glu-Glu-Glu-Glu-Thr-Ala-Gly-Ala-Pro-Gln-Gly-Leu-Phe-Arg-Gly-NH2 | |
CP-0625 |
Pancreatic Polypeptide (1-17)-(Ala31,Aib32)-Neuropeptide Y (18-36) (human) |
Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 | |
CP-0626 |
Pancreatic Polypeptide, avian |
Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asp-Ala-Pro-Val-Glu-Asp-Leu-Ile-Arg-Phe-Tyr-Asp-Asn-Leu-Gln-Gln-Tyr-Leu-Asn-Val-Val-Thr-Arg-His-Arg-Tyr-NH2 | |
CP-0627 |
Pancreatic Polypeptide (bovine) |
Ala-Pro-Leu-Glu-Pro-Glu-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Glu-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | 102082-88-2 |
CP-0628 |
Pancreatic Polypeptide (31-36) (free acid) (human) |
Leu-Thr-Arg-Pro-Arg-Tyr | |
CP-0629 |
Pancreatic Polypeptide,human |
Ala-Pro-Leu-Glu-Pro-Val-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Gln-Tyr-Ala-Ala-Asp-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CP-0630 |
Pancreatic Polypeptide (31-36) (human) |
Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CP-0631 |
Pancreatic Polypeptide (rana temporaria) |
Ala-Pro-Ser-Glu-Pro-His-His-Pro-Gly-Asp-Gln-Ala-Thr-Gln-Asp-Gln-Leu-Ala-Gln-Tyr-Tyr-Ser-Asp-Leu-Tyr-Gln-Tyr-Ile-Thr-Phe-Val-Thr-Arg-Pro-Arg-Phe-NH2 | 132187-74-7 |
CP-0632 |
Pancreatic Polypeptide, rat |
Ala-Pro-Leu-Glu-Pro-Met-Tyr-Pro-Gly-Asp-Tyr-Ala-Thr-His-Glu-Gln-Arg-Ala-Gln-Tyr-Glu-Thr-Gln-Leu-Arg-Arg-Tyr-Ile-Asn-Thr-Leu-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CP-0633 |
Pannexin-1 Fragment (4512) |
Val-Gln-Gln-Lys-Ser-Ser-Leu-Gln-Ser-Glu-Ser-Gly-Asn | |
CP-0634 |
Pannexin-1 Fragment (4515) |
Glu-Lys-Asn-Ser-Arg-Gln-Arg-Leu-Leu-Asn-Pro-Ser | |
CP-0635 |
Papain Inhibitor |
Gly-Gly-Tyr-Arg | |
CP-0636 |
PAR-2 (6-1) amide (human) |
Val-Lys-Gly-Ile-Leu-Ser-NH2 | |
CP-0637 |
PAR-3 (1-6) amide (human) |
Thr-Phe-Arg-Gly-Ala-Pro-NH2 | |
CP-0638 |
PAR-4 (1-6) amide (human) |
Gly-Tyr-Pro-Gly-Gln-Val-NH2 | |
CP-0639 |
PAR-3 (1-6) amide (mouse) |
Ser-Phe-Asn-Gly-Gly-Pro-NH2 | |
CP-0640 |
PAR-4 (1-6) amide (mouse) |
Gly-Tyr-Pro-Gly-Lys-Phe-NH2 | |
CP-0641 |
PAR-2 (1-6) amide (mouse, rat) |
Ser-Leu-Ile-Gly-Arg-Leu-NH2 | |
CP-0642 |
PAR-2 (1-6) (human) |
Ser-Leu-Ile-Gly-Lys-Val | |
CP-0643 |
PAR-3 (1-6) (human) |
Thr-Phe-Arg-Gly-Ala-Pro | |
CP-0644 |
PAR-4 (1-6) (human) |
Gly-Tyr-Pro-Gly-Gln-Val | |
CP-0645 |
Parallel topology β-Amyloid modified peptide |
Cys-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Tyr-Asn-Gly-Lys-Asp-Glu-Ala-Phe-Phe-Val-Leu-Lys-Gln-His-Trp | |
CP-0646 |
PAR-4 (1-6) (mouse) |
Gly-Tyr-Pro-Gly-Lys-Phe | |
CP-0647 |
PAR-1 (1-6) (mouse, rat) |
Ser-Phe-Phe-Leu-Arg-Asn | |
CP-0648 |
PAR-2 (1-6) (mouse, rat) |
Ser-Leu-Ile-Gly-Arg-Leu | |
CP-0649 |
PAR-1-selective peptide |
Thr-Phe-Leu-Leu-Arg-Asn | |
CP-0650 |
Parasin I |
Lys-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser | |
CP-0651 |
Parathyroid Hormone(1-34), bovine |
Ala-Val-Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
CP-0652 |
Parathyroid Hormone (1-34), human |
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
CP-0653 |
Parathyroid Hormone (1-38), human |
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly | |
CP-0654 |
Parathyroid Hormone (1-44), human |
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg | |
CP-0655 |
Parathyroid Hormone (70-84), human |
Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | |
CP-0656 |
Parathyroid Hormone (1-34)-Lys(Biotin), human |
Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-Lys(Biotin) | |
CP-0657 |
Parathyroid Hormone (1-34),rat |
Ala-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
CP-0658 |
PB1(703-711), Influenza |
Ser-Ser-Tyr-Arg-Arg-Pro-Val-Gly-Ile | |
CP-0659 |
p34cdc2-derived peptide |
Lys-Val-Glu-Lys-Ile-Gly-Glu-Gly-Thr-Tyr-Gly-Val-Val-NH2 | |
CP-0660 |
p60c-src Substrate I |
Tyr-Ile-Tyr-Gly-Ser-Phe-Lys | |
CP-0661 |
p60c-src Substrate II |
Ac-Ile-Tyr-Gly-Glu-Phe-NH2 | |
CP-0662 |
p60c-src Substrate I-Lys(Biotin) |
Tyr-Ile-Tyr-Gly-Ser-Phe-Lys(Biotin) | |
CP-0663 |
p60c-src Substrate II, Phosphorylated |
Ac-Ile-Tyr(PO3H2)-Gly-Glu-Phe-NH2 | |
CP-0664 |
PDGF β-Receptor (739-746) (phosphorylated) |
Tyr(PO3H2)-Met-Ala-Pro-Tyr-Asp-Asn-Tyr | |
CP-0665 |
PDGFRtide |
Gln-Glu-Glu-Glu-Tyr-Val-Phe-Ile-Glu | |
CP-0666 |
Pentagastrin |
Boc-beta-Ala-Trp-Met-Asp-Phe-NH2 | |
CP-0667 |
Pep-1 |
Lys-Glu-Thr-Trp-Trp-Glu-Thr-Trp-Trp-Thr-Glu-Trp-Ser-Gln-Pro-Lys-Lys-Lys-Arg-Lys-Val | |
CP-0668 |
Pep 4A |
Gly-Ser-Val-Val-I le-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg-NH2 | |
CP-0669 |
Pep 4AK |
Lys-Lys-Lys-Gly-Ser-Val-Val-Ile-Val-Gly-Arg-Ile-Ile-Leu-Ser-Gly-Arg-NH2 | |
CP-0670 |
Peptide B, bovine |
Phe-Ala-Glu-Pro-Leu-Pro-Ser-Glu-Glu-Glu-Gly-Glu-Ser-Tyr-Ser-Lys-Glu-Val-Pro-Glu-Met-Glu-Lys-Arg-Tyr-Gly-Gly-Phe-Met-Arg-Phe | |
CP-0671 |
Peptide F, bovine |
Tyr-Gly-Gly-Phe-Met-Lys-Lys-Met-Asp-Glu-Leu-Tyr-Pro-Leu-Glu-Val-Glu-Glu-Glu-Ala-Asn-Gly-Gly-Glu-Val-Leu-Gly-Lys-Arg-Tyr-Gly-Gly-Phe-Met | |
CP-0672 |
Peptide Standard 1 |
Cys-Pro-Asp-Phe-Gly-His-Ile-Ala-Met-Glu-Leu-Ser-Val-Arg-Thr-Trp-Lys-Tyr | |
CP-0673 |
Peptide T |
Ala-Ser-Thr-Thr-Thr-Asn-Tyr-Thr | |
CP-0674 |
Peptide YY (canine, mouse,porcine, rat) |
Tyr-Pro-Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CP-0675 |
Peptide YY (3-36) (canine,mouse, porcine, rat) |
Ala-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CP-0676 |
Peptide YY (13-36) (canine,mouse, porcine, rat) |
Ser-Pro-Glu-Glu-Leu-Ser-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CP-0677 |
Peptide YY, Human |
Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CP-0678 |
Peptide YY(3-36), PYY, human |
Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CP-0679 |
PGC-1α (205-216),Proliferator-activated Receptor Coactivator-1 α (205–216) |
Ac-Arg-Pro-Cys-Ser-Glu-Leu-Leu-Lys-Tyr-Leu-Thr-Thr-NH2 | |
CP-0680 |
PGLa |
Gly-Met-Ala-Ser-Lys-Ala-Gly-Ala-Ile-Ala-Gly-Lys-Ile-Ala-Lys-Val-Ala-Leu-Lys-Ala-Leu-NH2 | |
CP-0681 |
[Phe17]-Apelin 17 |
Lys-Phe-Arg-Arg-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | |
CP-0682 |
[Phe22] Big Endothelin-1 (19-37), human |
Ile-Ile-Trp-Phe-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg | |
CP-0683 |
[D-Phe12]-Bombesin |
Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Met-NH2 | |
CP-0684 |
[D-Phe7]-Bradykinin |
Arg-Pro-Pro-Gly-Phe-Ser-D-Phe-Phe-Arg | |
CP-0685 |
[Phe4]-Dermorphin (1-4) amide |
Tyr-D-Ala-Phe-Phe-NH2 | |
CP-0686 |
[Phe7] Dynorphin A (1-7), amide, porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Phe-NH2 | |
CP-0687 |
[Phe7] Dynorphin A (1-7), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Phe | |
CP-0688 |
[Phe1376]-Fibronectin Fragment (1371-1382) |
Arg-Gln-Asp-Arg-Val-Phe-His-Ser-Arg-Asn-Ser-Ile | |
CP-0689 |
[D-Phe12,Leu14]-Bombesin |
Pyr-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Leu-NH2 | |
CP-0690 |
[D-Phe6,Leu-NHEt13,des-Met14]-Bombesin (6-14) |
D-Phe-Gln-Trp-Ala-Val-Gly-His-Leu-NHEt | |
CP-0691 |
[D-Phe7] a-MSH, amide |
Ac-Ser-Tyr-Ser-Met-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2 | |
CP-0692 |
[D-Phe11]-Neurotensin |
pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Phe-Ile-Leu | |
CP-0693 |
[Phe2, Nle4]-ACTH (1-24) |
Ser-Phe-Ser-NLE-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CP-0694 |
[D-Phe12,Nle21,38]-CRF (12-41) (human, rat) |
D-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Nle-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Nle-Glu-Ile-Ile-NH2 | |
CP-0695 |
Phenylalanine-free protein 115 120 125 |
Gln-Gln-Lys-Glu-Pro-Met-Ile-Gly-Val-Asn-Gln-Glu-Leu-Ala-Tyr-Phe | |
CP-0696 |
[Phe2,Orn8]-Oxytocin |
Cys-Phe-Ile-Gln-Asn-Cys-Pro-Orn-Gly- NH2 (Disulfide bridge Cys1-Cys6） | |
CP-0697 |
[D-Phe2,6,Pro3]-LHRH |
Pyr-D-Phe-Pro-Ser-Tyr-D-Phe-Leu-Arg-Pro-Gly-NH2 | |
CP-0698 |
[Phe1,Ser2]-TRAP-6 |
Phe-Ser-Leu-Leu-Arg-Asn | |
CP-0699 |
[Phe1,Ser2,Tyr6]-PAR-1 (1-6) amide (human) |
Phe-Ser-Leu-Leu-Arg-Tyr- NH2 | |
CP-0700 |
[D-Phe7]-Somatostatin-14 |
Ala-Gly-Cys-Lys-Asn-Phe-D-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys3-Cys14) | |
CP-0701 |
[Phe2]-TRH |
Pyr-Phe-Pro- NH2 | |
CP-0702 |
[D-Phe7, D-Trp10]-Somatostatin 14 (7-14) |
D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr (Disulfide bridge: Cys2-Cys7) | |
CP-0703 |
[Phe13,Tyr19]-MCH (human, mouse, rat) |
Asp-Phe-Asp-Met-Leu-Arg-Cys-Met-Leu-Gly-Arg-Val-Phe-Arg-Pro-Cys-Trp-Gln-Tyr (Disulfide bridge: Cys7-Cys16) | |
CP-0704 |
[D-Phe2]-VIP (human, bovine, porcine, rat) |
His-D-Phe-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
CP-0705 |
PHI, porcine |
His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Arg-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH2 | |
CP-0706 |
PHI, rat |
His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Tyr-Ser-Arg-Leu-Leu-Gly-Gln-Ile-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Ile-NH2 | |
CP-0707 |
PHM-27/PHI, human |
His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-NH2 | |
CP-0709 |
Phosphate Acceptor Peptide |
Arg-Arg-Lys-Ala-Ser-Gly-Pro-Pro-Val | |
CP-0710 |
Phosphatase Substrate |
Leu-Lys-Arg-Ala-pThr-Leu-Gly-NH2 | |
CP-0711 |
Phosphorylase Kinase b-Subunit Fragment (420-436) |
Lys-Arg-Asn-Pro-Gly-Ser-Gln-Lys-Arg-Phe-Pro-Ser-Asn-Cys-Gly-Arg-Asp | |
CP-0712 |
Phosphorylated Protein Kinase C Substrate 1 |
Lys-Arg-Pro-pSer-Gln-Arg-His-Gly-Ser-Lys-Tyr-NH2 | |
CP-0713 |
Phosphorylated Protein Kinase C Substrate 2 |
Lys-Arg-pThr-Ile-Arg-Arg | |
CP-0714 |
Phyllolitorin |
Pyr-Leu-Trp-Ala-Val-Gly-Ser-Phe-Met-NH2 | |
CP-0715 |
Phyllomedusin |
Pyr-Asn-Pro-Asn-Arg-Phe-Ile-Gly-Leu-Met-NH2 | |
CP-0716 |
Physalaemin |
Pyr-Ala-Asp-Pro-Asn-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | |
| CP-0293 | PipClU | 161308-40-3 | |
CP-0717 |
PKA Inhibitor Substrate |
Gly-Arg-Thr-Gly-Arg-Arg-Asn-pSer-Ile-His-Asp-Ile-Leu | |
CP-0718 |
PKA Regulatory Subunit II Substrate |
Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-pSer-Val-Ala-Ala-Glu | |
CP-0719 |
PKCe pseudosubstrate derived peptide |
Glu-Arg-Met-Arg-Pro-Arg-Lys-Arg-Gln-Gly-Ser-Val-Arg-Arg-Arg-Val | |
CP-0720 |
PKI-tide |
Ile-Ala-Ala-Gly-Arg-Thr-Gly-Arg-Arg-Gln-Ala-Ile-His-Asp-Ile-Leu-Val-Ala-Ala | |
CP-0721 |
p3K, (Lys 58 Lys 60 Lys 63) Ea(52–68) |
Ala-Ser-Phe-Glu-Ala-Gln-Lys-Ala-Lys-Ala-Asn-Lys-Ala-Val-Asp-Lys-Ala | |
CP-0722 |
p3K truncated, (Lys 58 Lys 60 Lys 63) Ea(54-68) |
Phe-Glu-Ala-Lys-Gly-Ala-Lys-Ala-Asn-Lys-Ala-Val-Asp | |
CP-0723 |
Plasminogen Activator Inhibitor 1 (PAI-1) |
Ala-Arg-Met-Ala-Pro-Glu | |
CP-0724 |
Platelet-Derived Growth Factor Receptor Substrate 2 |
Ser-Val-Leu-pTyr-Thr-Ala-Val-Gln-Pro-Asn-Glu | |
CP-0725 |
Platelet-Derived Growth Factor Receptor Substrate 1; PDGF Receptor Substrate |
Asn-pTyr-Ile-Ser-Lys-Gly-Ser-Thr-Phe-Leu | |
CP-0726 |
Platelet Factor 4 (58-70) (human) |
Pro-Leu-Tyr-Lys-Lys-Ile-Ile-Lys-Lys-Leu-Leu-Glu-Ser | |
CP-0727 |
Platelet Membrane Glycoprotein IIB Peptide (296-306) |
Thr-Asp-Val-Asn-Gly-Asp-Gly-Arg-His-Asp-Leu | |
CP-0728 |
p5 Ligand for Dnak and and DnaJ |
Cys-Leu-Leu-Leu-Ser-Ala-Pro-Arg-Arg | |
CP-0729 |
PLM derived peptide |
Ile-Arg-Arg-Leu-Ser-Thr-Arg-Arg-Arg | |
CP-0730 |
P61 (343-355), M. leprae |
Arg-Val-Ala-Gln-Ile-Arg-Thr-Glu-Ile-Glu-Asn-Ser-Asp | |
CP-0731 |
P38 (411-425), M. leprae |
Ala-Gly-Gly-Gly-Val-Thr-Leu-Leu-Gln-Ala-Ala-Pro-Ala-Leu-Asp | |
CP-0732 |
P62 (417-429), M. leprae |
Leu-Leu-Gln-Ala-Ala-Pro-Ala-Leu-Asp-Lys-Leu-Lys-Leu | |
CP-0733 |
P69 (522-534), M. leprae |
Pro-Glu-Lys-Thr-Ala-Ala-Pro-Ala-Ser-Asp-Pro-Thr-Gly | |
CP-0734 |
Pneumadin (human) |
Ala-Gly-Glu-Pro-Lys-Leu-Asp-Ala-Gly-Val-NH2 | |
CP-0735 |
Pneumadin (rat) |
Tyr-Gly-Glu-Pro-Lys-Leu-Asp-Ala-Gly-Val-NH2 | |
CP-0736 |
Polistes Mastoparan |
Val-Asp-Trp-Lys-Lys-Ile-Gly-Gln-His-Ile-Leu-Ser-Val-Leu-NH2 | |
CP-0737 |
Polylysine |
Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys-Lys | |
CP-0738 |
pp60 C-SRC (521-533) |
Thr-Ser-Thr-Glu-Pro-Gln-Tyr-Gln-Pro-Gly-Glu-Asn-Leu | |
CP-0739 |
pp60 C-SRC Carboxy-Terminal Phosphoregulatory Peptide Phosphorylated |
Thr-Ser-Thr-Glu-Pro-Gln-pTyr-Gln-Pro-Gly-Glu-Asn-Leu | |
CP-0740 |
pp60(v-SRC) Autophosphorylation Site,Protein Tyrosine Kinase Substrate |
Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-Tyr-Thr-Ala-Arg-Gly | |
CP-0741 |
pp60(V-SRC) Autophosphorylation Site,Tyrosine Phosphopeptide |
Arg-Arg-Leu-Ile-Glu-Asp-Asn-Glu-pTyr-Thr-Ala-Arg-Gly | |
| CP-0234 | Pramlintide acetate | 196078-30-5 | |
CP-0742 |
Prepro-adrenomedullin (153 -185), human |
Ser-Leu-Pro-Glu-Ala-Gly-Pro-Gly-Arg-Thr-Leu-Val-Ser-Ser-Lys-Pro-Gln-Ala-His-Gly-Ala-Pro-Ala-Pro-Pro-Ser-Gly-Ser-Ala-Pro-His-Phe-Leu | |
CP-0743 |
Prepro-Atrial Natriuretic Factor (26-55) (human) |
Asn-Pro-Met-Tyr-Asn-Ala-Val-Ser-Asn-Ala-Asp-Leu-Met-Asp-Phe-Lys-Asn-Leu-Leu-Asp-His-Leu-Glu-Glu-Lys-Met-Pro-Leu-Glu-Asp | |
CP-0744 |
Prepro-Atrial Natriuretic Factor (56-92) (human) |
Glu-Val-Val-Pro-Pro-Gln-Val-Leu-Ser-Glu-Pro-Asn-Glu-Glu-Ala-Gly-Ala-Ala-Leu-Ser-Pro-Leu-Pro-Glu-Val-Pro-Pro-Trp-Thr-Gly-Glu-Val-Ser-Pro-Ala-Gln-Arg | |
CP-0745 |
Prepro- Atrial Natriuretic Factor (104-116), human |
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg | |
CP-0746 |
Prepro-Atrial Natriuretic Factor (104-123) (human) |
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg | |
CP-0747 |
Prepro-Nerve Growth Factor (99-115) (mouse) |
Pro-Glu-Ala-His-Trp-Thr-Lys-Leu-Gln-His-Ser-Leu-Asp-Thr-Ala-Leu-Arg | |
CP-0748 |
Prepro-Neuromedin S (70-103) (human) |
Phe-Leu-Phe-His-Tyr-Ser-Arg-Thr-Gln-Glu-Ala-Thr-His-Pro-Val-Lys-Thr-Gly-Phe-Pro-Pro-Val-His-Pro-Leu-Met-His-Leu-Ala-Ala-Lys-Leu-Ala-Asn | |
CP-0749 |
Prepro-Neuromedin U (104-136) (human) |
Phe-Leu-Phe-His-Tyr-Ser-Lys-Thr-Gln-Lys-Leu-Gly-Lys-Ser-Asn-Val-Val-Ser-Ser-Val-Val-His-Pro-Leu-Leu-Gln-Leu-Val-Pro-His-Leu-His-Glu | |
CP-0750 |
Preproenkephalin B (186-204), human |
Ser-Ser-Glu-Val-Ala-Gly-Glu-Gly-Asp-Gly-Asp-Ser-Met-Gly-His-Glu-Asp-Leu-Tyr | |
CP-0751 |
Preprogalanin 28-67, rat |
Thr-Lys-Glu-Lys-Arg-Gly-Trp-Thr-Leu-Asn-Ser-Ala-Gly-Tyr-Leu-Leu-Gly-Pro-His-Ala-Ile-Asp-Asn-His-Arg-Ser-Phe-Ser-Asp-Lys-His-Gly-Leu-Thr-Gly-Lys-Arg-Glu-Leu-Pro | |
CP-0752 |
Prepro TRH (53-74) |
Phe-Leu-Trp-Lys-Asp-Leu-Gln-Arg-Val-Arg-Gly-Asp-Leu-Gly-Ala-Ala-Leu-Asp-Ser-Trp-Ile-Thr | |
CP-0753 |
Prepro TRH (83-106) |
Glu-Glu-Glu-Glu-Lys-Asp-Ile-Glu-Ala-Glu-Glu-Arg-Gly-Asp-Leu-Gly-Glu-Gly-Gly-Ala-Trp-Arg-Leu-His | |
CP-0754 |
Prepro TRH (160-169) |
Ser-Phe-Pro-Trp-Met-Glu-Ser-Asp-Val-Thr | |
CP-0755 |
Prepro TRH (178-199) |
Phe-Ile-Asp-Pro-Glu-Leu-Gln-Arg-Ser-Trp-Glu-Glu-Lys-Glu-Gly-Glu-Gly-Val-Leu-Met-Pro-Glu | |
CP-0756 |
Prepro VIP (81-122) (human) |
His-Ala-Asp-Gly-Val-Phe-Thr-Ser-Asp-Phe-Ser-Lys-Leu-Leu-Gly-Gln-Leu-Ser-Ala-Lys-Lys-Tyr-Leu-Glu-Ser-Leu-Met-Gly-Lys-Arg-Val-Ser-Ser-Asn-Ile-Ser-Glu-Asp-Pro-Val-Pro-Val | |
CP-0757 |
Prepro VIP (111-122) (human) |
Val-Ser-Ser-Asn-Ile-Ser-Glu-Asp-Pro-Val-Pro-Val | |
CP-0758 |
Prepro VIP (156-170) (human) |
Ser-Ser-Glu-Gly-Glu-Ser-Pro-Asp-Phe-Pro-Glu-Glu-Leu-Glu-Lys | |
CP-0759 |
Pre-S1 (12-32) |
Met-Gly-Thr-Asn-Leu-Ser-Val-Pro-Asn-Pro-Leu-Gly-Phe-Phe-Pro-Asp-His-Gln-Leu-Asp-Pro | |
CP-0760 |
Pre-S2 (1-26) |
Met-Gln-Trp-Asn-Ser-Thr-Ala-Phe-His-Gln-Thr-Leu-Gln-Asp-Pro-Arg-Val-Arg-Gly-Leu-Tyr-Leu-Pro-Ala-Gly-Gly | |
CP-0761 |
Pressinoic acid |
Cys-Tyr-Phe-Gln-Asn-Cys（Disulfide bridge Cys1-Cys6） | 35748-51-7 |
CP-0762 |
Présure. 10. 145-148 |
Ala-Tyr-Phe-Tyr-Pro-Glu-Leu | |
CP-0763 |
Prion Peptide (106-126),Human |
Lys-Thr-Asn-Met-Lys-His-Met-Ala-Gly-Ala-Ala-Ala-Ala-Gly-Ala-Val-Val-Gly-Gly-Leu-Gly | |
CP-0764 |
Proadrenomedullin (1-20) (human) |
Ala-Arg-Leu-Asp-Val-Ala-Ser-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | |
CP-0765 |
Proadrenomedullin (12-20) (human) |
Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | |
CP-0766 |
Proadrenomedullin (45-92) (human) |
Glu-Leu-Arg-Met-Ser-Ser-Ser-Tyr-Pro-Thr-Gly-Leu-Ala-Asp-Val-Lys-Ala-Gly-Pro-Ala-Gln-Thr-Leu-Ile-Arg-Pro-Gln-Asp-Met-Lys-Gly-Ala-Ser-Arg-Ser-Pro-Glu-Asp-Ser-Ser-Pro-Asp-Ala-Ala-Arg-Ile-Arg-Val | |
CP-0767 |
Pro-Adrenomedullin N20, human |
Ala-Arg-Leu-Asp-Val-Ala-Ala-Glu-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | |
CP-0768 |
Pro-Adrenomedullin N20, rat |
Ala-Arg-Leu-Asp-Thr-Ser-Ser-Gln-Phe-Arg-Lys-Lys-Trp-Asn-Lys-Trp-Ala-Leu-Ser-Arg-NH2 | |
CP-0769 |
[Pro18, Asp21] β-Amyloid (17-21), iAb5 |
Leu-Pro-Phe-Phe-Asp | |
| CP-0991 | β I probe | Ser-Arg-Glu-Trp-Glu-Asp-Gly-Phe-Gly-Gly-Arg-Trp-Leu-Ser-Arg | |
| CP-0992 | β II probe | Ser-Ser-Leu-Asp-Leu-Ser-Gln-Phe-Pro-Met-Thr-Ala-Ser-Phe-Leu-Arg-Glu-Ser-Arg | |
| CP-0993 | β III probe | Ser-Ser-Glu-Ala-Cys-Val-Gly-Arg-Trp-Met-Leu-Cys-Glu-Gln-Leu-Gly-Val-Ser-Arg | |
CP-0770 |
[D-Pro2]-β-Casomorphin (1-5), bovine |
Tyr-D-Pro-Phe-Pro-Gly | |
CP-0771 |
[D-Pro2]-β-Casomorphin (1-5), bovine, amide |
Tyr-D-Pro-Phe-Pro-Gly-NH2 | |
CP-0772 |
Proctolin |
Arg-Tyr-Leu-Pro-Thr | |
CP-0773 |
Prodynorphin (228-240), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr | |
CP-0774 |
Prodynorphin (228-256), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Gln-Phe-Lys-Val-Val-Thr-Arg-Ser-Gln-Glu-Asp-Pro-Asn-Ala-Tyr-Tyr-Glu-Glu-Leu-Phe-Asp-Val | |
CP-0775 |
[D-Pro10]-Dynorphin A (1-11), porcine |
Tyr-Gly-Gly-Phe-Leu-Arg-Arg-Ile-Arg-D-Pro-Lys | |
CP-0776 |
proFIX18 |
Thr-Val-Phe-Leu-Asp-His-Glu-Asn-Ala-Asn-Lys-Ile-Leu-Asn-Arg-Pro-Lys-Arg | |
CP-0777 |
proFIX28 |
Thr-Val-Phe-Leu-Asp-His-Glu-Asn-Ala-Asn-Lys-Ile-Leu-Asn-Arg-Pro-Lys-Arg-Tyr-Asn-Ser-Gly-Lys-Leu-Glu-Glu-Phe-Val | |
CP-0778 |
[D-Pro194]-IL-1 β (193-195) (human) |
Lys-D-Pro-Thr | |
CP-0779 |
Proinsulin C-peptide (31-63), porcine |
Arg-Arg-Glu-Ala-Glu-Asn-Pro-Gln-Ala-Gly-Ala-Val-Glu-Leu-Gly-Gly-Gly-Leu-Gly-Gly-Leu-Gln-Ala-Leu-Ala-Leu-Glu-Gly-Pro-Pro-Gln-Lys-Arg | |
CP-0780 |
Proinsulin C-peptide (55-89), human |
Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg | |
CP-0781 |
Prolactin Releasing Peptide (1-31), bovine |
Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Ile-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
CP-0782 |
Prolactin Releasing Peptide (12-31), bovine |
Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
CP-0783 |
Prolactin Releasing Peptide (12-31), human |
Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Ala-Ser-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
CP-0784 |
Prolactin Releasing Peptide (1-31), rat |
Ser-Arg-Ala-His-Gln-His-Ser-Met-Glu-Thr-Arg-Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
CP-0785 |
Prolactin Releasing Peptide (12-31), rat |
Thr-Pro-Asp-Ile-Asn-Pro-Ala-Trp-Tyr-Thr-Gly-Arg-Gly-Ile-Arg-Pro-Val-Gly-Arg-Phe-NH2 | |
CP-0786 |
[Pro7]-Neurokinin B |
Asp-Met-His-Asp-Phe-Phe-Pro-Gly-Leu-Met- NH2 | |
CP-0787 |
[Pro34]-Neuropeptide Y, human, rat; [Pro34]-NPY, human, rat |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Pro-Arg-Tyr- NH2 | |
CP-0788 |
[Pro34]-Neuropeptide Y (porcine) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-Pro-Arg-Tyr- NH2 | |
CP-0789 |
[Pro34]Peptide YY, PYY, human |
Tyr-Pro-Ile-Lys-Pro-Glu-Ala-Pro-Gly-Glu-Asp-Ala-Ser-Pro-Glu-Glu-Leu-Asn-Arg-Tyr-Tyr-Ala-Ser-Leu-Arg-His-Tyr-Leu-Asn-Leu-Val-Thr-Arg-Pro-Arg-Tyr-NH2 | |
CP-0790 |
[D-Pro2,D-Phe7,D-Trp9]-Substance P |
Arg-D-Pro-Lys-Pro-Gln-Gln-D-Phe-Phe-D-Trp-Leu-Met-NH2 | |
CP-0791 |
proPT18 |
His-Val-Phe-Leu-Ala-Pro-Gln-Gln-Ala-Arg-Ser-Leu-Leu-Gln-Arg-Val-Arg-Arg | |
CP-0792 |
proPT28 |
His-Val-Phe-Leu-Ala-Pro-Gln-Gln-Ala-Arg-Ser-Leu-Leu-Gln-Arg-Val-Arg-Arg-Ala-Asn-Thr-Phe-Leu-Glu-Glu-Val-Arg-Lys | |
CP-0793 |
Prosaptide 769P |
Cys-D-Ala-Phe-Leu-Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | |
CP-0794 |
Prosaptide TX14(A) |
Thr-D-Ala-Leu-Ile-Asp-Asn-Asn-Ala-Thr-Glu-Glu-Ile-Leu-Tyr | |
CP-0795 |
Prosaptide, wild type |
Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | |
CP-0796 |
[Pro9] Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Pro-Leu-Met- NH2 | |
CP-0797 |
Protease – Activated Receptor-2, PAR-2 Agonist,amide |
Ser-Leu-Ile-Gly-Lys-Val-NH2 | |
CP-0798 |
Protein Kinase A Substrate |
Gly-Arg-Gly-Leu-Ser-Leu-Ser-Arg | |
CP-0799 |
Protein Kinase C (19-31) |
Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val | |
CP-0800 |
Protein Kinase C (530-558) |
Leu-Leu-Tyr-Glu-Met-Leu-Ala-Gly-Gln-Ala-Pro-Phe-Glu-Gly-Glu-Asp-Glu-Asp-Glu-Leu-Phe-Gln-Ser-Ile-Met-Glu-His-Asn-Val-NH2 | |
CP-0801 |
Protein Kinase C (19-36); Protein Kinase C Selective Inhibitor Protein |
Arg-Phe-Ala-Arg-Lys-Gly-Ala-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | |
CP-0802 |
Protein Kinase C Substrate |
Val-Arg-Lys-Arg-Thr-Leu-Arg-Arg-Leu | |
CP-0803 |
Protein Kinase C Substrate from EGF Receptor |
Lys-Arg-Thr-Leu-Arg-Arg | |
CP-0804 |
Protein Kinase C Substrate, Glycogen Synthase (1-8) |
Pro-Leu-Ser-Arg-Thr-Leu-Ser-Val-Ala-Ala-Lys-Lys-NH2 | |
CP-0805 |
Protein Kinase G Substrate; G-Subtide |
Gln-Lys-Arg-Pro-Arg-Arg-Lys-Asp-Thr-Pro | |
CP-0806 |
Protein Kinase p34(cd2) Substrate; CSH 103 |
Ala-Asp-Ala-Gln-His-Ala-Thr-Pro-Pro-Lys-Lys-Lys-Arg-Lys-Val-Glu-Asp-Pro-Lys-Asp-Phe | |
CP-0807 |
Pro-TGF-a |
His-Ala-Asp-Leu-Leu-Ala-Val-Val-Ala-Ala-Ser-Gln | |
CP-0808 |
[D-Pro2, D-Trp6,8,Nle10]-Neurokinin B |
Asp-D-Pro-His-Asp-Phe-D-Trp-Val-D-Trp-Leu-Nle-NH2 | |
CP-0809 |
[D-Pro4,D-Trp7,9,Nle11]-Substance P (4-11) |
D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Nle-NH2 | |
CP-0810 |
[D-Pro2, D-Trp7,9]-Substance P |
Arg-D-Pro-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Met-NH2 | |
CP-0811 |
[D-Pro4, D-Trp7,9,10]-Substance P (4-11) |
D-Pro-Gln-Gln-D-Trp-Phe-D-Trp-D-Trp-Met-NH2 | |
CP-0812 |
[D-Pro4, D-Trp7,9,10,Val8]-Substance P (4-11) |
D-Pro-Gln-Gln-D-Trp-Val-D-Trp-D-Trp-Met-NH2 | |
CP-0813 |
pro-ε-Tx1X/12 |
Leu-Lys-Arg-Thr-Ile-Arg-Thr-Arg-Leu-Asn-Ile-Arg | |
CP-0814 |
PRRS-PQGAB-C |
Gly-Thr-Asp-Trp-Leu-Ala-Asn-Lys-Phe-Asp-Trp-Ala | |
CP-0815 |
PRRS-PQGAB-M |
Thr-Tyr-Ala-Ser-Asn-Asp-Ser-Ser-Ser-His-Leu-Gln | |
CP-0816 |
PRRS-PQGAB-N |
Gly-Ser-Ser-Leu-Asp-Asp-Phe-Cys-Tyr-Asp-Ser-Thr | |
CP-0817 |
PRRS-RSAB-C |
Leu-Asn-Gly-Thr-Asp-Trp-Leu-Ser-Asn-His-Phe-Asp-Trp-Ala | |
CP-0818 |
PRRS-RSAB-N |
Ala-Gly-Gly-Ser-Ser-Ser-Thr-Tyr-Gln-Tyr | |
CP-0819 |
[pSer5]-Kemptide, Biotinylated |
Biotin-Leu-Arg-Arg-Ala-Ser(PO3H2)-Leu-Gly | |
| CP-0388 | PT-141 acetate | Ac-Nle-Asp-His-D-Phe-Arg-Trp-Lys (Asp-Lys) | 32780-32-8 |
| CP-0823 | pTH(3-34)(bovine) | Ser-Glu-Ile-Gln-Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe |
|
| CP-0820 | pTH(13-34)(human) | Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
| CP-0821 | pTH(28-48)(human) | Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser | |
| CP-0822 | pTH(53-84)(human) | Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | |
| CP-0998 | pTH-Related Protein Splice Isoform 3 (140-173) (human) | Thr-Ala-Leu-Leu-Trp-Gly-Leu-Lys-Lys-Lys-Lys-Glu-Asn-Asn-Arg-Arg-Thr-His-His-Met-Gln-Leu-Met-Ile-Ser-Leu-Phe-Lys-Ser-Pro-Leu-Leu-Leu-Leu | |
| CP-0999 | P55-TNFR | Leu-Pro-Gln-Ile-Glu-Asn-Val-Lys-Gly-Thr-Glu-Asp | |
| CP-1000 | P75-TNFR Fragment | Ser-Met-Ala-Pro-Gly-Ala-Val-His-Leu-Pro-Gln-Pro | |
| CP-1001 | p60 v-src (137-157) | Val-Ala-Pro-Ser-Asp-Ser-Ile-Gln-Ala-Glu-Glu-Trp-Tyr-Phe-Gly-Lys-Ile-Thr-Arg-Arg-Glu | |
| CP-0237 | PyAOP | 156311-83-0 | |
CP-0238 |
PyBrOP |
132705-51-2 |
|
CP-0239 |
PyClOP |
133894-48-1 |
|
CP-0292 |
PyClU |
135540-11-3 |
|
CP-0828 |
[pY185]MAP(177-189)kinase |
Asp-His-Thr-Gly-Phe-Leu-Thr-Glu-Tyr(PO3H2)-Val-Ala-Thr-Arg | |
CP-0829 |
[Pyr3]-Amyloid β-Protein(3-42) |
Pyr-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-Ile-Ala | |
CP-0830 |
[Pyr11]-Amyloid β-Protein(11-40) |
Pyr-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val | |
CP-0831 |
[Pyr1]-Apelin-13 |
pyr-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | |
CP-0832 |
Pyr-Gly-Arg-pNA |
Pyr-Gly-Arg-pNA | |
CP-0833 |
[Pyr4]-MBP(4-14) |
Pyr-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | |
CP-0834 |
[Pyr6,Pro9]-Substance P(6-11) |
Pyr-Phe-Phe-Pro-Leu-Met-NH2 | |
CP-0835 |
[Pyr5]-Substance P(5-11) |
Pyr-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CP-0836 |
[Pyr6]-Substance P(6-11) |
Pyr-Phe-Phe-Gly-Leu-Met-NH2 | |
CP-0837 |
[Pyr16]-VIP(16-28)(chicken) |
Pyr-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Val-Leu-Thr-NH2 | |
CP-0838 |
[Pyr16]-VIP(16-28)(human, bovine, porcine, rat) |
Pyr-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn- NH2 | |
CQ-0037 |
Q-K-R-P-S-Q-R-S-K-Y-L |
Gln-Lys-Arg-Pro-Ser-Gln-Arg-Ser-Lys-Tyr-Leu | |
CR-0019 |
Ranamargarin |
Asp-Asp-Ala-Ser-Asp-Arg-Ala-Lys-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | |
CR-0020 |
Ranatensin |
Pyr-Val-Pro-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2 | 29451-71-6 |
CR-0021 |
Ranatensin R |
Ser-Asn-Thr-Ala-Leu-Arg-Arg-Tyr-Asn-Gln-Trp-Ala-Thr-Gly-His-Phe-Met-NH2 | |
| CR-0008 | Ramage Linker | 212783-75-0 | |
CR-0022 |
rec Acetyl-Eglin c |
Ac-Thr-Glu-Phe-Gly-Ser-Glu-Leu-Lys-Ser-Phe-Pro-Glu-Val-Val-Gly-Lys-Thr-Val-Asp-Gln-Ala-Arg-Glu-Tyr-Phe-Thr-Leu-His-Tyr-Pro-Gln-Tyr-Asp-Val-Tyr-Phe-Leu-Pro-Glu-Gly-Ser-Pro-Val-Thr-Leu-Asp-Leu-Arg-Tyr-Asn-Arg-Val-Arg-Val-Phe-Tyr-Asn-Pro-Gly-Thr-Asn-Val-Val-Asn-His-Val-Pro-His-Val-Gly | |
CR-0023 |
Rcramp |
Gly-Leu-Val-Arg-Lys-Gly-Gly-Glu-Lys-Phe-Gly-Glu-Lys-Leu-Arg-Lys-Ile-Gly-Gln-Lys-Ile-Lys-Glu-Phe-Phe-Gln-Lys-Leu-Ala-Leu-Glu-Ile-Glu-Gln | |
CR-0024 |
RC-160(Vapreotide) |
D-Phe-Cys-Tyr-D-Trp-Lys-Val-Cys-Trp-NH2 | |
CR-0025 |
R-E-D-V |
Arg-Glu-Asp-Val | |
CR-0027 |
Renin Inhibitor Peptide |
His-Pro-Phe-His-Leu-D-Leu-Val-Tyr-NH2 | |
CR-0028 |
RES-701-1 |
Gly-Asn-Trp-His-Gly-Thr-Ala-Pro-Asp-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp | |
CR-0029 |
RES-701-3 |
Gly-Asn-Trp-His-Gly-Thr-Ser-Pro-Asp-Trp-Phe-Phe-Asn-Tyr-Tyr-Trp | |
CR-0030 |
26Rfa, Hypothalamic Peptide, frog |
Val-Gly-Thr-Ala-Leu-Gly-Ser-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Asn-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 | |
CR-0031 |
26Rfa, Hypothalamic Peptide, human |
Thr-Ser-Gly-Pro-Leu-Gly-Asn-Leu-Ala-Glu-Glu-Leu-Asn-Gly-Tyr-Ser-Arg-Lys-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 | |
CR-0032 |
RF-amide, Chicken |
Leu-Pro-Leu-Arg-Phe-NH2 | |
CR-0033 |
26Rfa, Hypothalamic Peptide, rat |
Ala-Ser-Gly-Pro-Leu-Gly-Thr-Leu-Ala-Glu-Glu-Leu-Ser-Ser-Tyr-Ser-Arg-Arg-Lys-Gly-Gly-Phe-Ser-Phe-Arg-Phe-NH2 | |
CR-0034 |
RF-amide peptide, Drosophila |
Thr-Asp-Val-Asp-His-Val-Phe-Leu-Arg-Phe-NH2 | |
CR-0035 |
RFDS |
Arg-Phe-Asp-Ser | |
| CR-0048 | R-F-NH2 | Arg-Phe-NH2 | |
CR-0036 |
RFRP-1 (Human) |
Met-Pro-His-Ser-Phe-Ala-Asn-Leu-Pro-Leu-Arg-Phe-NH2 | |
CR-0037 |
RGD |
Arg-Gly-Asp | |
| CG-0049 | R-G-D-C | Arg-Gly-Asp-Cys | |
CR-0038 |
RGD-4C |
Ala-Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys-Gly (isulfide bridge: Cys2-Cys10 , Cys4-Cys8) | |
| CG-0050 | R-G-D-S-P-A-S-S-K-P | Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys-Pro | |
| CG-0051 | R-G-D-T | Arg-Gly-Asp-Thr | |
CR-0039 |
RGDV |
Arg-Gly-Asp-Val | |
| CR-0052 | R-G-E-S | Arg-Gly-Glu-Ser | |
CR-0040 |
Rigin |
Gly-Gln-Pro-Arg | |
| CR-0053 | R-G-Y-S-L-G | Arg-Gly-Tyr-Ser-Leu-Gly | |
| CR-0007 | Rink Amide Linker | 145069-56-3 | |
| CR-0054 | R-JAG(188-206)R-Jagged-1(188 - 206), Notch Ligand | Cys-Asp-Asp-Tyr-Tyr-Tyr-Gly-Phe-Gly-Cys-Asn-Lys-Phe-Gly-Arg-Pro-Arg-Asp-Asp | |
CR-0041 |
RK9, p17 Gag(20-28) |
Arg-Leu-Arg-Pro-Gly-Gly-Lys-Lys-Lys | |
CR-0042 |
Rnase(90–105) |
Ser-Lys-Tyr-Pro-Asn-Cys-Ala-Tyr-Lys-Thr-Thr-Gln-Ala-Asn-Lys-His | |
CR-0043 |
RR-SRC |
Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Al a-Ala-Arg-Gly | |
CR-0044 |
RS domain derived peptide |
Gly-Arg-Ser-Arg-Ser-Arg-Ser-Arg-Ser-Arg | |
| CR-0055 | RSK Substrate, S6(231-239) | Arg-Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala-NH2 | |
CR-0045 |
R-S-R |
Arg-Ser-Arg | 115035-42-2 |
CR-0046 |
RSV M(187-195) |
Asn-Ala-Ile-Thr-Asn-Ala-Lys-Ile-Ile | |
CS-0089 |
S6-1 |
Arg-Arg-Leu-Ser-Ser-Leu-Arg-Ala | |
CS-0090 |
SALMF amide 1(S1) |
Gly-Phe-Asn-Ser-Ala-Leu-Met-Phe-NH2 | |
CS-0091 |
SALMF amide 2(S2) |
Ser-Gly-Pro-Tyr-Ser-Phe-Asn-Ser-Gly-Leu-Thr-Phe-NH2 | |
CS-0092 |
Salusin-alpha |
Ser-Gly-Ala-Leu-Pro-Pro-Ala-Pro-Ala-Ala-Pro-Arg-Pro-Ala-Leu-Arg-Ala-Gln-Arg-Ala-Gly-Pro-Ala-Gly-Pro-Gly-Ala-Lys-NH2 | |
CS-0093 |
Salusin-beta |
Ala-Ile-Phe-Ile-Phe-Ile-Arg-Trp-Leu-Leu-Lys-Leu-Gly-His-His-Gly-Arg-Ala-Pro-Pro | |
CS-0094 |
SAMs Peptide |
His-Met-Arg-Ser-Ala-Met-Ser-Gly-Leu-His-Leu-Val-Lys-Arg-Arg | 125911-68-4 |
CS-0053 |
Saposin C12 |
Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | |
CS-0095 |
Saposin C18 |
Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | |
CS-0096 |
Saposin C22 |
Cys-Glu-Phe-Leu-Val-Lys-Glu-Val-Thr-Lys-Leu-Ile-Asp-Asn-Asn-Lys-Thr-Glu-Lys-Glu-Ile-Leu | |
CS-0097 |
Sarafotoxin 6c |
Cys-Thr-Cys-Asn-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp(Disulfide bridge: Cys1-Cys15,Cys3-Cys11) | |
CS-0098 |
Sarafotoxin S6a |
Cys-Ser-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp(Disulfide bridge: Cys1 and Cys15/Cys3 and Cys11) | |
CS-0099 |
Sarafotoxin S6b |
Cys-Ser-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-Leu-Tyr-Phe-Cys-His-Gln-Asp-Val-Ile-Trp(Disulfide bridge: Cys1-Cys15,Cys3-Cys11) | |
CS-0100 |
Sarafotoxin S6c |
Cys-Thr-Cys-Asn-Asp-Met-Thr-Asp-Glu-Glu-Cys-Leu-Asn-Phe-Cys-His-Gln-Asp-Val-Ile-Trp | |
CS-0101 |
Sarafotoxin S6d |
Cys-Thr-Cys-Lys-Asp-Met-Thr-Asp-Lys-Glu-Cys-Leu-Tyr-Phe-Cys-His-Gln-Asp-Ile-Ile-Trp | |
CS-0102 |
[Sar1,Ala8]-Angiotensin II |
Sar-Arg-Val-Tyr-Ile-His-Pro-Ala | |
CS-0103 |
[Sar1] Angiotensin II |
Sar-Arg-Val-Tyr-Ile-His-Pro-Phe | |
CS-0104 |
[Sar1]-Angiotensin I/II(1-7)amide |
Sar-Arg-Val-Tyr-Ile-His-Pro-NH2 | |
CS-0105 |
[Sar1,Gly8]-Angiotensin II |
Sar-Arg-Val-Tyr-Ile-His-Pro-Gly | |
CS-0106 |
[Sar1,Ile4,8]-Angiotensin II |
Sar-Arg-Val-Ile-Ile-His-Pro-Ile | |
CS-0107 |
[Sar9]Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH2 | |
CS-0108 |
[Sar1,Thr8]-Angiotensin II |
Sar-Arg-Val-Tyr-Ile-His-Pro-Thr | |
CS-0109 |
[Sar1,Val5,Ala8]-Angiotensin II |
Sar-Arg-Val-Tyr-Val-His-Pro-Ala | |
CS-0110 |
Sauvagine, frog |
Pyr-Gly-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Ser-Leu-Glu-Leu-Leu-Arg-Lys-Met-Ile-Glu-Ile-Glu-Lys-Gln-Glu-Lys-Glu-Lys-Gln-Gln-Ala-Ala-Asn-Asn-Arg-Leu-Leu-Leu-Asp-Thr-Ile-NH2 | |
CS-0111 |
Schizophrenia Related Peptide |
Thr-Val-Leu | |
CS-0112 |
SCPA |
Ala-Arg-Pro-Gly-Tyr-Leu-Ala-Phe-Pro-Arg-Met-NH2 | |
CS-0113 |
SCPB |
Met-Asn-Tyr-Leu-Ala-Phe-Pro-Arg-Met-NH2 | |
CS-0114 |
Scrambled TRAP Fragment |
Phe-Ser-Leu-Leu-Arg-Asn-NH2 | |
CS-0115 |
Scyliorhinin I, amide, dogfish |
Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | |
CS-0116 |
Scyliorhinin II, amide ,dogfish |
Ser-Pro-Ser-Asn-Ser-Lys-Cys-Pro-Asp-Gly-Pro-Asp-Cys-Phe-Val-Gly-Leu-Met-NH2(Disulfide bridge Cys7-Cys13 ) | |
CS-0117 |
Scyliorhinin I, Scy I; Shark Substance P Related Peptide |
Ala-Lys-Phe-Asp-Lys-Phe-Tyr-Gly-Leu-Met | |
CS-0118 |
Secretin-Lys(Biotin), human |
His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-Lys(Biotin) | |
| CS-0010 | Secretin, porcine | His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2 | |
CS-0119 |
Secretin (5-27), porcine |
Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-nh2 | |
CS-0120 |
Secretin (rat) |
His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Gln-Asp-Ser-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2 | 121028-49-7 |
CS-0041 |
Secretin Human | His-Ser-Asp-Gly-Thr-Phe-Thr-Ser-Glu-Leu-Ser-Arg-Leu-Arg-Glu-Gly-Ala-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Gly-Leu-Val-NH2 | 108153-74-8 |
CS-0121 |
Selectin |
Cys-Gln-Lys-Leu-Asp-Lys-Ser-Phe-Ser-Met-Ile-Lys | |
| CS-0002 | Semax | Met-Glu-His-Phe-Pro-Gly-Pro | 80714-61-0 |
CS-0122 |
Sendai virus Nucleoprotein Fragment 321-336 |
His-Gly-Glu-Phe-Ala-Pro-Gly-Asn-Tyr-Pro-Ala-Leu-Trp-Ser-Tyr-Ala | 133531-91-6 |
CS-0123 |
Sendai Virus Nucleoprotein(SV9), 324-332 |
Phe-Ala-Pro-Gly-Asn-Tyr-Pro-Ala-Leu | |
CS-0124 |
SEQ ID NO:549 |
Phe-Leu-Gly-Lys-Ile-Trp-Pro-Ser-Tyr-Lys | |
CS-0125 |
[D-Ser1]-ACTH(1-24), human |
D-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Lys-Lys-Arg-Arg-Pro-Val-Lys-Val-Tyr-Pro | |
CS-0126 |
Ser-Ala-SAP-IIB |
Ser-Ala-Lys-Leu-Cys-Pro-Gly-Gly-Asn-Cys-Val (Disulfide bond) | |
CS-0127 |
[Ser8]-GLP-1(7-36)amide(human, bovine, guinea pig, mouse, rat) |
His-Ser-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 | |
CS-0128 |
[D-Ser14]-Humanin (HN) |
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-D-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-arg-Arg-Ala | |
CS-0129 |
[Ser4,Ile8]-Oxytocin |
Cys-Tyr-Ile-Ser-Asn-Cys-Pro-Ile-Gly-NH2 (Disulfide bridge Cys1-Cys6） | |
CS-0130 |
[D-Ser2]Leu-Enkephalin-Thr |
Tyr-D-Ser-Gly-Phe-Leu-Thr | |
| CS-0039 | Sermorelin acetate | 86168-78-7 | |
CS-0131 |
[Ser2]-Neuromedin C |
Gly-Ser-His-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CS-0132 |
[Ser140]-Myelin Proteolipid Protein (139-151) (depalmitoylated), human, bovine, dog, mouse, rat |
His-Ser-Leu-Gly-Lys-Trp-Leu-Gly-His-Pro-Asp-Lys-Phe | |
CS-0133 |
[Ser25]-PKC(19-31) |
Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val | |
CS-0134 |
[Ser25]-PKC(19-31), biotinylated |
Lys(Biotin)-Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val | |
CS-0136 |
[Ser25]-PKC(19 - 36) Substrate |
Arg-Phe-Ala-Arg-Lys-Gly-Ser-Leu-Arg-Gln-Lys-Asn-Val-His-Glu-Val-Lys-Asn | |
| CS-0018 | [D-Ser13]-Somatostatin-14 | Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-D-Ser-Cys (Disulfide bridge Cys3-Cys14) | |
CS-0135 |
Serum Thymic Factor |
Pyr-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn | |
CS-0137 |
S-F-L-L-R |
Ser-Phe-Leu-Leu-Arg | |
CS-0138 |
SH2 Domain Ligand (1) |
Ac-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 | |
CS-0139 |
SH2 Domain Ligand (2) |
Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu | |
CS-0140 |
SH2 Domain Ligand (3) |
Biotin-LC-Glu-Pro-Gln-pTyr-Glu-Glu-Ile-Pro-Ile-Tyr-Leu | |
CS-0141 |
SH2 Domain Ligand (4) |
Ac-pTyr-Tyr-pTyr-Ile-Glu | |
CS-0142 |
SH2 Domain Ligand (5) |
BiotinLC-Tyr(PO3H2)-Glu-Glu-Ile | |
CS-0143 |
sHNG, [Gly14]-HN, [Gly14]-Humanin |
Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala | |
| CS-0021 | Sialokinin-2 | Asp-Thr-Gly-Asp-Lys-Phe-Tyr-Gly-Leu-Met-NH2 | |
CS-0144 |
S-I-G-S-L-A-K |
Ser-Ile-Gly-Ser-Leu-Ala-Lys | |
| CS-0022 | Simian Virus 40 Large Tumor Antigen Amino-Terminal Peptide | AC-Met-Asp-Arg-Val-Leu-Ser-Arg-Tyr | |
| CS-0042 | Sincalide | 25126-32-3 | |
CS-0145 |
SIVmac239-1 |
Met-Gly-Val-Arg-Asn-Ser-Val-Leu-Ser-Gly-Lys-Lys-Ala-Asp-Glu | |
CS-0146 |
SIVmac239-2 |
Asn-Ser-Val-Leu-Ser-Gly-Lys-Lys-Ala-Asp-Glu-Leu-Glu-Lys-Ile | |
CS-0147 |
SIVmac251(gp140)Fragment(171-190)[Cys] |
Lys-Phe-Thr-Met-Thr-Gly-Leu-Lys-Arg-Asp-Lys-Thr-Lys-Glu-Tyr-Asn-Glu-Thr-Trp-Tyr-Cys | |
| CS-0023 | δ Sleep Inducing Peptide | Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | |
CS-0148 |
SL9, HIV-1 p17(77-85) |
Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu | |
CS-0149 |
SKIGKV-NH2 |
Ser-Lys-Ile-Gly-Lys-Val-NH2 | |
CS-0150 |
SMAP 29, Sheep Myeloid Antimicrobial Peptide 29 |
Arg-Gly-Leu-Arg-Arg-Leu-Gly-Arg-Lys-Ile-Ala-His-Gly-Val-Lys-Lys-Tyr-Gly-Pro-Thr-Val-Leu-Arg-Ile-Ile-Arg-Ile-Ala-Gly | |
CS-0151 |
SMCX(963-973)(human) |
Ser-Pro-Ala-Val-Asp-Lys-Ala-Gln-Ala-Glu-Leu | |
CS-0152 |
SMCY(950-960)(human) |
Ser-Pro-Ser-Val-Asp-Lys-Ala-Arg-Ala-Glu-Leu | |
CS-0153 |
Somatostatin-14 |
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys3-Cys14) | |
CS-0154 |
Somatostatin-14(2-9) |
Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys | |
CS-0155 |
Somatostatin-14(3-10) |
Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr | |
CS-0156 |
Somatostatin-14(3-14) |
Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bond) | |
CS-0157 |
Somatostatin-14(7-14) |
Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys | |
CS-0158 |
Somatostatin-25 |
Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide bridge: Cys14-Cys25) | |
CS-0159 |
Somatostatin-28 |
Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide bridge Cys17-Cys28) | 73032-94-7 |
CS-0160 |
Somatostatin-28(1-12) |
Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu | |
CS-0161 |
Somatostatin-28(1-14) |
Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys | |
CS-0162 |
Somatostatin-14(reduced) |
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys | |
CS-0163 |
Sodefrin acetate |
Ser-Ile-Pro-Ser-Lys-Asp-Ala-Leu-Leu-Lys | 161928-96-7 |
| CS-0044 | Somatostatin acetate | 38916-34-6 | |
CS-0164 |
Somatostatin Tumor Inhibiting Analog |
D-ß-Nal-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-NH2 (Disulfide bridge Cys2-Cys7 ) | |
| CS-0037 | SP1 | Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly | |
| CS-0040 | SP2 | Gly-Phe-Arg-Leu-Thr-Asn-Phe-Gly-Tyr-Phe-Glu-Pro-Gly-Lys | |
| CS-0043 | Speract | Gly-Phe-Asp-Leu-Asn-Gly-Gly-Gly-Val-Gly | |
CS-0165 |
Spinorphin, bovine |
Leu-Val-Val-Tyr-Pro-Trp-Thr | |
CS-0166 |
SRC-1(682-697) |
Ser-Leu-Thr-Ala-Arg-His-Lys-Ile-Leu-His-Arg-Leu-Leu-Gln-Glu-Gly | |
| CS-0055 | SRC Kinase Substrate | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly | |
| CS-0215 | SRC Kinase Substrate, amide | Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly-NH2 | |
CS-0167 |
STAL-2 |
Ser-Phe-Leu-Leu-Arg-Asn-NH2 | |
CS-0168 |
Staphylococcal Alpha-Toxin P1 |
Lys-Thr-Gly-Asp-Leu-Val-Thr-Tyr-Asp-Lys-Glu-Asn-Gly | |
CS-0169 |
Steroid Receptor Co-Factor Peptide |
Leu-Thr-Glu-Arg-His-Lys-Ile-Leu-His-Arg-Leu-Leu-Gln-Glu | |
CS-1070 |
Steroidogenesis-Activator Polypeptide (rat) |
Ile-Val-Gln-Pro-Ile-Ile-Ser-Lys-Leu-Tyr-Gly-Ser-Gly-Gly-Pro-Pro-Pro-Thr-Gly-Glu-Glu-Asp-Thr-Asp-Glu-Lys-Lys-Asp-Glu-Leu | |
| CS-0216 | Stresscopin, human | Thr-Lys-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2 | |
CS-0171 |
Stresscopin-Related Peptide(free acid)(human) |
His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val | |
CS-0172 |
Stresscopin-Related Peptide, human |
His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2 | |
CS-0173 |
Stresscopin-Related Peptide(6-43)(human) |
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2 | |
CS-0174 |
Sturgeon F |
Phe-Gly-Gly-Phe-Met-Lys-Gly-Lys-Tyr-Gly-Tyr | |
| CS-0217 | α-Substance IB | Arg-Gly-Pro-Phe-Pro-Ile | |
CS-0175 |
Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
| CS-0218 | Substance P(1-4) | Arg-Pro-Lys-Pro | 57468-16-3 |
CS-0176 |
Substance P(1-7) |
Arg-Pro-Lys-Pro-Gln-Gln-Phe | |
CS-0177 |
Substance P(1-9) |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly | |
CS-0178 |
Substance P(7-11) |
Phe-Phe-Gly-Leu-Met-NH2 | |
CS-0179 |
Substance P(9-11) |
Gly-Leu-Met-NH2 | |
CS-0180 |
Substance P(2-11)/Deca-Substance P |
Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CS-0181 |
Substance P, Free Acid |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met | |
CS-0182 |
Substance P-Gly-Lys-Arg |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Gly-Lys-Arg | |
CS-0183 |
Substance P(5-11)/Hepta-Substance P |
Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CS-0184 |
Substance P(6-11)/Hexa-Substance P |
Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CS-0185 |
Substance P-methyl ester |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-Ome | |
CS-0186 |
Substance P(3-11)/Nona-Substance P |
Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CS-0187 |
Substance P(4-11)/Octa-Substance P |
Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CS-0188 |
Substance P reversed sequence |
Met-Leu-Gly-Phe-Phe-Gln-Gln-Pro-Lys-Pro-Arg-NH2 | |
CS-0189 |
Suc-APA-pNA |
Suc-Ala-Pro-Ala-pNA | |
CS-0190 |
Succinyl-(Glu9,Ala11,15)-Endothelin-1(8-21) |
Suc-Asp-Glu-Glu-Ala-Val-Tyr-Phe-Ala-His-Leu-Asp-Ile-Ile-Trp | |
CS-0191 |
Suc-LEPF-pNA |
Suc-Leu-Glu-Pro-Phe-pNA | |
CS-0192 |
Suc-RGPF-pNA |
Suc-Arg-Gly-Pro-Phe-pNA | |
CS-0193 |
Suc-SDPF-pNA |
Sue-Ser-Asp-Pro-Phe-pNA | |
| CS-0024 | Sulfo-NHS | 106627-54-7 | |
| CS-0056 | Sulfosuccinimidyl biotin | 119616-38-5 | |
CS-0194 |
SV40 NLS |
Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly | |
CS-0195 |
SV40 Nuclear Transport Signal Peptide Analog |
Cys-Gly-Tyr-Gly-Pro-Lys-Lys-Lys-Arg-Lys-Val-Gly-Gly | |
CS-0196 |
Synapsin I-derived peptide |
Leu-Arg-Arg-Arg-Leu-Ser-Asp-Ala-Asn-Phe-NH2 | |
CS-0197 |
Synaptobrevin-2(73-79)(human, bovine, mouse, rat) |
Ala-Ser-Gln-Phe-Glu-Thr-Ser | |
CS-0198 |
Synaptobrevin-2(75-78)(human, bovine, mouse, rat) |
Gln-Phe-Glu-Thr | |
CS-0199 |
Syntide 2 |
Pro-Leu-Ala-Arg-Thr-Leu-Ser-Val-Ala-Gly-Leu-Pro-Gly-Lys-Lys | 108334-68-5 |
| CS-0219 | Systemin | Ala-Val-Gln-Ser-Lys-Pro-Pro-Ser-Lys-Arg-Asp-Pro-Pro-Lys-Met-Gln-Thr-Asp | |
| CT-0011 | T22 | Arg-Arg-Trp-Cys-Tyr-Arg-Lys-Cys-Tyr-Lys-Gly-Tyr-Cys-Tyr-Arg-Lys-Cys-Arg-NH2(Disulfide bridge: Cys4 and Cys17/Cys8 and Cys13) | |
CT-0668 |
γ-TAC4(32 - 50) |
Ala-Glu-Thr-Trp-Glu-Gly-Ala-Gly-Pro-Ser-Ile-Gln-Leu-Gln-Leu-Gln-Glu-Val-Lys | |
CT-0669 |
TACE(ADAM-17) |
Mca-Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg-Lys(Dnp)-NH2 | |
CT-0670 |
Tachykinin(111-129)Beta-Prepro(Human) |
Ala-Leu-Asn-Ser-Val-Ala-Tyr-Glu-Arg-Ser-Ala-Met-Gln-Asn-Tyr-Glu-Arg-Arg-Arg | |
CT-0671 |
γ-TAC4(30 - 61)-NH2 |
Thr-Glu-Ala-Glu-Thr-Trp-Glu-Gly-Ala-Gly-Pro-Ser-Ile-Gln-Leu-Gln-Leu-Gln-Glu-Val-Lys-Thr-Gly-Lys-Ala-Ser-Gln-Phe-Phe-Gly-Leu-Met-NH2 | |
CT-0672 |
TAT |
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-NH2 | |
CT-0673 |
TAT 2-4 |
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly | |
CT-0674 |
TA-0910, taltirelin |
1-methyl-4,5-dihydroorotyl-His-Pro-NH2 | |
| CT-0340 | TATU | 873798-09-5 | |
CT-0675 |
Tax8, HTLV -1(12-19) |
Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val | 125700-67-6 |
CT-0676 |
Tax9, HTLV -1(11-19) |
Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val | 94780-35-9 |
CT-0277 |
TCFH |
94790-35-9 |
|
CT-0678 |
TET 830 modified/T – helper epitope from tetanus toxoid |
Ala-Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu | |
| CT-0267 | Teriparatide acetate | 52232-67-4 | |
| CT-0269 | Terlipressin acetate | 14636-12-5 | |
| CT-0451 | Tetracosactide acetate | 16960-16-0 | |
| CT-0088 | TFFH | 164298-23-1 | |
CT-0679 |
TGF a(34-43)(rat) |
Cys-His-Ser-Gly-Tyr-Val-Gly-Val-Arg-Cys(Disulfide bridge:Cys1-Cys10) | |
CT-0680 |
[Thr6]-Bradykinin |
Arg-Pro-Pro-Gly-Phe-Thr-Pro-Phe-Arg | |
CT-0681 |
[Thr4, Gly7]-Oxytocin |
Cys-Tyr-Ile-Thr-Asn-Cys-Gly-Leu-Gly-NH2 (Disulfide bridge Cys1-Cys6 ) | |
CT-0682 |
[D-Thr2]Leu-Enkephalin-Thr |
Tyr-D-Thr-Gly-Phe-Leu-Thr | |
CT-0683 |
[Thr30]-Neuropeptide Y, human |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Thr-Ile-Thr-Arg-Gln-Arg-Tyr-NH2 | |
CT-0684 |
[Thr46]-Osteocalcin(45-49)(human) |
Phe-Thr-Gly-Pro-Val | |
| CT-0271 | Thymopentin | 69558-55-0 | |
| CT-0273 | Thymosin alpha1 acetate | 62304-98-7 | |
| CT-0275 |
Thymosin beta4 acetate | 77591-33-4 | |
CT-0685 |
TIP 39(39 mer) |
Ser-Leu-Ala-Leu-Ala-Asp-Asp-Ala-Ala-Phe-Arg-Glu-Arg-Ala-Arg-Leu-Leu-Ala-Ala-Leu-Glu-Arg-Arg-His-Trp-Leu-Asn-Ser-Tyr-Met-His-Lys-Leu-Leu-Val-Leu-Asp-Ala-Pro | |
CT-0686 |
TNF-α(10-36)(human) |
Asp-Lys-Pro-Val-Ala-His-Val-Val-Ala-Asn-Pro-Gln-Ala-Glu-Gly-Gln-Leu-Gln-Trp-Leu-Asn-Arg-Arg-Ala-Asn-Ala-Leu | |
CT-0687 |
TNF-α(31-45), human |
Arg-Arg-Ala-Asn-Ala-Leu-Leu-Ala-Asn-Gly-Val-Glu-Leu-Arg-Asp | |
CT-0688 |
TNF-α(46-65) (human) |
Asn-Gln-Leu-Val-Val-Pro-Ser-Glu-Gly-Leu-Tyr-Leu-Ile-Tyr-Ser-Gln-Val-Leu-Phe-Lys | |
CT-0689 |
TNF-α(71-82), human |
Ser-Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | |
CT-0690 |
TNF-α(72-82), human |
Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg | |
CT-0691 |
TNF-α(78-96)(human) |
His-Thr-Ile-Ser-Arg-Ile-Ala-Val-Ser-Tyr-Gln-Thr-Lys-Val-Asn-Leu-Leu-Ser-Ala | |
| CT-0280 | TNTU | 125700-73-4 | |
CT-0692 |
N(p-Tosyl)-GPR-pNA |
N(p-Tosyl)-Gly-Pro-Arg-pNA | |
| CT-0341 | 1-Tosylimidazole | 2232-08-8 | |
| CT-0281 |
TOTU |
136849-72-4 | |
| CT-0285 | TPTU | 125700-71-2 | |
CT-0693 |
Transduction Peptide 1 (α II) |
Ser-Ser-Leu-Thr-Ser-Arg-Asp-Phe-Gly-Ser-Trp-Tyr-Ala-Ser-Arg | |
CT-0694 |
Transforming Growth Factor ß1 Peptide, TGF-ß1 (60-66), amide |
Lys-Val-Leu-Ala-Leu-Tyr-Asn-Lys-NH2 | |
CT-0695 |
Transglutaminase Substrate,biotinylated |
BiotinThr-Val-Gln-Gln-Glu-Leu | |
CT-0696 |
TRAP-6(2-6) |
Phe-Leu-Leu-Arg-Asn | |
CT-0697 |
TRAP-14 |
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe | |
CT-0698 |
TRAP-5 amide |
Ser-Phe-Leu-Leu-Arg-NH2 | |
CT-0699 |
TRAP-14 amide |
Ser-Phe-Leu-Leu-Arg-Asn-Pro-Asn-Asp-Lys-Tyr-Glu-Pro-Phe-NH2 | |
| CT-1031 | TRH | Pyr-His-Pro-NH2 | |
CT-0700 |
TRH-AMC |
Pyr-His-Pro-AMC | |
CT-0701 |
TRH, Free Acid |
Pyr-His-Pro | |
CT-0702 |
TRH-Gly |
Pyr-His-Pro-Gly | |
CT-0703 |
TRH-SH Pro |
Cys-Lys-Arg-Gln-His-Pro-Gly-Lys-Arg-Cys | |
| CT-0276 | Triptorelin
acetate |
57773-63-4 | |
CT-0704 |
Triptorelin, [DTrp6]-LH-RH,Amide |
Glp-His-Trp-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2 | |
| CT-0319 | 3-(Tritylmercapto)propionic acid | 27144-18-9 | |
CT-0705 |
[Trp7,β-Ala8]-Neurokinin A(4-10) |
Asp-Ser-Phe-Trp-β-Ala-Leu-Met-NH2 | |
CT-0706 |
[Trp3,Arg5]-Ghrelin(1-5) |
Gly-Ser-Trp-Phe-Arg | |
CT-0707 |
[Trp63, 64] - C3a(63 - 77) |
Trp-Trp-Gly-Lys-Lys-Tyr-Arg-Ala-Ser-Lys-Leu-Gly-Leu-Ala-Arg | |
CT-0708 |
[D-Trp8,D-Cys14]-Somatostatin-14 |
Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-D-Cys (Disulfide bridge Cys3-Cys14) | |
CT-0709 |
[Trp4]-Kemptide |
Leu-Arg-Arg-Trp-Ser-Leu-Gly | |
CT-0710 |
[D-Trp2] Met-Enkephalin, amide |
Tyr-D-Trp-Gly-Phe-Met-NH2 | |
CT-0711 |
D-Trp-gamma MSH |
Tyr-Val-Met-Gly-His-Phe-Arg-D-Trp-Asp-Arg-Phe-Gly | |
CT-0712 |
[D-Trp32]-Neuropeptide Y(human) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-D-Trp-Arg-Gln-Arg-Tyr-NH2 | |
CT-0713 |
[D-Trp34]-Neuropeptide Y, human; [D-Trp34]-NPY, human |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-Thr-Arg-D-Trp-Arg-Tyr-NH2 | |
CT-0714 |
[D-Trp32]-Neuropeptide Y(porcine) |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Leu-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-Tyr-Ile-Asn-Leu-Ile-D-Trp-Arg-Gln-Arg-Tyr-NH2 | |
CT-0715 |
[Trp11]-Neurotensin |
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Trp-Ile-Leu | |
CT-0716 |
[Trp11] Neurotensin(8-13) |
Arg-Arg-Pro-Trp-Ile-Leu | |
CT-0717 |
[D-Trp11]-Neurotensin |
Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Trp-Ile-Leu | |
CT-0718 |
[D-Trp8]-Somatostatin-14 |
Ala-Gly-Cys-Lys-Asn-Phe-Phe-D-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge Cys3-Cys14) | |
CT-0719 |
[D-Trp2,7,9]-Substance P |
Arg-D-Trp-Lys-Pro-Gln-Gln-D-Trp-Phe-D-Trp-Leu-Met-NH2 | |
CT-0720 |
[D-Trp12,Tyr34]-pTH(7-34)amide(bovine) |
Phe-Met-His-Asn-Leu-D-Trp-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | |
CT-0721 |
Tryptophan Motif Peptide |
Gly-Gly-Trp-Ser-His-Trp-NH2 | |
| CT-0284 | TSNT | 77451-51-5 | |
| CT-0282 | TSTU | 105832-38-0 | |
CT-0722 |
Tuftsin |
Thr-Lys-Pro-Arg | |
CT-0723 |
ε-TxIX12 |
Glu-Cys-Cys-Glu-Asp-Gly-Trp-Cys-Cys-Thr-Ala-Ala | |
CT-0724 |
Type B Allatostatin |
Ala-Tyr-Ser-Tyr-Val-Ser-Glu-Tyr-Lys-Arg-Leu-Pro-Val-Tyr-Asn-Phe-Gly-Leu-NH2 | |
CT-0725 |
[Tyr15]-ACTH (7-15) |
Phe-Arg-Trp-Gly-Lys-Pro-Val-Gly-Tyr | |
CT-0726 |
[Tyr1] Adipokinetic Hormone, locust |
Tyr-Leu-Asn-Phe-Thr-Pro-Asn-Trp-Gly-Thr-NH2 | |
CT-0727 |
[Tyr69, Ala71, 72, Lys74]-C3a(69-77) |
Tyr-Ala-Ala-Ala-Leu-Lys-Leu-Ala-Arg | |
CT-0728 |
[D-Tyr6, β-Ala11, β-Phe13, Nle14]-Bombesin |
Pyr-Gln-Arg-Leu-Gly-D-Tyr-Gln-Trp-Ala-Val-Beta-Ala-His-β-Phe-Nle-NH2 | |
CT-0729 |
[Tyr0]-Apelin-13 (human, bovine, mouse, rat) |
Tyr-Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe | |
CT-0730 |
[Tyr8]-Atrial Natriuretic Peptide (5-27), rat; [Tyr8]-Atriopeptin II, rat |
Ser-Ser-Cys-Tyr-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg (Disulfide bridge Cys3-Cys19 ) | |
CT-0731 |
[Tyr0]-Atriopeptin II(rat) |
Tyr-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg (Disulfide bridge Cys4-Cys20 ) | |
CT-0732 |
[Tyr0]-BNP-32(human) |
Tyr-Ser-Pro-Lys-Met-Val-Gln-Gly-Ser-Gly-Cys-Phe-Gly-Arg-Lys-Met-Asp-Arg-Ile-Ser-Ser-Ser-Ser-Gly-Leu-Gly-Cys-Lys-Val-Leu-Arg-Arg-His (Disulfide bridge: Cys 11-Cys 27) | |
CT-0733 |
[Tyr4]-Bombesin |
Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH2 | |
CT-0734 |
[Tyr8] Bradykinin |
Arg-Pro-Pro-Gly-Phe-Ser-Pro-Tyr-Arg | |
CT-0735 |
[Tyr27]-a-CGRP(27-37)(canine, mouse, rat) |
Tyr-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CT-0736 |
[Tyr0]-α-CGRP, human |
Tyr-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH2 (Disulfide bridge: Cys 2-Cys 7) | |
CT-0737 |
[Tyr22]-α-CGRP(22 - 37), rat |
Tyr-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 | |
CT-0738 |
[Tyr0]-α-CGRP, [Tyr0]-α-CGRP, rat |
Tyr-Ser-Cys-Asn-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asp-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Glu-Ala-Phe-NH2 (Disulfide bridge: Cys 2-Cys 7) | |
CT-0739 |
[Tyr0]-C-Peptide(dog) |
Tyr-Glu-Val-Glu-Asp-Leu-Gln-Val-Arg-Asp-Val-Glu-Leu-Ala-Gly-Ala-Pro-Gly-Glu-Gly-Gly-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ala-Leu-Gln | |
CT-0740 |
[Tyr0]-C-Peptide(human) |
Tyr-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln | |
CT-0741 |
[Tyr0]-C-Type Natriuretic Peptide(32-53)(human, porcine, rat) |
Tyr-Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys (Disulfide bridge: Cys 7-Cys 23) | |
CT-0742 |
[Tyr15]Fibrinopeptide B |
Pyr-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-Tyr | |
CT-0743 |
[Tyr0]Fibrinopeptide A, human |
Tyr-Ala-Asp-Ser-Gly-Glu-Gly-Asp-Phe-Leu-Ala-Glu-Gly-Gly-Gly-Val-Arg | |
CT-0744 |
[Tyr15]Fibrinopeptide B, human |
Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg-Tyr | |
CT-0745 |
[Tyr0]Gastric Inhibitory Peptide(23-42), human; [Tyr22]Gastric Inhibitory Peptide(22-42), human |
Tyr-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys-Gly-Lys-Lys-Asn-Asp-Trp-Lys-His-Asn-Ile-Thr-Gln | |
CT-0746 |
[Tyr0]-Hypercalcemia Malignancy Factor (1-40) |
Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Ile-Arg-Ala-Thr-Ser | |
CT-0747 |
[Tyr4]-MBP (1-11) |
Ac-Ala-Ser-Gln-Tyr-Arg-Pro-Ser-Gln-Arg-His-Gly | |
CT-0748 |
[Tyr9]-β-MSH(porcine); (Tyr49)-β-Lipotropin(41-58)(porcine) |
Asp-Glu-Gly-Pro-Tyr-Lys-Met-Glu-Tyr-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | |
CT-0749 |
[Tyr0]-Neurokinin A |
Tyr-His-Lys-Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2 | |
CT-0750 |
[Tyr0]-Neurokinin B |
Tyr-Asp-Met-His-Asp-Phe-Phe-Val-Gly-Leu-Met-NH2 | |
CT-0751 |
[D-Tyr11]-Neurotensin |
Glp-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-DTyr-Ile-Leu | |
CT-0752 |
[Tyr8,Nle11]Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Nle-NH2 | |
CT-0753 |
[Tyr4,D-Phe12]-Bombesin |
Pyr-Gln-Arg-Tyr-Gly-Asn-Gln-Trp-Ala-Val-Gly-D-Phe-Leu-Met-NH2 | |
CT-0754 |
[Tyr65,Phe67]-C5a(65-74)(human) |
Tyr-Ser-Phe-Lys-Asp-Met-Gln-Leu-Gly-Arg | |
CT-0755 |
[Tyr6,D-Phe7,D-His9]-Substance P(6-11) |
Tyr-D-Phe-Phe-D-His-Leu-Met-NH2 | |
CT-0756 |
[Tyr0]-Prepro-Atrial Natriuretic Factor(104-123) (human) |
Tyr-Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg | |
CT-0757 |
[Tyr34]-pTH(7-34) amide(bovine) |
Phe-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ser-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Tyr-NH2 | |
CT-0758 |
[Tyr1]-pTH(1-34), human |
Tyr-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
CT-0759 |
[Tyr27]-pTH(27-48)(human) |
Tyr-Leu-Gln-Asp-Val-His-Asn-Phe-Val-Ala-Leu-Gly-Ala-Pro-Leu-Ala-Pro-Arg-Asp-Ala-Gly-Ser | |
CT-0760 |
[Tyr43]-pTH(43-68)(human) |
Tyr-Arg-Asp-Ala-Gly-Ser-Gln-Arg-Pro-Arg-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly | |
CT-0761 |
[Tyr52]-pTH(52-84)(human) |
Tyr-Lys-Lys-Glu-Asp-Asn-Val-Leu-Val-Glu-Ser-His-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | |
CT-0762 |
[Tyr63]-pTH(63-84), human |
Tyr-Glu-Lys-Ser-Leu-Gly-Glu-Ala-Asp-Lys-Ala-Asp-Val-Asn-Val-Leu-Thr-Lys-Ala-Lys-Ser-Gln | |
CT-0763 |
[Tyr1]-pTH(1-34 (rat) |
Tyr-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Ala-Ser-Val-Glu-Arg-Met-Gln-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe | |
CT-0764 |
[Tyr0]-pTH-Related Protein(1-34)(human, rat) |
Tyr-Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala | |
CT-0765 |
[Tyr36]-pTH-Related Protein(1-36)(human, rat) |
Ala-Val-Ser-Glu-His-Gln-Leu-Leu-His-Asp-Lys-Gly-Lys-Ser-Ile-Gln-Asp-Leu-Arg-Arg-Arg-Phe-Phe-Leu-His-His-Leu-Ile-Ala-Glu-Ile-His-Thr-Ala-Glu-Tyr | |
CT-0766 |
[Tyr1]Somatostatin |
Tyr-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys (Disulfide bridge: Cys3-Cys14） | |
CT-0767 |
[Tyr11]Somatostatin |
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys（Disulfide bridge: Cys3-Cys14） | |
CT-0768 |
[Tyr11]-Somatostatin-14 |
Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Tyr-Thr-Ser-Cys (Disulfide bridge: Cys 3-Cys 14) | |
CT-0769 |
[Tyr12]-Somatostatin-28(1-14) |
Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Tyr-Arg-Lys | |
CT-0770 |
[Tyr0]-Stresscopin(human) |
Tyr-Thr-Lys-Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2 | |
CT-0771 |
[Tyr0]-Stresscopin-Related Peptid (human) |
Tyr-His-Pro-Gly-Ser-Arg-Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-NH2 | |
CT-0772 |
[Tyr8]Substance P |
Arg-Pro-Lys-Pro-Gln-Gln-Phe-Tyr-Gly-Leu-Met-NH2 | |
CT-0773 |
[D-Tyr27,36, D-Thr32]-Neuropeptide Y, human |
Tyr-Pro-Ser-Lys-Pro-Asp-Asn-Pro-Gly-Glu-Asp-Ala-Pro-Ala-Glu-Asp-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-His-D-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-D-Tyr-NH2 | |
CT-0774 |
[D-Tyr27,36, D-Thr32]-Neuropeptide Y(27-36), rat; [D-Tyr27,36, D-Thr32]-NPY(27-36), rat |
D-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-D-Tyr-NH2 | |
CT-0775 |
[Tyr1]-TRAP-7 |
Tyr-Phe-Leu-Leu-Arg-Asn-Pro | |
CT-0776 |
[Tyr5,D-Trp6,8,9,Arg-NH210]-Neurokinin A(4-10) |
Asp-Tyr-D-Trp-Val-D-Trp-D-Trp-Arg-NH2 | |
CT-0777 |
Tyr-ACTH(4-9) |
Tyr-Met-Glu-His-Phe-Arg-Trp | |
CT-0778 |
Tyr-Amyloid P Component(27-38)amide |
Tyr-Glu-Lys-Pro-Leu-Gln-Asn-Phe-Thr-Leu-Cys-Phe-Arg-NH2 | |
CT-0779 |
Tyr-Bradykinin |
Tyr-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg | |
CT-0780 |
Tyr-CRF(human, rat) |
Tyr-Ser-Glu-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Ala-Arg-Ala-Glu-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Met-Glu-Ile-Ile-NH2 | |
CT-0781 |
Tyr-CRF(ovine) |
Tyr-Ser-Gln-Glu-Pro-Pro-Ile-Ser-Leu-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Glu-Val-Leu-Glu-Met-Thr-Lys-Ala-Asp-Gln-Leu-Ala-Gln-Gln-Ala-His-Ser-Asn-Arg-Lys-Leu-Leu-Asp-Ile-Ala-NH2 | |
CT-0782 |
Tyr-Leptin(26-39)(human) |
Tyr-Lys-Val-Gln-Asp-Asp-Thr-Lys-Thr-Leu-Ile-Lys-Thr-Ile-Val | |
CT-0783 |
Tyrosinase(206-214)(human) |
Ala-Phe-Leu-Pro-Trp-His-Arg-Leu-Phe | |
CT-0784 |
Tyrosinase(243-251)(human) |
Lys-Cys-Asp-Ile-Cys-Thr-Asp-Glu-Tyr | |
CT-0785 |
Tyrosinase(192-200)(human, mouse) |
Ser-Glu-Ile-Trp-Arg-Asp-Ile-Asp-Phe | |
CT-0786 |
Tyrosine Kinase Peptide 3 [RRLIEDAE-pY-AARG],Acetylated, Amide,Phosphorylated |
Ac-Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-pTyr-Ala-Ala-Arg-Gly-NH2 | |
CT-0787 |
Tyrosine Protein Kinase JAK 2 |
Val-Leu-Pro-Gln-Asp-Lys-Glu-pTyr-pTyr-Lys-Val-Lys-Glu-Pro-Gly-Glu | |
CT-0788 |
Tyr-PDGF A-Chain(194-211) |
Tyr-Gly-Arg-Pro-Arg-Glu-Ser-Gly-Lys-Lys-Arg-Lys-Arg-Lys-Arg-Leu-Lys-Pro-Thr | |
CT-0789 |
[Tyr38, Phe42,46]-Osteocalcin(38-49)(human) |
Tyr-Gln-Glu-Ala-Phe-Arg-Arg-Phe-Phe-Gly-Pro-Val | |
CT-0790 |
Tyr-Proinsulin C-Peptide(55-89)(human) |
Tyr-Arg-Arg-Glu-Ala-Glu-Asp-Leu-Gln-Val-Gly-Gln-Val-Glu-Leu-Gly-Gly-Gly-Pro-Gly-Ala-Gly-Ser-Leu-Gln-Pro-Leu-Ala-Leu-Glu-Gly-Ser-Leu-Gln-Lys-Arg | |
CT-0791 |
[Tyr1]-delta-Sleep Inducing Peptide |
Tyr-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu | |
CT-0792 |
Tyr-Somatostatin-14 |
Tyr-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide bridge: Cys4-Cys15) | |
CT-0793 |
Tyr-Somatostatin-28 |
Tyr-Ser-Ala-Asn-Ser-Asn-Pro-Ala-Met-Ala-Pro-Arg-Glu-Arg-Lys-Ala-Gly-Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-Ser-Cys(Disulfide bridge: Cys18-Cys29) | |
| CT-1032 | [Tyr0]-Urocortin(rat) | Tyr-Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | |
CT-0794 |
Tyr-Uroguanylin(rat) |
Tyr-Thr-Asp-Glu-Cys-Glu-Leu-Cys-Ile-Asn-Val-Ala-Cys-Thr-Gly-Cys(Disulfide bridge: Cys4 and Cys12/Cys7 and Cys15) | |
CT-0795 |
Tyr-W-MIF-1 |
Tyr-Pro-Trp-Gly-NH2 | |
CU-0008 |
Universal TT epitope P2(830-844) |
Gln-Tyr-Ile-Lys-Ala-Asn-Ser-Lys-Phe-Ile-Gly-Ile-Thr-Glu-Leu | |
CU-0022 |
Uperolein |
Pyr-Pro-Asp-Pro-Asn-Ala-Phe-Tyr-Gly-Leu-Met-NH2 | |
CU-0009 |
Urechistachykinin I |
Leu-Arg-Gln-Ser-Gln-Phe-Val-Gly-Ser-Arg-NH2 | |
CU-0010 |
Uremic Pentapeptide(U5-Peptide) |
Asp-Leu-Trp-Gln-Lys | |
CU-0011 |
Urocortin, human |
Asp-Asn-Pro-Ser-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | |
CU-0012 |
Urocortin II, human |
Ile-Val-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Gln-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Ala-Arg-Ala-Ala-Arg-Glu-Gln-Ala-Thr-Thr-Asn-Ala-Arg-Ile-Leu-Ala-Arg-Val-Gly-His-Cys-NH2 | |
CU-0013 |
Urocortin III, human |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Leu-Leu-Phe-Asn-Ile-Ala-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Gln-Ala-Ala-Ala-Asn-Ala-His-Leu-Met-Ala-Gln-Ile-NH2 | |
CU-0014 |
Urocortin II, mouse |
Val-Ile-Leu-Ser-Leu-Asp-Val-Pro-Ile-Gly-Leu-Leu-Arg-Ile-Leu-Leu-Glu-Gln-Ala-Arg-Tyr-Lys-Ala-Ala-Arg-Asn-Gln-Ala-Ala-Thr-Asn-Ala-Gln-Ile-Leu-Ala-His-Val-NH2 | |
CU-0015 |
Urocortin III, mouse |
Phe-Thr-Leu-Ser-Leu-Asp-Val-Pro-Thr-Asn-Ile-Met-Asn-Ile-Leu-Phe-Asn-Ile-Asp-Lys-Ala-Lys-Asn-Leu-Arg-Ala-Lys-Ala-Ala-Ala-Asn-Ala-Gln-Leu-Met-Ala-Gln-Ile-NH2 | |
CU-0016 |
Urocortin, rat |
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val-NH2 | |
CU-0017 |
Urocortin(rat)(free acid) |
Asp-Asp-Pro-Pro-Leu-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Thr-Leu-Leu-Glu-Leu-Ala-Arg-Thr-Gln-Ser-Gln-Arg-Glu-Arg-Ala-Glu-Gln-Asn-Arg-Ile-Ile-Phe-Asp-Ser-Val | |
CU-0018 |
Urodilatin CCC/ANP-95-126 |
Thr-Ala-Pro-Arg-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Met-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr(Disulfide bridge Cys11- Cys 27) | |
CU-0019 |
Uroguanylin, human |
Asn-Asp-Asp-Cys-Glu-Leu-Cys-Val-Asn-Val-Ala-Cys-Thr-Gly-Cys-Leu(Disulfide bridge: Cys4-Cys12,Cys7-Cys15) | |
CU-0020 |
Urotensin I |
Asn-Asp-Asp-Pro-Pro-Ile-Ser-Ile-Asp-Leu-Thr-Phe-His-Leu-Leu-Arg-Asn-Met-Ile-Glu-Met-Ala-Arg-Ile-Glu-Asn-Glu-Arg-Glu-Gln-Ala-Gly-Leu-Asn-Arg-Lys-Tyr-Leu-Asp-Glu-Val-NH2 | 83930-33-0 |
CU-0021 |
Urotensin II , goby |
Ala-Gly-Thr-Ala-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val (Disulfide bridge:Cys6-Cys11) | |
CU-0023 |
Urotensin II(Frog) |
Ala-Gly-Asn-Leu-Ser-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Val-OH(Disulfide bridge: Cys7-Cys12) | |
CU-0024 |
Urotensin II , human |
Glu-Thr-Pro-Asp-Cys-Phe-Trp-Lys-Tyr-Cys-Val(Disulfide bridge:Cys5-Cys10) | |
CU-0025 |
Urotensin II, rat; [Pyr110]-Prepro-Urotensin II (110-123),rat |
Glp-His-Gly-Thr-Ala-Pro-Glu-Cys-Phe-Trp-Lys-Tyr-Cys-Ile(Disulfide bridge: Cys8-Cys13) | |
CU-0026 |
Uru-TK II, Urechistachykinin II |
Ala-Ala-Gly-Met-Gly-Phe-Phe-Gly-Ala-Arg-NH2 | |
CV-0019 |
[Val35]-β-Amyloid(1-42) |
Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-Val-Val-Gly-Gly-Val-Val-I le-Ala | |
CV-0020 |
[Val671]-Amyloid b/A4 Protein Precursor770(667-676) |
Ser-Glu-Val-Lys-Val-Asp-Ala-Glu-Phe-Arg | |
CV-0021 |
[Val4]-Angiotensin III |
Arg-Val-Tyr-Val-His-Pro-Phe | |
CV-0022 |
[Val5] Angiotensin I, human |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-His-Leu | |
CV-0023 |
[Val5] Angiotensin II, human |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe | |
CV-0024 |
[Val5,Asn9]-Angiotensin I |
Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Asn-Leu | |
CV-0025 |
Val-Asp-(Arg8)-Vasopressin |
Val-Asp-Cys-Tyr-Phe-Gln-Asn-Cys-Pro-Arg-Gly-NH2 (Disulfide bridge: Cys3-Cys8) | 100930-18-5 |
CV-0026 |
[D-Val22] Big Endothelin-1 (16-38), human |
His-Leu-Asp-Ile-Ile-Trp-D-val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Leu-Gly-Ser-Pro-Arg-Ser | |
CV-0027 |
[Val3]-β-Casomorphin (1-4)amide(bovine) |
Tyr-Pro-Val-Pro-NH2 | |
CV-0028 |
Valorphin |
Val-Val-Tyr-Pro-Trp-Thr-Gln | |
CV-0029 |
Valosin Peptide (VQY), porcine |
Val-Gln-Tyr-Pro-Val-Glu-His-Pro-Asp-Lys-Phe-Leu-Lys-Phe-Gly-Met-Thr-Pro-Ser-Lys-Gly-Val-Leu-Phe-Tyr | |
CV-030 |
[D-Val22, Phe33] Big Endothelin-1(16-38), human |
His-Leu-Asp-Ile-Ile-Trp-D-Val-Asn-Thr-Pro-Glu-His-Val-Val-Pro-Tyr-Gly-Phe-Gly-Ser-Pro-Arg-Ser | |
CV-031 |
[Val438]-Tyrosinase(432-444)(human) |
Ser-Tyr-Leu-Gln-Asp-Ser-Val-Pro-Asp-Ser-Phe-Gln-Asp | |
CV-032 |
VA-ß-MSH, Lipotropin-γ, Proopiomelanocortin-derived |
Val-Ala-Ala-Glu-Lys-Lys-Asp-Glu-Gly-Pro-Tyr-Arg-Met-Glu-His-Phe-Arg-Trp-Gly-Ser-Pro-Pro-Lys-Asp | |
CV-0033 |
Vanilloid Receptor Subtype 1(VR1) |
Cys-Glu-Asp-Ala-Glu-Val-Phe-Lys-Asp-Ser-Met-Val-Pro-Gly-Glu-Lys | |
CV-0034 |
Vasoactive Intestinal Contractor[VIC] |
Cys-Ser-Cys-Asn-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridge: Cys1 and Cys11/Cys3 and Cys15 ) | |
CV-0035 |
Vasoactive Intestinal Constractor[VIC]; Endophilin Beta, Mouse |
Cys-Ser-Cys-Asn-Ser-Trp-Leu-Asp-Lys-Glu-Cys-Val-Tyr-Phe-Cys-His-Leu-Asp-Ile-Ile-Trp(Disulfide bridges Cys1-Cys15, Cys3-Cys11) | |
CV-0036 |
Vasoactive Intestinal peptide |
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
CV-0037 |
Vasonatrin Peptide(VNP) |
Gly-Leu-Ser-Lys-Gly-Cys-Phe-Gly-Leu-Lys-Leu-Asp-Arg-Ile-Gly-Ser-Met-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr ((Disulfide bridge: Cys6-Cys22) | |
CV-0013 |
Vasopressin acetate |
9034-50-8 |
|
CV-0038 |
V5 Epitope Tag |
Gly-Lys-Pro-Ile-Pro-Asn-Pro-Leu-Leu-Gly-Leu-Asp-Ser-Thr | |
CV-0039 |
Vesicular Stomatitis Virus peptide |
Arg-Gly-Tyr-Val-Tyr-Gln-Gly-Leu | |
CV-0040 |
VIP, Antagonist |
Lys-Pro-Arg-Arg-Pro-Tyr-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
CV-0041 |
VIP, guinea pig |
His-Ser-Asp-Ala-Leu-Phe-Thr-Asp-Thr-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Met-Lys-Lys-Tyr-Leu-Asn-Ser-Val-Leu-Asn-NH2 | |
CV-0042 |
VIP(6-28)(human, bovine,porcine, rat) |
Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
CV-0043 |
VIP(10-28)(human, bovine,porcine, rat) |
Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
CV-0044 |
VIP(1-12), human, porcine,rat |
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg | |
CV-0045 |
VIP, human, porcine, rat; VIP(28 amino acids) |
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-NH2 | |
CV-0046 |
VIP-Lys(Biotin), human,porcine, rat |
His-Ser-Asp-Ala-Val-Phe-Thr-Asp-Asn-Tyr-Thr-Arg-Leu-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Asn-Ser-Ile-Leu-Asn-Lys(Biotin) | |
CV-0047 |
VIP Receptor-Binding Inhibitor L-8-K |
Leu-Met-Tyr-Pro-Thr-Tyr-Leu-Lys | |
| CV-0054 | VLAL | Val-Leu-Ala-Leu-NH2 | |
CV-0048 |
VL9, RT, (346-354) |
Val-Ile-Tyr-Gln-Tyr-Met-Asp-Asp-Leu | |
CV-0049 |
VSV-G Peptide |
Tyr-Thr-Asp-Ile-Glu-Met-Asn-Arg-Leu-Gly-Lys | |
| CW-0001 | W-G | Trp-Gly | |
CW-0004 |
W-K-Y-M-V-M-NH2 |
Trp-Lys-Tyr-Met-Val-Met-NH2 | |
CW-0005 |
WWamide-1 |
Trp-Lys-Glu-Met-Ser-Val-Trp-NH2 | |
CW-0006 |
WWamide-2 |
Trp-Arg-Glu-Met-Ser-Val-Trp-NH2 | |
CW-0007 |
WWamide-3 |
Trp-Lys-Gln-Met-Ser-Val-Trp-NH2 | |
| CX-0018 | Xenin | Met-Leu-Thr-Lys-Phe-Glu-Thr-Lys-Ser-Ala-Arg-Val-Lys-Gly-Leu-Ser-Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu | |
CX-0009 |
Xenopsin |
Pyr-Gly-Lys-Arg-Pro-Trp-Ile-Leu | |
CX-0010 |
Xenopsin-Related Peptide 1(XP-1) |
His-Pro-Lys-Arg-Pro-Trp-Ile-Leu | |
CX-0011 |
Xenopsin-Related Peptide 2(XP-2) |
Phe-His-Pro-Lys-Arg-Pro-Trp-Ile-Leu | |
| CY-0003 | Y-A | Tyr-Ala | |
CY-0002 |
Y-R-G-D-S |
Tyr-Arg-Gly-Asp-Ser | 134282-68-1 |
| CY-0004 | dY-V-G | D-Tyr-Val-Gly | |
CZ-0152 |
Z-Ala-Ala-Leu-pNA |
Z-Ala-Ala-Leu-pNA | 61043-33-2 |
CB-0119 |
Z-(2Br)-OSu |
128611-93-8 |
|
CC-0201 |
Z-(2Cl)-OSu |
65853-65-8 |
|
CZ-0153 |
Z-D-E-V-D-AMC |
Z-Asp-Glu-Val-Asp-AMC | |
CZ-0154 |
Z-F-R-AMC |
Z-Phe-Arg-AMC | |
| CZ-0092 | Z-Gly-Gly-Ile-OH |
102601-54-7 | |
| CZ-0065 | Ziconotide
acetate |
H-Cys-Lys-Gly-Lys-Gly-Ala-Lys-Cys-Ser-Arg-Leu-Met-Tyr -Asp-Cys-Cys-Thr-Gly-Ser-Cys-Arg-Ser-Gly-Lys-Cys-NH2（Cys1-Cys16, Cys8-Cys20, Cys15-Cys25） |
107452-89-1 |
The above products we offer are intended for laboratory research use or production use only, not for human use.
These chemicals are not intended to use as food additives, drugs, cosmetics, household chemicals or other inappropriate applications.
The listing of a material on this site does not constitute a license to its use in infringement of any patent.